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ABSTRACT 
 
Each member of the protein kinase C (PKC) family activates cell signaling 
pathways with different and sometimes opposing cell functions, such as cell division, 
migration, or death.  Because of the importance of these processes in human diseases and 
disorders like cancer, stroke, and Alzheimer’s disease, there is a need for drugs which 
modify the action of PKC.  However, drug design is difficult due to the complicated 
nature of PKC regulation. 
To better understand the differential regulation of PKC activity, these studies 
probe the structure, dynamics, and reactivity of one of the domains responsible for PKC 
regulation, C1B.  C1B binds signaling molecules and translocates PKC to membranes in 
order to release the kinase domain from inhibition.  Mutagenesis and ligand-binding 
assays monitored with fluorescence and nuclear magnetic resonance (NMR) techniques 
show that a single variable residue in C1B dramatically affects the sensitivity to signal 
activators.  Investigation of the domain structure and dynamics using NMR revealed the 
identity of this residue alters the dynamics of the activator binding loops, without 
changing the structure.  NMR studies of the C1B variants in membrane-mimicking 
micelles showed this residue also changes the interaction of the regulatory domain with 
lipids.  These results demonstrate PKC isoforms have evolved specific functions by 
tuning dynamics and membrane affinity. 
Alternatively, PKC can be activated by reactive oxygen species by a mechanism 
that does not require binding of signaling molecules or membrane localization.  To 
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investigate the role of C1B in this type of signaling, the regulatory domain reactivity is 
monitored via NMR and gel electrophoresis.  These studies reveal a particular cysteine 
residue in C1B that is most reactive, an alternative conformation of C1B in which this 
residue is more exposed, and modification of C1B leads to unfolding and zinc loss.  
Because the regulatory domains are responsible for auto-inhibition of the kinase domain, 
C1B unfolding provides a plausible explanation for activation of PKC by reactive oxygen 
species. 
The relation of the intrinsic C1B properties to the activation of PKC can be used 
to develop drugs with a single mechanism and to better understand how closely related 
signaling proteins develop specific functions. 
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NOMENCLATURE 
 
14-doxyl PC 1-Palmitoyl-2-Stearoyl-(14-Doxyl)-sn-Glycero-3-Phosphocholine 
CPMG Carr-Purcell-Meiboom-Gill 
CRIP Cysteine-Rich Intestinal Protein 
DAG Diacylglycerol 
DARR Dipolar Assisted Rotational Resonance 
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HDex Hydrogen-Deuterium Exchange 
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IAC Iodoacetamide 
IPAP In-Phase Anti-Phase 
IPTG Isopropyl-D-1-Thiogalactopyranoside 
KSR Kinase Suppressor of Ras 
MES 2-(N-Morpholino)Ethanesulfonic Acid 
MRCK CDC42-Binding Protein Kinases 
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NMR Nuclear Magnetic Resonance 
NOE Nuclear Overhauser Effect 
OD Optical Density 
P13A Phorbol 13-Acetate 
PAR 4-(2-Pyridylazo)-Resorcinol 
PC Phosphatidylcholine 
PDB Protein Data Bank 
PDB ID Protein Data Bank Identification Number 
PDBu Phorbol 12,13-Dibutyrate  
PE Phorbol Ester 
PEG-mal Polyethylene Glycol Maleimide 
PG Phosphatidylglycerol 
PKC Protein Kinase C 
PKD Protein Kinase D 
PLC Phospholipase C 
PRE Paramagnetic Relaxation Enhancement 
PS Phosphatidylserine 
Pyk2 Proline-Rich Tyrosine Kinase 2 
RACK Receptor for Activated C-Kinase 
RAG-1 Recombination Activating Gene Product 
Ras GRP Ras Guanyl Nucleotide-Releasing Protein 
RDC Residual Dipolar Coupling 
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sub-ns Sub-Nanosecond 
SUMO Small Ubiquitin-Like Modifer 
TCEP Tris(2-Carboxyethyl)phosphine 
WT Wild-Type 
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CHAPTER I  
INTRODUCTION 
 
PKC function and regulation 
Since the discovery of protein kinase C (PKC) as the target of the tumor 
promoting plant compounds called phorbol esters, it has been the subject of much 
research.  PKC is a family of highly regulated multi-modular serine/threonine kinases 
that act in cell signaling.  PKC proteins phosphorylate a diverse group of protein targets, 
playing a role in several cell signaling pathways such as: adhesion, migration, 
transformation, apoptosis, and cell cycle checkpoint.
1-3
  Regulation of signaling is 
achieved through maturation of PKC by phosphorylation,
4
 differential cell localization 
through interactions with other anchoring proteins,
5
 and an autoinhibitory region that 
responds to second messengers.  Misregulation of PKC has been implicated as a 
contributing factor to cardiovascular disease, cancer progression, mental illness, and 
Alzheimer’s disease.6-9  However, a better understanding of PKC regulation is required 
to effectively utilize PKC activation or inhibition as a disease therapy.  For this reason, 
this dissertation is focused on differentiating the roles that one of the domains in the 
autoinhibitory region plays in activation of PKC family members in the presence of 
various ligands/ activators. 
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Figure 1. Model of PKC autoinhibition.  “PS” represents the pseudo-substrate region.  
“N” and “C” mark the N- and C- termini.  Domains not to scale. 
 
 
 
A model of PKC regulation by the autoinhibitory region is shown in Figure 1.  
The N-terminal autoinhibitory region in the latent cytosolic PKC, places the pseudo-
substrate region in the catalytic active site located on the C-terminal kinase domain.  
This inhibits the activity of the mature phosphorylated form of PKC until the regulatory 
domains within the autoinhibitory region bind to second messengers.  This localizes the 
protein to the membrane and releases the pseudo-substrate domain so that the kinase 
domain is available to bind and phosphorylate the substrate.
10
  There are at least 10 
isoforms of PKC in humans which are divided into three sub-classes based upon the 
composition of the regulatory domains: conventional, novel, and atypical.   
Conventional PKC’s, such as α, βI, II, and γ, contain three independently folded 
and conserved domains in the regulatory region called C1A, C1B, and C2 (Figure 2).  
The C2 domain binds to calcium allowing it to associate with the phosphatidylserine 
(PS) containing plasma membrane.
11
  Next, the C1 domains bind to diacylglycerol 
(DAG), which releases the pseudo-substrate region to fully activate conventional PKC.
12
  
DAG and calcium are both products of phosphatidylinositol triphosphate cleavage by 
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phospholipase C (PLC), which makes conventional PKC isoforms unique in their ability 
to respond specifically to this signaling source. 
 
 
 
Figure 2. PKC subfamilies categorized by regulatory domains.  “PS” represents the 
pseudo-substrate region.  “N” and “C” mark the N- and C- termini.  Domains not to 
scale. 
 
 
 
Novel PKC isoforms (δ, ε, η, θ) shown in Figure 2 have a C2-like domain that 
does not bind calcium, and therefore C1A and C1B are solely responsible for membrane 
binding and activation.  However, the C2-like domain plays a role in PKC activation 
through protein-protein interactions and/or associates with acidic components in 
membranes.
13
  Due to higher DAG affinities, the novel PKC isoforms are localized to 
subcellular compartments which contain high local concentrations of DAG, such as the 
Golgi, endoplasmic reticulum, or nucleus, even with basal levels of PLC or phosphatidic 
acid phosphatase signaling.
14,15
  Some novel isoforms then translocate to the plasma 
membrane when DAG concentrations are high during PLC or phosphatidic acid 
phosphatase signaling similar to conventional isoforms.
16
 
Atypical PKC isoforms (ζ, ι) do not respond to changes in calcium or DAG 
concentrations because they do not contain a C2 domain and possess only a C1-like 
domain (Figure 1).  Atypical PKC isoforms are regulated through protein-protein 
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interactions which occur in regions of the regulatory domain, as well as interactions 
between the C1-like domain with the kinase domain or ceremide.
17,18
   
The arrangement of the domains in the latent PKC that promotes the pseudo-
substrate interaction with the active site is not known for any PKC isoforms.  Recently, 
the first structure of a complete PKC protein was determined to 4.0 Å resolution using x-
ray diffraction and small-angle X-ray scattering.
19
  However, because C2 was bound to 
calcium, this structure represents an intermediate in the activation pathway and does not 
contain any inter-regulatory domain interactions.  Binding and PKC activation studies 
have shown that a C1A to C2 domain interaction occurs in the absence of DAG 
signaling and maintains the PKC latent state.
20,21
  The binding interface and the changes 
that occur due to ligand binding have still yet to be elucidated.  The dynamics and 
flexibility between the domains as well as the overall instability makes studying the full 
length PKC difficult.  For this reason, the work presented here was carried out on either 
the C1B domain or the joint C1B-C2 domain, in attempts to apply the knowledge 
learned to the overall PKC activation mechanism. 
C1 domains 
There are 15 structures from different C1 domains deposited in the protein data 
bank (PDB), two are crystal structures and the rest were determined with NMR.  Figure 
3A shows the structures of the C1B domains from novel PKC determined by x-ray 
crystallography 
22
 and conventional PKC determined by NMR (PDB ID = 2ELI, lowest 
energy structure).  These structures demonstrate the common features seen for all known 
C1 structures: a -sheet core with a C-terminal -helix, two zinc coordination sites 
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which maintain the fold, and what is best described as an unzipped -sheet that forms 
two ligand binding loops referred to as 12 and 34.  The backbone structures are super-
imposable with an RMSD of 1.8 Å and the greatest variability is in the 34 ligand 
binding loop. 
In spite of the structural similarities, the affinity of C1 domains for DAG varies 
over several orders of magnitude between C1 domains from different isoforms and 
between C1A and C1B of the same isoform.
23,24
  The crystal structure of PKC C1B 
domain bound to a water soluble phorbol ester shows that the ligand is hydrogen bonded 
to the amide backbone of three residues in the ligand binding loops: T242, L251, and 
G253.
22
  Phorbol esters are tumor promoting plant compounds that constitutively 
activate PKC.  Ligand binding, either phorbol ester or DAG, is thought to conceal a 
hydrophilic patch between the loops allowing the hydrophobic side-chains to interact 
with membranes.  However, there are no structures available of DAG bound C1 or C1 
bound to any ligands in the presence of membrane-mimics.  Several non-DAG-binding 
C1 domains homologous to the atypical PKC isoforms (PKC and PKC) have also been 
identified, such as those in c-Raf, kinase suppressor of Ras (KSR), and Vav.  The loss of 
conventional DAG binding is attributed to either missing residues in the 34 loop (c-Raf 
and KSR)
25
 or replacement of the hydrophobic residues with hydrophilic residues (Vav 
and atypical PKC).
26,27
  While it is clear the 34 loop contributes to ligand binding, the 
relationship between the subtle differences in the loops of various C1 domains and the 
drastic difference in ligand affinities is unclear. 
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The sequence within the ligand binding loops of novel and conventional C1 
domains is 30% identical and 46% similar, compared to the overall 26% identity and 
50% similarity of the entire domain as shown in Figure 3B.  Conserved residues include 
the zinc coordination residues (highlighted in green), a PT pair at the C-terminal hinge of 
the 12 loop, and the QG motif on the C-terminal hinge of the 34 loop (all highlighted 
in pink).  Interestingly, only one of the residues hydrogen bonding to phorbol ester in the 
crystal structure is conserved amongst all phorbol ester binding C1 domains.  However, 
there is a distinct trend in the 22
nd
 C1 residue, located in the N-terminal hinge of the 34 
loop (labeled in Figure 3A and highlighted in yellow in Figure 3B).  C1 domains which 
contain a tryptophan at position 22 have a high affinity for DAG, such as those in novel 
PKC isoforms or conventional PKC C1A domains.  Conversely, conventional PKC C1B 
domains, with a tyrosine at position 22 bind weakly to DAG even though they bind 
tightly to phorbol ester.  Mutation of this residue, Tyr123 in the conventional C1B to 
Trp and Trp252 in the novel C1B to Tyr, led to reversed ligand affinity and 
specificity.
28
  This residue does not contact the ligand in any known C1-ligand 
complexes; therefore it is unclear why its identity affects ligand binding.  The work in 
chapter II attempts to elucidate the role that this residue plays to tune DAG affinity.  
This knowledge used in combination with the role of lipid binding determined in chapter 
III, will be a powerful tool in designing C1 domain isoform specific drugs. 
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Figure 3. C1 domain structure and sequence comparison.  A) Structure alignment of 
a C1B domains from a novel PKC (crystal structure PDB ID: 1PTQ) and a 
conventional PKC (NMR structure PDB ID: 2ELI) with the termini, secondary 
structure, and position 22 labeled. B) Sequence alignment of all C1A and C1B from 
novel (“n”) and conventional (“c”) PKC isoforms of Rattus norvegicus.  Zinc 
coordinating residues are highlighted in green, conserved loop residues in pink, and 
position 22 in yellow.  The ligand binding loops are labeled and underlined in nC1A.   
 
 
 
C1 domain as a drug target 
Since the discovery of the PKC membrane targeting C1 domain as the receptor 
for tumor-promoting phorbol esters, C1 has been an attractive drug target.  One of the 
major challenges with this approach is that in addition to the various C1 domain 
physiological ligands and functions, many of the C1 domains are promiscuous with 
several possible ligands.  The diacylglycerol-binding C1 domains of PKC have been 
reported to bind not only to phorbol ester, diacylglycerol (DAG), and their analogs, but 
also interact with macrocyclic lactones, indolactams, iridals, polyacetates, alcohols, and 
other proteins.  To complicate matters further, the affinity to a given ligand varies 
dramatically between the different domains.  For example, while both of the tandem C1 
domains from the PKC and isoforms have a high affinity for DAG, only the 
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first C1 domain (C1A) in PKC and PKC maintain this high affinity.  However, the 
second C1 domain (C1B) from PKC and PKC has a higher affinity to phorbol ester 
than the C1A domains.  The various PKC isoforms activate different signaling pathways, 
bringing about sometimes opposing cellular events.  An effective drug must be able to 
act specifically on the intended isoform, but there are still many questions as to what 
dictates C1 domain ligand affinities and specificities. 
In spite of these challenges, several natural products have been found to 
effectively target C1 and treat devastating human diseases.  Ingenol-3-angelate (PEP005) 
derived from plant sap has been used successfully as a topical treatment for skin 
cancers.
29
  It was shown to act via binding to the C1 domain to activate PKC30  In 
addition to prevention of tumor growth, marine microbe produced bryostatins are a 
promising treatment for cognitive impairment.  At low doses, bryostatin-1 selectively 
binds and activates C1 domains of PKC and PKC, which up-regulates the α-secretase 
amyloid processing pathway, decreasing the formation of plaques found in Alzheimer’s 
disease.
31
  Treatment of transgenic Alzheimer’s diseased mice with bryostatin-1 
prevented synaptic loss, plaque deposition, and memory deficits.
32
  Similarly, when 
given to rats after a stroke, bryostatin-1 improved learning and memory, prevented the 
loss of neurons, and restored the spines and synapses of dendrites.
33,34
  Prostratin, a C1 
domain-binding drug isolated from tree bark, has potential to eradicate HIV in infected 
individuals.  It has been shown to induce expression of latent HIV proviruses in T-cells, 
making infected cells susceptible to the current antiretroviral therapy.
35
  While treatment 
with prostratin activates multiple PKC isoforms, this effect has been attributed to 
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activation of novel PKC(s).
36
  These studies conducted using natural products 
demonstrate the potential human health benefit that could come of designing drugs to 
target C1 domains. 
Current efforts focus on chemical modification of these and other known C1 
ligands to increase PKC isoform specificity.  For example, compounds referred to as 
DAG-lactones are made by circularizing DAG and subsequent modification of the 
exposed chemical functional groups.  C1 domains bind to DAG-lactones with multiple 
orders of magnitude higher affinity than to DAG, and some have shown promising 
selectivity among the PKC isoforms.
37
  A branched DAG-lactone (HK654) reduced 
tumor growth in two human prostate cancer cell lines by specifically activating PKC, 
demonstrating the potential DAG derivatives have for development of cancer 
treatment.
38
 
Analogs of the naturally occurring high affinity ligands have also been made by 
substituting different functional groups;
39
 however, these molecules have a large number 
of asymmetric centers, resulting in complicated synthesis.  Studies using modified 
phorbol esters and the naturally occurring variations point to the hydrophobicity of the 
side-chain being a major factor dictating tumor promotion versus tumor inhibition.
40,41
  
Indolactam, a natural occurring tumor promoter, was modified to form benzolactam and 
subsequently to form 8-octyl-benzolactam-V9 which shows selective binding to the C1B 
domain of novel PKC isoforms and selectively translocates two of the novel PKC 
isoforms.
42
  As mentioned above, bryostatin has already been proven to be a useful drug 
without modification, however synthesized bryostatin analogs have been designed which 
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can be produced in larger quantities and exhibit isoform selectivity.
43
  Because C1 
domains are not only found in all twelve human PKC isoforms, but also several other 
signaling proteins, designing specific activators or inhibitors for this domain could have 
an even further reaching impact. 
Homologous DAG-binding C1 domains have been found in several other types 
of mammalian proteins such as protein kinase D (PKD), chimaerins, Ras guanyl 
nucleotide-releasing proteins (Ras GRP), Munc-13, DAG kinases, and the CDC42-
binding protein kinases (MRCK).  Like PKC, many of these protein families have 
potential as cancer treatment targets.  PKD inhibitors have proven effective against 
prostate and pancreatic cancer, but the search for selective inhibitors is still ongoing.
44
  
2‑chimaerin is down regulated in several types of cancer, and overexpression has been 
shown to stop breast cancer cell proliferation.
45
  Conversely, Ras GRP3 is overexpressed 
in several types of cancer, and down regulation led to a decreased cancer phenotype in a 
human prostate cancer cell line.
46
  DAG kinases regulate the other DAG signaling 
pathways by depleting DAG levels, and have recently been implicated in hepatocellular 
carcinoma progression.
47
  Knockdown of MRCK/ isoforms along with inhibition of 
ROCK prevented colorectal carcinoma cell invasion
48
 and decreased breast cancer cell 
invasion.
49
  The functional diversity of these C1 domains containing proteins and their 
link to multiple cancer types provides even more motivation for development of 
selective activators and inhibitors.  The work presented here is a significant step in 
determining factors that dictate the differences in affinity and specificity of C1 domains 
for ligands and lipids.  
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Zinc coordination in the C1 domain 
In addition to investigations of C1 domain ligand and lipid binding properties in 
Chapters II and III, properties of C1B that allow for activation of PKC by reactive 
oxygen species are also characterized in Chapter IV.  Results show a specific zinc-
coordinating cysteine residue makes C1B susceptible to reactive oxygen species.  The 
coordination number and geometry of this zinc site change depending on the 
environmental conditions.  In order to put this work into the context of the large field of 
zinc coordinating proteins, a brief introduction to the types and properties of zinc 
binding sites is presented here. 
C1 domains are just one of the many types of proteins which coordinate zinc.  It 
is estimated that 10% of the human proteome is made up of zinc binding proteins.
50
  
Zinc sites in proteins are classified according to their biological function as catalytic, 
regulatory, or structural zinc sites.  Catalytic zinc sites contain three or four protein 
ligands of histidine, glutamate, aspartate, or sometimes cysteine residues and almost 
always one water molecule.  To aid in catalysis, the zinc acts as a Lewis acid and the 
water is hydrolyzed to a hydroxide ion, polarized to act as a base, or displaced so that 
zinc stabilizes a negative reaction product.  A thorough review of catalytic zinc sites in 
all six types of enzyme families has been written by David Auld.
51
 
Regulatory zinc sites are found in proteins responsible for zinc storage or 
transport.  These proteins function to ensure zinc is available for the proteins that require 
it, but not free in an uncoordinated form in the cell because of its toxicity.
52
  This family 
varies wildly in the identity and number of residues coordinating zinc, in order to 
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accommodate both weak binding in the case of zinc transport and tight binding in the 
case of zinc scavenging.    
C1 domains belong to the largest class of zinc binding proteins, which are those 
with structural zinc sites, often referred to as zinc fingers.
50
  In this class of proteins the 
zinc is present to stabilize the proper fold of the protein.  Molecular dynamics 
simulations of a zinc finger revealed that zinc binds at an early stage of folding and 
facilitates the formation of the native protein structure.
53
  Zinc fingers are important for 
many cellular processes such as transcription regulation, metabolism, and signal 
transduction.
51
  They are characterized by the presence of a four residue zinc binding 
motif that is made up of a combination of cysteine and histidine residues.  In “classical” 
zinc fingers the zinc binding motif is close together in primary structure, with only a 
couple residues separating the zinc ligands.  In the case of C1 domains, the zinc ligands 
are far apart in primary sequence, with 48 residues separating ligands for the same zinc 
site.  This type of zinc finger fold is referred to as the treble clef motif.   
In addition to C1 domains, the treble clef motif is found in proteins such as 
recombination activating gene product (RAG-1), ribosomal proteins S14 and L24e, 
FYVE domains, retinoic X receptor, T4 endonuclease VII, cysteine-rich intestinal 
protein (CRIP), proline-rich tyrosine kinase 2 (Pyk2)-associated protein β, and the MH1 
domain of Smad3.  These proteins have a wide variety of functions from binding to 
DNA, protein, or small molecules to enzymatic activities.
54
  However, zinc coordination 
is considered only important to maintain the proper fold, with the functional areas lying 
outside of the zinc coordination sphere.   
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A growing body of evidence is revealing that zinc finger metal coordination can 
serve a direct role in protein regulation.  One function of particular interest to the C1 
domain is that the coordination sites can act as redox switches for sensing reactive 
oxygen species in the cell.
55,56
  This is of interest because PKC plays a major role in cell 
signaling triggered by reactive oxygen species that are generated by the mitochondria 
during metabolism.
57
  The data presented in chapter IV characterizes the role of the C1B 
domain zinc coordination sites in activation of PKC via reactive oxygen species.  Further 
investigation of zinc coordination dynamics of other zinc fingers could reveal a wide 
spread mechanism of protein regulation.  
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CHAPTER II  
THE DAG SENSITIZING RESIDUE 22 MODULATES BINDING LOOP 
CONFORMATIONAL EXCHANGE

 
 
Background 
The ligand affinity and specificity of C1 domains varies drastically between the 
various PKC isoforms, in spite of their sequence and structural similarities shown in 
Figure 3.  While several small molecules show promise in binding C1 domains to treat 
human disorders such as cancers, strokes, Alzheimer’s disease, HIV, and cardiovascular 
disorder (see Chapter I), rational drug development is difficult without understanding the 
properties that dictate ligand affinity and specificity.  Because the different PKC 
isoforms bring about different, and sometimes even opposing, cell signaling events, it is 
vital that C1 targeting drugs bind specifically to the intended isoform.
2
  Furthermore, 
these small molecules would also be useful to deconvolute the specific pathways 
activated by the different isoforms.  The work presented in this chapter addresses the 
effect that a single variable residue has on the DAG and phorbol ester binding affinity 
and specificity of C1B domains.  Through the use of ligand binding studies and NMR, 
properties of C1B are determined that vary consistently between conventional and novel 
                                                 
*Parts of this chapter are reprinted with permission from Stewart MD, Morgan B, Massi 
F and Igumenova TI (2011) Probing the determinants of diacylglycerol binding affinity 
in the C1B domain of protein kinase C. Journal of Molecular Biology 408: 949-70. 
Copyright 2011 Elsevier. 
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PKC isoforms.  This information could be used to aid in the design of selective C1 
binding small molecules. 
The variable residue of interest is the 22
nd
 residue within the C1 domain, which is 
highlighted in yellow in Figure 3B.  In C1 domains that bind tightly to DAG such as 
those from C1A domains or novel PKC C1B domains, there is a Trp at position 22.  
Conversely, there is a conserved Tyr at position 22 in conventional PKC C1B domains, 
which bind weakly to DAG.  Replacement of Trp with Tyr in novel PKC C1B or Tyr 
with Trp in conventional PKCC1B reversed the affinities for DAG such that the Trp 
containing constructs bound with high DAG affinity, regardless of the isoform.
28
  In the 
known structures of both novel and conventional C1B domains, the side-chain of this 
residue faces away from the ligand binding pocket that lies between the 12 and 34 
loops (Figure 3A).  Because it does not form the ligand binding surface, the strong 
dependence on its identity is not easily understood. 
 
 
 
Figure 4. The sequence alignment of the constructs used in this study.  The 
sequences of 53 amino acid constructs of conventional PKC C1B (C1B), novel PKC 
C1B (C1B), and their position 22 mutants (Y123W and W252Y respectively) are 
shown.  Position 22 is highlighted in yellow, zinc coordinating residues in green, and 
conserved loop residues in pink.  Numbering corresponds to the first and last residue of 
the construct in their respective full length PKC proteins. 
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To gain insight into the origin of these effects, experiments are performed using 
the conventional C1B domain from PKC (C1B) and a position 22 Tyr to Trp mutant 
(residue 123 in the PKC numbering scheme, Y123W), as shown in Figure 4.  Similar to 
the study described above with C1B, the mutation increases DAG affinity by more than 
an order of magnitude.  Consistent with what is known about the structures of novel and 
conventional C1 domains, there are no substantial structural differences between C1B 
and Y123W.  Dynamics studies show that the mutation does not change the sub-
nanosecond dynamics, but there are large differences in conformational exchange in the 
absence of DAG.  
Next, to test the correlation between conformational exchange and DAG affinity 
the effects of the reverse mutation is tested using the C1B domain from novel PKC 
(C1B) and its position 22 mutant (residue 252 in the PKC numbering scheme, 
W252Y), as shown in Figure 4.  The DAG affinity measured with NMR and 
fluorescence titrations decreased more than 30-fold in the mutant.  Similar to C1B, the 
structure and sub-nanosecond dynamics are not affected by the mutation.  However, 
R1relaxation dispersion NMR experiments revealed a significant decrease in 
conformation exchange in W252Y.  Together the data suggest a connection between 
ligand affinity/specificity and conformational exchange dynamics of the apo C1 domain.  
Future drug design could take advantage of the different dynamic properties of C1 
domains to alter ligand affinity or select for a given C1 domain. 
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Methods 
Protein sample preparation and assignments 
53 amino acid constructs of C1B were amplified by PCR using PKC cDNA 
obtained from Open Biosystems.  For C1B the sequence was of Mus musculus 
(residues 100-152) and C1B sequence was from Rattus norvegicus (residues 229-281).  
The primary structure in the C1B region does not vary between these two species.  The 
amplified DNA was cloned as a fusion to the small ubiquitin-like modifier (SUMO) into 
the pET SUMO vector using the provided protocol (Invitrogen).  Mutagenesis was 
performed on the resulting plasmids to make the Y123W mutant from C1B and 
W252Y mutant from C1B using the QuikChange® Site-Directed Mutatgenesis kit from 
Stratagene and appropriate primers.  The purified plasmids were transformed into 
BL21(DE3) E. coli cells for over-expression and purification. 
All four proteins (C1B, Y123W, C1B, and W252Y) were expressed as 
SUMO-fusion proteins by induction with 0.5 mM IPTG (isopropyl-D-1-
thiogalactopyranoside, purchased from Fisher Scientific) overnight at 15 °C.  For natural 
abundance protein preparations, the cells were induced upon reaching an optical density 
at 600 nm (OD600) of 0.6 - 0.8.  Isotope labeling was accomplished using the method of 
Marley et al.
58
  The method involved re-suspending cells grown on Luria-Bertani broth 
in M9 minimal medium supplemented with 3 g/L of [
13
C-6]-D-glucose and 1 g/L of 
15
NH4Cl (Cambridge Isotopes), and inducing over-expression at OD600 of 1.8-2.0.  
Fractionally deuterated protein samples were produced using M9 minimal media 
containing 75% 
2
H2O, 3 g/L of [
13
C-6]-D-glucose, and 1 g/L of 
15
NH4Cl.  The cells were 
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harvested by centrifugation at 4 °C and lysed at room temperature using a B-PER 
protein-extraction reagent (Thermo Scientific).  The fusion protein was purified using a 
HisTrap HP Ni affinity column (GE Healthcare Life Sciences).  The fractions containing 
fusion protein were pooled and SUMO was cleaved from C1B with 0.25 mg of SUMO 
protease at room temperature in the presence of 1 mM 1,4- dithiothreitol (DTT).  The 
vector for his-tagged SUMO protease was provided by Dr. Pingwei Li and SUMO 
protease was purified by members of our laboratory.  Cleavage was >90% complete in 
~3 hours for C1Bconstructs and in 12 hours for C1B constructs.  Fresh DTT was 
added half way through C1B construct cleavage due to DTT instability in solution.  
C1B was separated from SUMO and SUMO protease using gel-filtration on a HiPrep 
16/60 Sephacryl S-100 column (GE Healthcare Life Sciences) carried out in 50 mM 2-
(N-morpholino)ethanesulfonic acid (MES) buffer and 150 mM KCl at pH 6.5. 
All NMR experiments were carried out in NMR Buffer (10 mM [
2
H-4]imidazole 
(pH 6.5; Cambridge Isotopes), 150 mM KCl, 8% 
2
H2O, 1 mM tris(2-
carboxyethyl)phosphine, and 0.02% NaN3) at 25ºC on Varian Inova or VNMRS 
spectrometers operating at 500 (11.7 Tesla) or 600 MHz (14.1 Tesla) unless otherwise 
stated.  The temperature was calibrated using methanol.  NMR data were processed with 
nmrPipe
59
 and assigned using SPARKY 3.
60
  Backbone resonance assignments for apo 
C1B and C1B were carried out on uniformly 15N,13C enriched 1 mM samples using 
CBCA(CO)NH and HNCACB three-dimensional NMR experiments.
61
  Y123W and 
W252Y spectra were assigned using C1Band C1B assignments. 
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Ligand binding assays 
2-dihexanoyl-sn-glycero-3-[phospho-L-serine] (DPS) and 1,2-dioctanoyl-sn-
glycerol (DOG) were purchased from Avanti Polar Lipids.  [
2
H38]-
dodecylphosphocholine (DPC) and [
2
H6]-dimethyl sulfoxide (DMSO) were from 
Cambridge Isotopes, and phorbol 12,13-dibutyrate (PDBu) was from Sigma-Aldrich.  A 
stock solution of mixed micelles was prepared by combining chloroform solutions of 
DPS and DPC with a molar ratio of 3:7.  Chloroform was removed under a stream of 
nitrogen gas until only a dry film remains, and then placed under vacuum for two hours.  
The detergent film was re-suspended in the NMR buffer and vortexed for one minute to 
form a clear micelle solution.  The NMR titration samples contained DPC/DPS micelles 
with a total detergent concentration of 10 mM and 0.1 mM uniformly 
15
N-enriched C1 
domain.  DOG or PDBu dissolved in [
2
H6]-DMSO was added stepwise directly to the 
NMR sample and 
1
H-
15
N heteronuclear single quantum coherence (HSQC) spectra were 
collected at each concentration.  The concentration of DMSO at the titration endpoint 
was less than 8% (v/v).  Three-dimensional assignment experiments were performed on 
0.5 mM C1B or 0.4 mM C1B saturated with DOG or PDBu respectively in DPC/DPS 
micelles to verify the assignments. 
Titration curves were constructed using the above ligand titrations for all cross-
peaks that shift more than 0.05 ppm due to ligand addition by plotting either the change 
in 
1
H or 
15
N (H or N respecitively), whichever shift was larger for C1B constructs 
or the overall change in chemical shift () normalized to 1H for C1B constructs using 
the following equation 
62
: 
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Equation 1 
2122 ])152.0([ NH    
versus the absolute ligand concentration (L0).  The curves were then fit with the 
following single-site binding equation 
63
: 
Equation 2 
])4)(([)2/( 2100
2
00000 LPLPKLPKP ddPL    
where 
PL is the difference between chemical shifts of the apo and bound states and 0P
is the total protein concentration.  Total chemical shift perturbation analysis was 
calculated as the difference between the apo spectrum and the spectrum at saturation 
using Equation 1. 
DOG titration of C1Band Y123W for fluorescence measurements was carried 
out in the exact same manner as the NMR titration with the exception of the protein 
concentration which was 0.5 M and the buffer used which was 10 mM MES (Fisher 
Scientific) instead of imidazole.  DOG in DMSO was added using a 25l Hamilton 
syringe, the cuvette was mixed by tapping, and then set for ten minutes before 
measurement.  After each subsequent addition of DOG the total fluorescence intensity 
was measured with a 335-nm cutoff filter on an ISS Koala fluorometer (ISS, Champaign, 
IL) after excitation at 295 nm.  The total fluorescence intensity of an identical sample 
without protein and titrated simultaneously was subtracted to correct for any change due 
to DOG/DMSO addition that did not arise from protein binding.  The fraction of protein 
bound to DOG was calculated as F/F0, where F is the absolute value of the intensity 
change corrected for protein dilution during the titration, and F0 is the fluorescence 
intensity before titrating DOG.  The average fraction bound from three titrations 
 21 
 
corrected for the overall change at DOG saturation versus the total DOG concentration 
was fit with the following equation: 
Equation 3 
])4)(([)2/1()/( 2100
2
000000 LPLPKLPKPFF ddnorm   
where the parameters are the same as those in Equation 2.  Using SDS-PAGE combined 
with silver-staining, it was established that about ~50% of the protein adsorbs on the 
quartz cuvette walls.  This behavior was not alleviated by coating the cuvette with 
Sigmacote (Sigma-Aldrich).  Therefore, the total protein concentration was treated as an 
adjustable parameter when fitting the binding data. 
Sub-ns dynamics 
The amide backbone transverse (R2), longitudinal (R1), and 
1
H-
15
N heteronuclear 
Overhauser effect (NOE) relaxation rate constants were obtained for all spectrally 
resolved high-signal to noise cross-peaks at two fields (14.1 T and 11.7 T) using 
standard methods.
64
  R2 and R1 were collected in an interleaved pseudo-3D manner with 
nine time points from 12-180 ms for R2 and 30-600 ms for R1, three of which were 
duplicates.  The NOE data were collected with a 3 s saturation period and 5 s recycle 
delay.  Peak intensities were used to quantify relaxation rates and duplicate points (R1 
and R2) or root-mean-square noise level of the base planes (NOE) were used to estimate 
the error of the measurement.   
The rotational diffusion properties of C1B were evaluated with HYDRONMR65 
and R2/R1 ratios,
66
 using the ensemble-averaged NMR structure of C1B67 kindly 
provided by Dr. Ulrich Hommel.  HYDRONMR calculations were carried out with 
atomic element radii a of 2.5 Å (minimum) and 2.8 Å (maximum).  The a values in this 
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range were shown previously to provide the best agreement with experimental data for 
proteins with intermediate anisotropy.
68
  Estimation of the rotational diffusion tensor 
based on the R2/R1 ratios was done using the program R2R1_diffusion (available from 
the laboratory of Dr. Arthur G. Palmer, III at Columbia University).  Residues that are 
exchange-broadened and/or have NOE values less than 0.65 were eliminated from the 
analysis using the criteria outlined in Tjandra et al.
66
 and the results of the rotating-frame 
relaxation dispersion experiments described below. 
Relaxation data sets were analyzed using Lipari-Szabo model-free formalism
69
 
for the case of axially symmetric rotational diffusion, as implemented in the program 
ModelFree4.20.
70
  The formalism relies on the explicit separation of timescales for local 
and overall rotational motions.  The information on the internal motions of 
15
N-
1
H 
vectors is obtained in the form of generalized order parameters, S
2
, which report on 
spatial restriction of motion, and effective correlation times, e, which report on the rate 
of motion.  Five different models having the following parameterization are 
implemented in ModelFree4.20 to facilitate the relaxation data analysis: (1) S
2
; (2) S
2
, e; 
(3) S
2
, Rex; (4) S
2
, e, Rex; and (5) S
2
f, S
2
s, s.  Rex is the contribution of conformational 
exchange to the R2; S
2
f and S
2
s are the generalized order parameters for the fast and slow 
internal motions; and s is the time constant for the slow internal motion. 
The Fast-Modelfree program
71
 was used to generate the input files and carry out 
the model selection according to Mandel et al.
70
  ModelFree4.20 was used for the 
simultaneous optimization of the rotational diffusion tensor and motional parameters for 
the 
15
N spins assigned to Models 1 and 2.  Model selection and rotational diffusion 
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tensor optimization were iterated until no changes were detected in the model 
assignment and tensor parameters.  The optimized values of the axially symmetric 
rotational diffusion tensor were m=3.19  0.03 (3.07  0.03) ns, D||/D=1.36  0.08 
(1.37  0.08), =92.1  7.1 (94.7  7.6), and =267.8  9.4 (275.9  9.2) for C1B 
(Y123W), respectively.   and  are the Euler angles relating the principle Z axis of the 
diffusion tensor to the Z axis of the molecular frame of the ensemble-averaged NMR 
structure of C1B.  The final calculation was carried out for all spins using the 
optimized parameters for the rotational diffusion tensor. 
Because of the many missing loop residues in intermediate change on the NMR 
timescale and number of residues with Rex contributions to R2 in C1B, model-free 
analysis was not possible for C1B and W252Y sub-ns dynamics comparison.  Instead, 
the R1 and NOE relaxation rates of C1B and W252Y were used to determine sub-ns 
dynamics on a per residue basis with the reduced 
72,73
 spectral density mapping approach 
74,75
: 
Equation 4 
   1
5
4
87.0 12  NOERd
J
H
N
H



 
where d = (0hHN/8
2
)(1/<rXH>
3
); 0 is the permeability of free space; h is Planck’s 
constant; H (N) is the gyromagnetic ratio of 
1
H (
15
N), and rXH is the length of the N-H 
bond.   
Conformational exchange 
In order to quantify conformational exchange in all four constructs, off-resonance 
and near-resonance relaxation dispersion (R1) experiments were performed at 11.7 T 
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and 14.1 T with established pulse sequences.  The radio frequency amplitudes (1) were 
calibrated using the scaling of the 
1
JNH coupling constant with varying off-resonance 
decoupling.  R1 is modulated according to the following relationships by varying 1 and 
the resonance offset (): 
Equation 5 

2
2
2
11 sincos RRR   
Equation 6 )/arctan( 1    
Equation 7 
22
1  e  
where  is the angle between the effective radiofrequency field (e) and the direction of 
the static magnetic field.  R2 is a sum of the transverse relaxation rate constant in the 
absence of exchange (R2
0
) and the contribution due to exchange (Rex).  For a two-state 
fast conformational exchange between A ↔ B, Rex is related to the exchange parameters 
as follows: 
Equation 8 ex
RRR  022  
Equation 9 
22
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in which  and .  k1 and k-1 are the forward and reverse rate 
constants; pA and pB are the populations; and N is the residue-specific 
15
N chemical 
shift difference for the conformers A and B. 
15
N magnetization was aligned with e using a 90x-delay-90y element for near-
resonance experiments and a 6 ms tan/tanh adiabatic ramp starting -15,000 Hz from the 
carrier frequency for off-resonance experiments.  Relaxation delays were a maximum of 

ex  pA pBN
2

kex  k1  k1
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160 ms.  1/2 varied 560-1270 Hz for near-resonance and 1110-1980 Hz for off-
resonance experiments.  The carrier offset was varied such that  ranged from 68-90º for 
near-resonance and 25-68º for off-resonance experiments. 
R2 was calculated using Equation 5 and plotted against e
2
.  The curves collected 
at 11.7 T and 14.1 T were fit to Equation 8 and Equation 9 with ex, kex, and R2
0 
as 
adjustable parameters.  Because individually fit curves converged with similar kex 
values, (C1B1.292.25 / Y123W 0.781.68 / C1B0.69-1.03 / W252Y 1.59-2.06) 
x10
4
 s
-1
 all residues with Rex > 1 s
-1
 at 11.7 T were fit with a global kex value.  ex was 
scaled to 14.1 T when globally fitting with data collected at 11.7 T to account for 
differences in N
2
. 
Measurements of 
15
N-
1
H residual dipolar couplings (RDCs)  
Weakly aligned samples of C1B and Y123W were prepared in stretched 
polyacrylamide gels.
76,77
  6% gels were prepared using the appropriate dilution of 40% 
acrylamide and bis-acrylamide solution, 37.5:1 (Bio-Rad), 0.1% w/v ammonium 
persulfate (Fisher Scientific), and 0.08% v/v N,N,N',N'-tetramethylethylenediamine 
(Fisher Scientific), and cast at a diameter of 6 mm.  The gel was soaked overnight with 
0.5 mM C1B or Y123W and then axially stretched into a 4.2 mm NMR tube using the 
apparatus obtained from New Era Enterprises.
78
  Site-specific residual dipolar couplings, 
1
DNH, were calculated from the in-phase anti-phase (IPAP)
79
 spectra as the difference 
between the splitting of the 
15
N doublet components in the aligned and isotropic spectra. 
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Water exchange 
The rate of quickly exchanging amide 
1
H was measured using the CLEAN-EX 
pulse sequence, 
80
 in which water magnetization is transferred to exchanging 
1
H with 
subsequent detection of excited amide 
1
H with a fHSQC.  The experiment was 
performed as described with mixing times varying from 4-50 ms using excitation 
sculpting
81
 of the 3-9-19 water gate sequence
82,83
 for water suppression on a Bruker 800 
Avance system with a cryoprobe.  The resulting data were fit to the following equation 
to obtain the exchange rate with water, H2Oex: 
Equation 10 
mappAmappB kRR
BexA
ex ee
RkR
OH
V
V  )(
11
2
0
,1,1  


 
where V is the peak volume at a given mixing time, m; V0 is the peak volume in a 
reference fully relaxed fHSQC with a 9s relaxation delay; R1A  and R1B are the relaxation 
rates of the amide 
1
H and water 
1
H respectively under the conditions of the CLEAN-EX 
experiment. R1A was fit as an adjustable parameter.  R1B was measured using mixing 
times up to 200 ms and fit linearly to obtain the water decay rate.  After fitting, H2Oex 
was corrected for the degree of water saturation as described.
80
  Correction of H2Oex 
rather than individual points was appropriate as the saturation was found to be 73% and 
varied less than 1% between the different mixing times and samples.   
The rate of slowly exchanging amide 
1
H was measured by dissolving a 
dehydrated NMR sample containing protein and NMR buffer with D2O and rapidly 
collecting a series of HSQC spectra over time.  The rate of decay in the peak intensity 
for slowly exchanging peaks was fit to an exponential decay using the same methods as 
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relaxation data fitting described above.  The rates were corrected for the initial delay 
between D2O addition and beginning data collection. 
Determining Trp252 side-chain NOEs 
The interactions of the native Trp253 side-chain in C1B were investigated using 
15
N-edited NOESY, 
15
N-edited ROESY, and 
13
C-edited NOESY tuned for aromatic 
residues.  
15
N-edited experiments were collected on 0.3 mM uniformly enriched 
15
N 
C1B, and 13C-edited NOESY was collected on 2.4 mM uniformly enriched 13C-15N 
C1B.  The 13C-edited NOESY was collected as described in the Varian BioPack User 
Guide using the supplied pulse sequence with the appropriate flag for aromatic carbons 
and 100 ms mixing time.  The 
15
N-NOESY experiment was executed using a pulse 
sequence supplied by Dr. Lewis Kay as described previously with a 140 ms mixing 
time.
84
  The ROESY experiment was implemented in the same manner as TOCSY as 
described
84
 except for a square 5 KHz spinlock pulse was applied during a 60 ms mixing 
time.   
Results of C1B and Y123W studies 
Y123W mutation increases the affinity of C1B to DAG 
To determine the lipid cofactor binding affinities of C1B and Y123W, 
diacylglycerol binding assays were carried out in a micellar environment.  Because 
chemical shifts change based upon the local chemical environment, NMR is an excellent 
method for observing ligand binding.  By observing the 
15
N-
1
H HSQC spectra of 
uniformly 
15
N-enriched C1B as a function of increasing concentration of DOG, a short-
chain DAG analog, the residues which undergo the largest change in chemical 
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environment upon binding can be determined.  All residues, with the exception of 
proline, contain an amide group in the protein backbone.  The residue identity of the 
cross-peaks in the spectra can be assigned using three-dimensional NMR experiments as 
described in the methods, which then provides residue specific information about the 
ligand binding site. 
These titration experiments were carried out in the presence of DPC/DPS mixed 
micelles with a ratio of 30% phosphatidylserine and 70% phosphatidylcholine head-
group components, in order to keep the protein-DOG complex soluble and to mimic the 
composition of the plasma membrane where the phosphatidylserine content is 25-35% 
(data shown in Figure 5).
85
   For C1B, the binding regime is intermediate-to-fast on the 
chemical-shift time scale, which is reflected in the smooth trajectories of the cross-peaks 
in response to increasing DOG concentration.  This occurs when the sum of the kon and 
koff (kex) is significantly greater than the difference in chemical shifts between the apo 
and bound protein.  In Y123W, the binding regime is slow-to-intermediate, which 
indicates the kex is significantly less than the difference in chemical shifts of the apo and 
bound protein.  The differences in the DOG titration behavior between C1B and 
Y123W proteins are illustrated in the insets of Figure 5 using Leu122 as an example.  
Leu122 is located at the N-terminal hinge of loop 34 adjacent to the mutation site and 
is one of the residues that show a strong response to ligand binding.   
For all C1B residues that show a strong response to DOG in the HSQC spectra, 
binding curves were constructed by plotting the absolute change in 
1
H and/or 
15
N 
chemical shifts as a function of DOG concentration.  The curves were fit using Equation 
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2, with PL and Kd treated as local and global parameters, respectively.  Representative 
1
H and 
15
N binding curves for several residues are shown in Figure 6A and B.  The 
dissociation constant Kd for DOG in the presence of micelles was determined to be 24.2 
± 2 M. 
In the mutant, the slow-to-intermediate regime of the DOG binding process has 
precluded the determination of Kd by NMR methods.  While there are no Trp residues in 
the primary structure of C1B, the Y123W mutation provides Trp at position 123 for 
use as a fluorescence probe of protein-DOG interactions.  Fluorescence spectroscopy 
was used to monitor the quenching of Trp fluorescence for Y123W in response to DOG 
binding in the presence of DPC/DPS micelles.  The normalized change of fluorescence 
intensity as a function of DOG concentration is shown in Figure 6C.  Fitting the curve of 
Figure 6C with Equation 3 revealed that even at the total protein concentration in the low 
M range the protein-DOG interaction still remains in the tight binding regime.  Further 
decrease in the total protein concentration was not a viable option due to the high 
background fluorescence of detergent micelles and the low efficiency of chemical 
quenching of Trp fluorescence by DOG.
86
  Using the data presented in Figure 6C, an 
upper limit of 0.23 M can be placed on the Kd. 
In addition to DOG-binding studies, NMR titrations of C1B and Y123W were 
carried out with PDBu, a short-chain phorbol ester (Figure 7).  In both proteins, the 
binding regime is slow-to-intermediate, indicating the formation of high-affinity 
complexes.  This result is in complete agreement with previous studies of C1B from 
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PKCI/II, where the affinities of wild-type and mutant proteins to the phorbol ester 
were similar, and comparable to the affinity of the Y123W mutant to DAG.
28
 
A comparison of the titration spectra of Figure 5 and Figure 7 indicates that 
binding of PDBu and DOG affects the same set of residues in C1B.  One feature that is 
common to all three high-affinity complexes (C1B-PDBu, Y123W-DOG, and Y123W-
PDBu) is the appearance of the Gly110 resonance under conditions close to ligand 
saturation.  Gly110 is located at the tip of loop 12 and is the only residue that is 
broadened beyond detection in the spectra of apo-forms.  Overall, the DOG and PDBu 
titration data suggest that (i) C1B interacts with both ligands using the same structural 
segments, and (ii) formation of high-affinity protein-ligand complexes is accompanied 
by the structural rearrangement of the 12 and 34 loops and partial or complete loss of 
their mobility. 
The results of the ligand-binding experiments demonstrate that the Y123W 
mutation increases the affinity of C1B to diacylglycerol at least 100-fold, from 24.2 
M to <0.23 M.  These findings are in good agreement with the data obtained for the 
C1B domain from PKCI/II, where a 33-fold increase in DOG binding affinity was 
detected, while both constructs bound tight to PDBu using ultracentrifugation lipid-
binding assays.
28
  The next step was to understand the molecular basis of this drastic 
change in the DOG-binding affinity.  To accomplish this, the effect of the Y123W 
mutation on both the structure and dynamics of C1B was investigated using NMR 
techniques.
 31 
 
 
Figure 5. NMR-detected titration of C1B (A) and Y123W (B) with DOG in the presence of DPC/DPS micelles. The 
binding process is intermediate-to-fast and slow-to-intermediate on the chemical-shift timescale for C1B and Y123W, 
respectively.  The insets show the differences in the binding regimes for C1B and Y123W using Leu122 as an example.  
Large chemical shift perturbations are observed in the ligand-bound versus apo-spectra. 
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Figure 6. DOG binding curves for C1B and Y123W detected by NMR and 
fluorescence spectroscopy.  In (A) and (B), the absolute values of the 
1
H and 
15
N 
chemical shift changes, 1H and 15N, are plotted as a function of DOG concentration 
for several representative residues.  The binding curves were fit with Equation 2 using 
the dissociation constant Kd as a global parameter.  (C) Normalized change in the 
fluorescence of Y123W plotted as a function of DOG concentration.  The error bars 
represent the standard deviation between three experiments.  Large errors in Kd indicate 
that, in this protein concentration range, the binding is still tight, and only an upper limit 
of 0.23 M can be given to the Kd value.  The solid line is provided as a visual aid. 
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Figure 7. NMR-detected titration of C1B(WT) and Y123W with phorbol 12,13-
dibutyrate (PDBu) in the presence of 10 mM DPC/DPS micelles.  The binding 
process is slow-to-intermediate on the chemical-shift timescale for both C1B and 
Y123W indicating comparable PDBu affinities.  Large chemical shift perturbations 
are observed in the apo- versus ligand-bound spectra, suggesting that binding of 
PDBu with concomitant micelle insertion is accompanied by changes in the 
conformation of the ligand-binding loops. 
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Figure 8. Assessment of structural differences between C1B and Y123W 
using chemical shift perturbation analysis and RDCs.  Structural Zn
2+
 ions 
are shown as black spheres in (A), (C), and (D).  Prolines and residues that are 
missing from the 
15
N-
1
H HSQC spectra are shown in grey.  In (A), chemical 
shift perturbation () was calculated between the apo-forms of Y123W and 
C1B, and mapped onto the ensemble-averaged NMR structure of C1B.  (B) 
Comparison of the 
1
DNH RDCs between the Y123W and C1B.  Empty circles 
correspond to the 12 and 34 loop residues.  Fitting the data with a linear 
function produces a slope of 1.0 within experimental error, suggesting that 
minimum perturbations are imposed on the backbone of C1B by the Y123W 
mutation.  In (C) and (D),  was calculated between the DOG-bound and apo 
forms of C1B (C) and Y123W (D).  In both proteins, the regions involved in 
interactions with ligand are the 12 and 34 loops and their hinges.  In (D), the 
Tyr at position 123 was replaced with Trp in the ensemble-averaged NMR 
structure of C1B using WHATIF.87 
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The structures of C1B and Y123W are similar in both apo- and ligand-bound forms 
The structural perturbation imposed on C1B by the Y123W mutation were 
assessed using chemical shift perturbation analysis () and RDCs measured for all 
spectrally resolved 
15
N-
1
H groups.  The results for the apo-forms of C1B and Y123W 
are shown in Figure 8A and B.  In Figure 8A,  values are color-coded and mapped onto 
the NMR structure of C1B.  Only the site of the mutation experiences a noticeable 
change in the electronic environment, whereas other parts of the protein, including 
ligand-binding loops 12 and 34, are essentially unperturbed.  RDCs between the 15N 
and 
1
H spins of amide groups, 
1
DNH, are exquisitely sensitive to the changes of the 
backbone conformation and have been previously used to evaluate structural 
perturbations in point mutants.
88,89
  
1
DNH values were measured for the apo-forms of 
both C1B and Y123W weakly aligned in 6% stretched polyacrylamide gels.  Figure 8B 
shows the correlation between the 
1
DNH values in Y123W and C1B.  Data points 
corresponding to the loop residues are shown with open circles.  Fitting the data with an 
unconstrained linear function produces an intercept of 0 and a slope of 1 within 
experimental error.  Based on the results of chemical shift perturbation analysis and 
good correlation between the 
1
DNH values, it can be concluded that the mutation at 
position 22 does not impose any significant perturbation on the conformation of the 
C1B backbone. 
The DOG titration data were used to generate Figure 8C and D, where the 
chemical shift perturbations  were calculated between the DOG-bound and apo-forms 
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of C1B (C) and Y123W (D).  The regions affected by DOG binding in the presence of 
DPC/DPS micelles are essentially the same in C1B and Y123W and include the 
following structural elements: the C-terminal half of loop 12 (residues Tyr109 and 
Ser111); the C-terminal hinge of 12 (Thr113, Phe114, and Cys115); the N-terminal 
hinge of 34 (Leu121 and Leu122); and the entire loop 34 comprising the stretch of 
residues from Tyr123 to Gln128, with the only exception of Gly129.  Thus, the data 
suggest that the C1B and Y123W interact with micelle-embedded DOG using the same 
structural segments that include the 12 and 34 loops and their hinges.  Given the 
similarities in the patterns of chemical shift perturbations and site-specific 
1
DNH values, 
it appears that in both apo- and DOG-bound forms the structure of C1B is not 
substantially affected by the mutation. 
Sub-nanosecond dynamics of C1B backbone are not affected by the Y123W mutation 
Relaxation parameter sets comprising R1, R2, and 
1
H-
15
N NOE were measured 
for all spectrally resolved 
15
N-
1
H groups in C1B and Y123W at two static magnetic 
fields, 11.7 and 14.1 T.  The generalized order parameters, S
2
NH, generated by the model-
free analysis of the relaxation data were used to assess the effect of the mutation on the 
sub-ns dynamics of C1B backbone.  S2NH values report on the spatial restriction of the 
motions of 
15
N-
1
H vectors, with 1 and 0 corresponding to completely restricted and 
unrestricted motions, respectively. 
Model-free treatment requires an estimate of the rotational diffusion properties of 
C1B. HYDRONMR calculations were carried out on an ensemble-averaged C1B 
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NMR structure with two values of a, 2.5 and 2.8 Å, as described in Materials and 
Methods.  For a = 2.5 (2.8) Å, the overall rotational correlation time m was calculated as 
3.13 (3.40) ns with the following eigenvalues of the diffusion tensor: Dz=6.41 (5.88) x 
10
7 
s
-1
, Dy=4.67 (4.33) x 10
7
 s
-1
, and Dx=4.88 (4.51) x 10
7
 s
-1
.  Because the difference 
between Dx and Dy is small (4% for both values of a), the diffusion tensor can be treated 
as axially symmetric with D||/D=1.34 (1.33).  The analysis of R2/R1 ratios for C1B 
produced m=3.28 ns and D||/D=1.30, which is in good agreement with HYDRONMR 
results.  Since the R1 and R2 values are essentially identical between C1B and Y123W 
for all 
15
N spins not subject to conformational exchange, the conclusion about the axial 
symmetry of the rotational diffusion tensor holds for Y123W as well.  The values of m 
and D||/D obtained from the R2/R1 analysis were used as an initial input for the first 
round of model selection. 
A comparison of the calculated S
2
NH for C1B and Y123W, along with the 
diagram of secondary structure elements and ligand-binding loop regions 12 and 34, 
is shown in Figure 9A.  In C1B, the mean S2NH for the secondary structure elements 
and 12/34 loop regions is 0.852 ± 0.031 and 0.813 ± 0.074, respectively.  For the 
Y123W mutant, the values are quite similar to those of the C1B, 0.856 ± 0.031 and 
0.826 ± 0.069.  Thus, the differences in the mobility between the loop regions and the 
secondary structure elements are subtle.  However, in both proteins the two most 
dynamic non-terminal residues belong to the loop regions.  Ser111, with S
2
NH of 0.729 ± 
0.018 (0.750 ± 0.019) in C1B (Y123W), is located in the middle of loop 12.  Residue 
 38 
 
123, with S
2
NH of 0.653 ± 0.020 (0.687 ± 0.024) in the C1B (Y123W), is the mutation 
site located at the N-terminal hinge of the loop 34. 
 
 
Figure 9. Comparison of the backbone dynamics of C1B and Y123W.   (A) The 
generalized order parameters, S
2
NH, are plotted as a function of primary structure.  
Shaded areas correspond to 12 and 34 loops, and the mutation site is indicated with an 
arrow.  It is evident from the plot that sub-nanosecond dynamics of the protein backbone 
are not perturbed by the Y123W mutation.  (B) Comparison of the R2
CPMG
 values for 
C1B and Y123W.  Elevated R2
CPMG
 values indicate the presence of conformational 
exchange on the s-ms timescale.  In C1B, the most dynamic region is the C-terminal 
hinge of loop 34, while in Y123W it is both hinges of 34 and the C-terminal hinge of 
12. 
 
 
 
Another noteworthy feature of the S
2
NH profile of Figure 9A is the mobility of the 
N- and C-termini.  In C1B, His102, Cys132, Cys135 and Cys151 coordinate one of the 
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two structural Zn
2+
 ions (Figure 3).  His102 is the third and Cys151 is the next-to-last 
residue of the N- and C-termini, respectively.  The S
2
NH of His102 is 0.798 ± 0.021 in 
C1B (it is unresolved in Y123W), indicating that the coordination bond with Zn2+ 
restricts the motion of His102.  S
2
NH values for Cys151 and Gly152 are not available, 
since neither residue could be adequately fit with any of the five models.  However, their 
R2 values are substantially reduced compared to the mean values for non-exchanging 
residues, indicating increased flexibility.  Leu150 immediately precedes Cys151 and is 
highly dynamic with S
2
NH of 0.403 ± 0.077 (0.455 ± 0.075) in C1B (Y123W).  This 
increase in the flexibility of the Leu150-Gly152 stretch is attributed to the loss of the 
coordination bond between Cys151 and structural Zn
2+
.  This will be discussed in more 
detail in Chapter IV. 
While the sub-ns dynamics of C1B and Y123W are very similar, there are 
significant differences in their conformational exchange behavior.  Conformational 
exchange refers to the processes that occur on the s-ms timescale and manifest 
themselves in the elevated R2 values for all 
15
N spins whose magnetic environment 
changes as a result of the exchange process.  R2 values measured in a Carr-Purcell-
Meiboom-Gill (CPMG)-type experiment, R2
CPMG
, are shown in Figure 9B.  In C1B, the 
most dynamic region is the C-terminal hinge of loop 34, comprising residues Gln128 
and Gly129.  In Y123W C1B, there are two additional regions that are affected by the 
exchange process, the C-terminal hinge of the 12 loop and the N-terminal region of the 
34 loop.  The implication of these findings for the model-free analysis of sub-
nanosecond dynamics is that the subset of residues fit by Models 3 and 4 in the Y123W 
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mutant is significantly larger than that in C1B (Figure 10).  The next step was to 
determine how the kinetics of the exchange process is altered in the Y123W mutant and 
evaluate the relevance of these changes to the observed DAG binding affinities. 
 
 
 
Figure 10. A plot of Rex values obtained from the model-free analysis of C1B and 
Y123W. Eight residues the C1Band thirteen residues in Y123W were fit with Models 
3 and 4, which explicitly account for the contribution of chemical exchange to the 
observed relaxation rates.  The differences in the conformational dynamics are 
pronounced for the hinges of the ligand-binding loops (highlighted in gray). 
 
 
 
Conformational dynamics of C1B are altered by the Y123W mutation 
The conformational dynamics of C1B backbone was characterized using 
relaxation dispersion analysis of 
15
N rotating-frame relaxation rate constant, R1.  R1 
experiments are sensitive to the exchange processes that occur on the timescale of 
microseconds.  The relaxation dispersion data for C1B and Y123W were fit with a 
two-state model for the exchange process that is fast on the chemical-shift timescale.  
The parameters of the model describe the exchange between two conformers A and B, 
AB, in terms of the exchange rates kex and a composite parameter ex (Equation 9).  
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The latter contains information on the structural differences between the conformers 
(N
2
) and the thermodynamics of the process (pApB).  The conformers A and B will be 
referred to as the ground and excited states, respectively. 
Table 1 summarizes the results of the global fit for all exchange-broadened 
residues whose Rex > 0.5 s
-1
 at 11.7 Tesla.  kex decreased significantly, from 15,400 to 
9,600 s
-1
, in the Y123W mutant.  The “Group” column in Table 1 indicates the location 
of the residues in relation to the ligand-binding loops.  12N, 12C, 34N, and 34C 
refer to the N- and C-terminal hinges of the 12 and 34 loops.  It is evident from Table 
1 that all residues for which quantifiable dispersion was detected are located in the hinge 
regions of 12 and 34.  In addition, four residues in Y123W (Gly111, Leu125, His127, 
and Gln128) and two in C1B (Gly111 and Leu125) are broadened by the exchange 
process, but the low intensity of their cross-peaks precluded the measurement of 
relaxation dispersion curves. 
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Table 1. Summary of the conformational exchange parameters in C1B and 
Y123W. 
Residue 
R2
0 (s-1), 
14.1 T 
R2
0 (s-1), 
11.7 T 
ex  10
3 (s-2)a kex (s
-1) Groupb 
C1B 
Tyr109 4.87 ± 0.12 4.65 ± 0.11 21.6 ± 3.0 
15400 ± 400 
12N 
Tyr123 4.17 ± 0.07 4.00 ± 0.05 31.5 ± 1.7 34N 
Gln128 5.52 ± 0.17 5.06 ± 0.13 115.9 ± 5.0 34C 
Gly129 5.48 ± 0.22 5.10 ± 0.15 164.8 ± 7.0 34C 
Met130 4.80 ± 0.06 4.79 ± 0.04 13.8 ± 1.1 34C 
Other dynamic residues: G111 (12) and Leu125 (34) 
Y123W 
Ile106 4.84 ± 0.05 4.59 ± 0.04 10.5 ± 0.8 
9600 ± 200 
12N 
Thr108 4.74 ± 0.07 4.60 ± 0.07 8.2 ± 1.3 12N 
Thr113 4.52 ± 0.21 4.27 ± 0.19 99.1 ± 4.5 12C 
Phe114 4.84 ± 0.06 4.63 ± 0.05 17.8 ± 1.1 12C 
Leu122 5.26 ± 0.17 4.91 ± 0.14 138.5 ± 4.0 34N 
Trp123 4.18 ± 0.08 3.70 ± 0.07 58.3 ± 1.8 34N 
Gly124 5.58 ± 0.10 5.16 ± 0.08 37.5 ± 1.9 34N 
Gly129 6.10 ± 0.41 5.48 ± 0.25 284.0 ± 8.1 34C 
Met130 4.82 ± 0.06 4.74 ± 0.06 29.6 ± 1.3 34C 
Other dynamic residues: Gly111 (12), Leu125 (34), His127 (34), and Gln128 
(34C) 
a ex is given for 14.1 T. 
b
 12N, 12C, 34N, and 34C refer to the N- and C-terminal hinges of the 12 and 34 
loops. 
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Figure 11. Comparison of conformational dynamics in C1B and Y123W.  (A) 
Comparison of relaxation dispersion curves for individual residues in C1B (solid 
circles) and Y123W (open circles).  For clarity, only the 14.1 T data are shown.  The 
solid lines correspond to the global fits with parameters summarized in Table 1.  Residue 
groups are defined in Table 1.  (B) Intra- and inter-loop hydrogen bonds that stabilize 
12 and 34.  Because the loop region in the NMR ensemble of C1B is poorly defined, 
a homology model of C1B that is based on the structure of C1B (1PTQ) is presented.  
Five residues that show quantifiable dispersion amplitudes in either C1B or mutant, 
Thr113, Leu122, Gly124, Gln128, and Gly129, are involved in those hydrogen bonds.  
(C) Conformational dynamics of loop hinges in 12 and 34.  Residues that have 
quantifiable dispersion in both C1B and Y123W are underlined.  Residues with 
quantifiable dispersion in either C1B or Y123W are shown with regular and bold fonts, 
respectively. 
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Residue-specific relaxation dispersion curves showing the dependence of R2 
values on the spin-lock amplitude are presented in Figure 11A.  The residues of 12N 
show very small dispersion amplitudes in both proteins.  The 12C hinge comprising 
residues Thr113 and Phe114 does not undergo conformational exchange in C1B.  In 
contrast, these two residues show significant dispersion in the mutant (Figure 11A, first 
column).  The same pattern is observed for the 34N, which includes Leu122, the 
mutation site Tyr/Trp123, and Gly124 (Figure 11A, second column).  While Tyr123 
shows small but non-negligible dispersion in C1B, the profiles are flat for Leu122 and 
Gly124.  In the Y123W mutant, the dispersion for all three residues of the 34N hinge is 
prominent.  The 34C region comprising Gln128, Gly129, and Met130 is dynamic in 
both proteins, but the dispersion amplitude in the mutant is substantially increased for 
Gly129 and Met130 compared to C1B (Figure 11A, third column).  To summarize, the 
Y123W mutation leads to a significant increase in conformational flexibility of C1B on 
the s timescale, especially in the 12C and 34N regions. 
Figure 11B highlights several residues that are involved in the formation of 
hydrogen bonds that stabilize both intra- and inter-loop structure.  Because the loops are 
poorly defined in the NMR ensemble of C1B, a homology model generated using the 
crystal structure of C1B is presented.22  This hydrogen-bonding pattern is also shared 
by C1B90,91 which has a 75.5% sequence identity with C1B.  The C=O group of 
Gln128 side-chain serves as a hydrogen bond acceptor for its own backbone N-H group 
and the N-H of Tyr109.  In addition, the NH2 group of the Gln128 side-chain is a 
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hydrogen-bond donor to Gly124, located on the same loop 34, and Tyr109 located on 
loop 12.  The N-H of Gly129, which shows the largest dispersion amplitude in both 
C1B and Y123W, is involved in the hydrogen-bonding interaction with the C=O of 
H107.  Finally, Leu122 N-H and Thr113 C=O form a donor-acceptor pair that stabilizes 
the inter-loop structure.  These hydrogen bonds are essential to maintaining the integrity 
of the anti-parallel -sheets formed by strands 1/4 and 2/3, as shown in Figure 11C. 
Three residues that have measurable dispersion in both C1B and Y123W are 
Tyr/Trp123, Gly129, and Met130.  The cross-peak positions of Met130 and Gly129 are 
essentially coincident in C1B and Y123W HSQC spectra, yet their ex values are 
drastically different.  The implications are that (i) in both proteins, the population of the 
excited state is fairly small and the major contribution to the observed population-
averaged chemical shift comes from the ground state; and (ii) the conformational 
equilibrium between the ground and excited states in the Y123W mutant is altered 
compared to that in C1B.  The kex value in the mutant is 9,600 s
-1
 compared to 15,400 
s
-1
 in C1B.  This means that either k1 or k-1 or both decrease as a result of the mutation.  
A simultaneous increase of the activation energies in forward (Ea,1) and reverse (Ea,-1) 
directions is unlikely because that would imply a substantial increase in the energy of the 
transition state due to the mutation.  Because the excited state populations are small, k1 
<< k-1 and Ea,1 >> Ea,-1 for both proteins.  The change in the energy of the excited state 
brought about by the mutation would contribute significantly to Ea,-1 and negligibly to 
Ea,1.  Then, k1
C1B
 ≈ k1
Y123W
 and the ratio of the fractional populations of the excited 
states in the mutant and C1B can be estimated as: pB
Y123W
/pB
C1B
 = kex
C1B
/kex
Y123W
 = 
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1.60.  In addition, the plot of ex values in the mutant versus C1B for Tyr/Trp123, 
Gly129, and Met130 shows a linear correlation with a slope of 1.73 (Figure 12).  If it is 
assumed that N is similar for these three residues in C1B and Y123W, then the 
linear correlation implies a 1.73-fold population shift in the mutant.  This means the 
mutation alters the conformational exchange equilibrium, thereby increasing the 
population of the excited state by 60-70%. 
 
 
 
Figure 12. Φex values in Y123W compared to C1B A plot of Φex values of Y123W 
versus C1B (WT) for three residues that show quantifiable dispersion in both 
proteins.  The slope of the fitted line is 1.73 ± 0.03.  
 
 
 
In addition to the population shift, some structural features of the excited state in 
the Y123W mutant are likely to be different from those of the C1B.  This conclusion is 
based on the observation that residues Thr113, Phe114, Leu122, Trp123, and Gly124 
have substantial dispersion amplitudes in Y123W but show either very little (Tyr123) or 
no (all others) dispersion in C1B.  These regions correspond to the C- and N-terminal 
hinges of 12 and 34 loops that stabilize the structure of the 2/3 anti-parallel beta-
sheet, as shown in Figure 11C. 
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Based on the identity of the residues affected by the conformational exchange 
and their position in the three-dimensional structure of C1B, the process that is 
detected in the relaxation dispersion experiments may involve transient breaking and 
formation of hydrogen bonds between the anti-parallel 1/4 strands in C1B, and both 
1/4 and 2/3 strands in the Y123W mutant (Figure 11C).  This process may also be 
accompanied by the opening and closing of ligand-binding loops.   
Results of C1B and W252Y studies  
W252Y mutation decreases C1B affinity for DOG 
To assess the effect of the W252Y mutation on ligand binding, DOG was added 
stepwise to C1B or W252Y in the presence of DPC/DPS mixed micelles and observed 
by a decrease in tryptophan fluorescence or with HSQC spectra (Figure 13).  When 
observed with NMR HSQC spectra, C1B exhibited slow-exchange behavior; cross-
peaks corresponding to the bound conformation were present at DOG concentrations 
below the C1B concentration (Figure 13A).  The decrease in tryptophan fluorescence 
was used to estimate the binding affinity.  The Kd value from the fit of the fluorescence 
data is lower than the detectable protein concentration, so only an upper limit can be 
placed on the Kd of less than 0.2 M.  However, W252Y exhibited fast-exchange 
behavior similar to the DOG titration of C1B (Figure 13B and Figure 5A).  By plotting 
the change in chemical shift that occurs for a given DOG concentration and globally 
fitting all affected residues to Equation 2, the Kd of W252Y for DOG in mixed micelles 
was determined to be 5.5 ± 0.4 M.  The fitting results of four representative residues 
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are shown in Figure 13D.  From these data, it is concluded the W252Y mutation 
decreases the DOG affinity more than 28-fold.  Together with the C1B / Y123W 
reported by Newton’s group28 and the C1B / Y123W reported in the previous section, 
there is good evidence that Trp at position 22 increases DOG affinity well over an order 
of magnitude regardless of the PKC isoform. 
Changes in 
15
N or 
1
H chemical shift reflect a change in the electronic 
environment of the corresponding residue backbone.  Figure 14 shows the changes in 
chemical shift between apo and DOG-bound in DPC/DPS micelles plotted for all 
quantifiable residues and mapped onto the crystal structure and W252Y homology 
model.  C1B and W252Y residues located on the -helix and both ligand binding loops 
show a large change in chemical shift due to DOG binding.  The chemical shift 
perturbation is not quantifiable for many loop residues due to exchange broadening in 
the absence of ligand (denoted with purple asterisks or colored purple in Figure 14).  
Once both constructs are saturated with DOG, the exchange broadening in the loops is 
quenched.  The residues that are quantifiable for both constructs have similar chemical 
shift perturbations due to DOG binding, revealing a similar chemical environment for 
residues in the DOG-bound structure regardless of the W252Y mutation. 
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Figure 13. C1B and W252Y binding to DOG in the presence of mixed micelles. An 
overlay of HSQC spectra excerpts collected on uniformly 
15
N enriched C1B (A) or 
W252Y (B) in apo-state (black), or increasing concentration of DOG in the presence of 
10 mM DPC/DPS micelles (blue to red rainbow colored).  Labels of residues exchange-
broadened in the apo spectrum are purple.  Due to the fast exchange regime of C1B 
shown in (A), the affinity of C1B for DOG was estimated using the decrease in 
fluorescence as shown in (C) and described in the methods.  Each point is an average of 
three trials normalized to fluorescence decrease at the highest DOG concentration.  The 
curve is a fit to Equation 3 which produced values of P0 = 0.17 ± 0.01 M and Kd = 2.6 
± 1.1 nM.  Because of the tight binding regime, only an upper limit is put on the Kd of 
0.2 M. (D) The change in chemical shift due to binding DOG is plotted in for 
representative residues in W252Y.  The curves represent a global fit of all significantly 
shifting residues to Equation 2 to yield a Kd of 5.5 ± 0.4 M.   
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Figure 14. The change in chemical shift between apo and DOG saturated C1B 
varients.  Chemical shift change determined by Equation 1 is plotted versus the primary 
structure in (A) and onto the C1B apo crystal structure for C1B (B) and homology 
model for W252Y (C).  Significantly shifting residues are labeled in (B) and (C).  
Residues which are exchange-broadened in apo are denoted with a purple asterisk (A) or 
colored purple (B and C).  Proline is colored gray in (B) and (C). 
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Figure 15. Phorbol ester binding properties of C1B and W252Y.  (A) An overlay of 
HSQC spectra of C1B and W252Y in apo-state (black and cyan respectively) and in the 
presence of two fold PDBu with respect to protein concentration and mixed DPC/DPS 
micelles (red and blue respectively).  Side-chain cross-peaks are denoted with “*”.  (B) 
The change in backbone chemical shift due to binding PDBu (two fold protein 
concentration) in the presence of mixed micelles, as determined with Equation 1.  The 
ligand binding loops, -helix, and mutation site are highlighted with gray and yellow 
respectively.  The residues exchange-broadened in the apo spectrum are denoted with a 
purple asterisk. 
 
 
 
In a similar experiment, PDBu was added stepwise to C1B and W252Y in 
mixed micelles.  An overlay of HSQC spectra is shown in Figure 15A.  Both constructs 
bind PDBu in the slow NMR timescale regime, reminiscent of the tight C1B DOG 
binding.  This is consistent with the Newton Laboratory’s previous results showing that 
even though mutation of Trp252 in C1B to Tyr caused a 10-fold decrease in membrane 
localization in response to DAG, it retained similar membrane localization in response to 
PDBu.
28
  In addition, the same residues respond to PDBu binding and to the same degree 
in both C1B and W252Y.  Comparison of the change in chemical shifts due to DAG 
 52 
 
binding to the change caused by PDBu binding (Figure 13 and Figure 15B) reveals the 
same loop residues respond to the binding of both ligands.  These residues are also 
similar to the conventional C1B residues which respond to DOG and PDBu binding 
(Figure 8 and Figure 7).  Both phorbol esters and DAG bind in the 12-34 loop pocket 
as previously hypothesized from the crystal structure of C1B bound to water soluble 
phorbol ester.
22
 
W252Y mutation has a minor affect on the chemical shifts of C1B  
To access the effect of the mutation on the structure of C1B, chemical shifts 
were compared to those of W252Y in Figure 16 for apo and DOG saturated states.  The 
data are not available for seven of the loop residues in the apo comparison due to 
exchange broadening in one or both of the constructs (purple asterisks in Figure 16).  An 
overlay of C1B and W252Y spectra in each state is shown for a 12 residue (Ser240) 
and a 34 residue (Val255).  In the apo state, small differences in chemical shifts are 
observed for residues close in space to the mutation site (Figure 16A).  Cross-peaks from 
all of the non-proline residues are present in the DOG-bound spectra; from this it is clear 
that the only significant chemical shift differences due to the mutation are at or directly 
adjacent to the mutation site (Figure 16B).  This is an indication that similar to C1B, 
the dominant structure of C1Bin solution does not change dramatically due to the 
identity of residue 22. 
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Figure 16. The overall change in chemical shifts due to the W252Y mutation when 
apo (A) or DOG saturated (B).  The residues surrounding the mutation site are 
significantly shifted and other residues near the mutation in tertiary structure in the 12 
and -helix are also affected.  An excerpt of the C1B and W252Y HSQC spectra in 
each state is shown for a 12 loop residue (Ser240) and 34 loop residue (Val255), 
showing that while the change in chemical shift due to binding is large, the change due 
to the mutation is small in comparison.  
 
 
 
 54 
 
 
Figure 17. Effect of W252Y mutation on backbone dynamics.  (A) J(0.87H) 
calculated using R1 and NOE collected at 14.1 T  and (B) R2 values measured with 
CPMG at 14.1 T are plotted for all high signal-to-noise and resolved residues in C1B 
(black) and W252Y (cyan).  Black lines connect residues with available data. 
 
 
 
The W252Y mutation alters conformational exchange, without affecting sub-nanosecond 
dynamics 
The reduced spectral density mapping approach was used to determine J(0.87H) 
from R1 and NOE collected at 14.1 T for all spectrally resolved backbone cross-peaks in 
C1Band W252Y.  J(0.87H) is an average of 13 ± 2 ps for C1B and W252Y 
constructs.  Figure 17A shows the J(0.87H) obtained for both constructs.  The only 
residues more than two standard deviations from the average are Leu279 and Cys281.  
They exhibit elevated dynamics in both constructs, likely due to zinc coordination 
dynamics of Cys281 as discussed in Chapter IV.  There are no significant changes in 
sub-nanosecond timescale dynamics due to the mutation. 
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As mentioned above in the context of C1B results, R2 is reflective of both sub-
nanosecond timescale dynamics as well as conformational exchange on the s-ms 
timescale (Equation 8).  If the backbone of a residue experiences a different electronic 
environment in two exchanging conformations, the R2 as determined using CPMG 
experiments will be elevated as is seen for both C1B and W252Y.  The most dynamic 
region in both constructs is the 34 loop.  Many of the C1B 34 loop cross-peaks are 
exchanged broadened to the extent that R2 cannot be accurately measured; however, all 
those that are measureable are significantly more elevated in C1B than in the mutant 
(Figure 17B).  Several residues in the C-terminal region also show elevated R2, but the 
elevation is the same for both C1B and W252Y.  These residues show little to no 
dispersion in the following analysis, thus likely represent a dynamic process independent 
of loop motion and on a different timescale, such as zinc coordination dynamics (more in 
Chapter IV).  
R1experiments were performed on C1B and W252Y, in a similar manner as 
C1B and Y123W, to quantify and better understand the nature of the conformational 
exchange process.  For both C1B and W252Y C1B five residues produced cross-
peaks which were well resolved, high signal-to-noise, and had a Rex greater than 1 s
-1
 at 
11.7 T.  The data collected at 14.1 T and fit to Equation 8 and Equation 9 are shown in 
Figure 18A with the location of the residues in the structure highlighted in red in Figure 
18B.  Three of these residues (left column) are dispersive in C1B, but show no 
dispersion in W252Y.  Two residues are dispersing in both constructs (middle column), 
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but the Rex is much larger for C1B.  The three residues which show the largest 
quantifiable dispersion in W252Y (right column) are too broadened by the exchange 
process to quantify in C1B.  The severely broadened residues, which are intermediate 
on the NMR chemical shift timescale (11 total in C1B and 2 total in W252Y), are 
colored in purple in Figure 18B.  Asn267 and Tyr238 were not quantifiable in W252Y 
due to overlap of the cross-peaks in the HSQC spectra.  These residues are colored white 
in Figure 18B along with proline.  Two residues in C1B and four in W252Y also 
showed some contribution of Rex to R2 (gold in Figure 18B), but were left out of global 
analysis because Rex was less than 1 s
-1
.  While all of these residues are located on or 
near the hinge of the ligand binding loops, the difference in identity and quantity of 
exchanging residues likely points to a difference in the structure of the higher energy 
conformation sampled by the two constructs, as was seen for C1B and Y123W.   
The five quantifiable residues in each construct were fit globally for data 
collected at 11.7 and 14.1 T to determine a kex for the exchange process.  A summary of 
the fitting parameters is given in Table 2.  The conformational exchange occurs faster for 
the W252Y mutant (kex 18,300 ± 900 s
-1
) than for C1B (kex 8,100 ± 200 s
-1
).  The two 
residues with quantifiable dispersion in both constructs have a significantly larger ex in 
C1B compared to W252Y as shown in Table 2 for Val255 and Leu259.  Val255 
decreases almost 3-fold in the mutant, while Leu259 decreases more than an order of 
magnitude.  Because ex does not systematically vary for the two residues as was seen 
for C1B / Y123W in Figure 12, the change cannot be due solely to a change in 
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thermodynamics.  This means that there is a larger difference in chemical shifts between 
the ground and excited states for at least one of these residues in the C1B construct 
compared to W252Y and the populations may or may not be shifted more toward the 
excited state in C1B.  Because the chemical shifts in the HSQC represent a population 
weighted average of the ground and excited states and C1B has similar chemical shifts 
as W252Y, the population of the excited state is small for both constructs.  The residue 
specific ex does not correlate with the change in 
15
N chemical shift of the given residue 
due to binding DOG, or PDBu.  For instance, the residue with the largest ex in each 
construct (Gly258 in W252Y and Leu259 in C1B) show relatively small shifts due to 
ligand binding.  To gain insight into the structural changes between the ground and 
excited states these residues are examined in the crystal structure of C1B. 
The dotted lines in Figure 18B depict the hydrogen bonds that form between the 
12 and 34 ligand binding loops (1PTQ) as discussed in the C1B results section.  All 
of the residues forming these hydrogen bonds in C1B respond to the process that is 
causing conformational exchange.  In contrast, only Gly258 shows quantifiable 
dispersion in W252Y, while Thr242, Gly253, and Gln257 show a weak response to this 
process.  In summary, C1B is undergoing a conformational exchange process that may 
be linked to breaking and formation of hydrogen bonds that bridge the ligand binding 
loops.  When W252 is mutated to Tyr, the conformational exchange becomes faster, the 
excited state that is sampled is closer in structure to the ground state, and fewer residues 
are affected. 
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Figure 18. Conformational exchange in loop residues is attenuated in W252Y.  A) 
Relaxation dispersion data measured with R1 experiments at 14.1 T are shown for the 
five residues with quantifiable dispersion in C1B (filled circles) and W252Y (open 
circles).  Curves are a result of globally fitting with data at 14.1 T and 11.7 T.  Data for 
Asn237, Gly258, and Trp252 (right column) were not available for C1B due to severe 
exchange broadening.  The location of residues broadened beyond quantification 
(purple), quantifiable with R1(red), and in exchange with Rex less than 1s
-1
 at 11.7 T 
(yellow) are mapped onto (B) C1B crystal structure (1PTQ) and (C) a mutant in which 
Trp252 is replaced with Tyr using Swiss PDB viewer.  Proline and unresolved residues 
are colored white.  Loop stabilizing hydrogen bonds are shown with black dotted lines. 
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Table 2. Parameters from R1 global fitting. 
 
 
 
 
 
 
Probing changes in loop conformations with H2O exchange rates 
Water exchange rates for apo C1B and W252Y were measured using CLEAN-
EX and hydrogen-deuterium exchange (HDex) methods.  Half of the C1 domain residues 
exchange at a rate quantifiable with one of these two methods.  The rates for quantifiable 
residues are plotted in Figure 19A, and the approximate exchange rate for each residue is 
mapped onto the structure in Figure 20.  The lack of large differences in exchange rates 
is consistent with the two domains having a similar structure in the dominant 
conformation.  In many cases, a slow rate of amide to water exchange correlates with the 
amide forming a hydrogen bond in the protein structure.
92-94
  For both constructs, the 
residues which were quantifiable with CLEAN-EX are located on the tips of the ligand 
binding loops, the exterior side of the -helix and near the C-terminus.  None of these 
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rapidly exchanging residue’s amide groups adopt a hydrogen bonding geometry in the 
crystal structure.  The residues exchanging slowly with water were quantifiable with 
HDex and are located in the -sheets and zinc binding regions of the tertiary structure.  
All of the amide groups with hydrogen bonding geometry in the -sheets slowly 
exchange with water (green or blue in Figure 20), as would be expected. 
Contrary to the prediction from the structure, the amides found in hydrogen 
bonding geometry which originate from or coordinate to a side-chain atom to form the 
inter-loop network, are exchanged to deuterium to a point beyond detection in the first 
HSQC in both C1B and W252Y.  This includes the three amides participating in the 
four hydrogen bonds formed by the Gln257 side-chain, as well as the Lys256 backbone 
amide on the 34 loop, which is hydrogen bonding with the side-chain of a 12 loop 
residue, Asn237 (amide residues are yellow in Figure 20).  These hydrogen bonds are 
likely less stable than those formed by the core of the protein, consistent with the theory 
that their loss/formation leads to a change in loop conformations which gives rise to the 
conformational exchange described above. 
Because most of the ligand binding loop residues exchange in a timescale 
between what is quantifiable with either CLEAN-EX or HDex, it is difficult to speculate 
on differences between C1B and W252Y in loop hydrogen bonding patterns.  However, 
the largest quantifiable differences in water exchange rates between C1B and W252Y 
are seen for Ser240 and His270 as plotted in Figure 19B.  His270 is located on the -
helix, close in tertiary structure to the mutation site, while Ser240 is located on the 12 
loop, across the ligand binding cavity from the mutation site (Figure 19C).  The faster 
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exchange of His270 and slower exchange of Ser240 in C1Bwhen compared to 
W252Y, is consistent with C1B existing in a more “closed-loop” form in which the 34 
loop is shifted toward the 12 loop and away from the -helix.  However, because what 
is measured is the exchange rate of the averaged populations in conformational 
exchange, it is not possible to say from these data if C1Bis slightly more closed when 
compared to W252Y in one or both of the conformations, or if it samples the same 
closed population but more frequently than W252Y. 
 
 
 
Figure 19. Water exchange rates determined by CLEAN-EX and HDex 
experiments.  Exchange rates are plotted for quantifiable residues in (A) for C1B 
(black) and W252Y (cyan).  (B) The ratio of the CLEAN-EX peak volume (V) at a given 
mixing time (m) divided by the peak volume in the reference fHSQC (Vo) for His270 
(triangles) and Ser240 (circles) in both C1B (black) and W252Y (cyan).  Curves are a 
result of the fit to Equation 10.  C) The location of Ser240 and His270 relative to the 
mutation site and the 34 loop in the C1B crystal structure. 
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Figure 20. Ranges of C1B water exchange rate ranges mapped onto the structure.  
The range in yellow was determined by residues which exchange in a timescale between 
what is observable for CLEAN-EX or HDex.  When C1B residues were exchanged 
broadened, the residues are colored according to W252Y.  The Trp252 side-chain is 
colored based on exchange of H1. Pro241 and Met239 for which data are not available 
are colored white.  The hydrogen bonds found in the crystal structure are shown with 
dashed lines.  Those involving an amide group in slow exchange are shown in black, 
while the others are shown in purple. 
 
 
 
 
Figure 21. Trp252 side-chain solvent accessibility.  A) The ratio of the CLEAN-EX 
peak volume (V) at a given mixing time (m) divided by the peak volume in the 
reference fHSQC (Vo) for the W252 side-chain amide.  B) NOE and ROE cross-peaks 
from the W252 side-chain amide.  Red cross-peaks are opposite the sign of the diagonal. 
 
 
 
It is also interesting to note that the W252 side-chain amide proton, H1, 
exchanges rapidly with water at a rate of 2.3 s
-1 
as shown in Figure 21A.  In addition, 
NH1 gives rise to a strong NOE cross-peak in 
15
N-edited NOESY at the resonance of 
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water that can be seen in Figure 21B.  Also shown in Figure 21B, 
15
N-edited ROESY 
revealed this cross-peak has the same sign as the diagonal, indicating it is due to 
chemical exchange.
95
  No other inter-residue NOE cross-peaks were found in these 
NOESY experiments or in aromatic 
13
C-edited NOESY.  Together, these data support 
the theory that the W252 side-chain is predominantly solvent exposed without contacts 
with other residues. 
Discussion 
The objective of this study was to investigate the properties of C1 domains that 
produce varying DAG binding affinities.  This is an important objective to achieve in 
order to eventually develop drugs which target a specific C1 domain to bring about an 
intended action on a specific PKC isoform or signaling protein.  It was previously 
established that the identity of the residue at position 22, whether Trp or Tyr, tuned the 
DAG affinity of the C1B domain from PKC and PKC and led to differing cellular 
localization.
28
  However, this residue does not make direct ligand contacts in the crystal 
structure of C1B bound to a water soluble phorbol ester.22  Therefore, it is unclear how 
to use this information to engineer a drug that can take advantage of this difference.  
These experiments investigate the underlying changes in structure or dynamics that are 
brought about by this varying residue and lead to drastically different DAG binding 
affinities, in attempts to eventually target these differences. 
First, it is established that differences in DAG affinity seen by Newton’s group 
were mimicked by the lone C1B domains in this in vitro system.  This was evidenced by 
the titration of C1B, C1B and their position 22 mutants, Y123W and W252Y, with 
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DOG in the presence of mixed micelles, which serves as a membrane mimic and keeps 
the resulting complex soluble.  Fitting of the change in Trp fluorescence or chemical 
shift measured by NMR resulted in Kd’s that follow the same trend seen in C1B and 
C1B and their position 22 mutants studied by Newton’s laboratory (Figure 6 and Figure 
13); in both conventional and novel isoforms, DAG affinity is increased when a Trp is at 
position 22.  In addition, phorbol ester binding affinity remains high as demonstrated by 
binding on the slow NMR timescale (Figure 7 and Figure 15) regardless of Tyr or Trp at 
position 22, which was also the case for C1B.28 
In spite of the differences in binding affinities, the structure does not change 
significantly based upon the identity of position 22.  This is based on the similarity in the 
chemical shifts of the wild-type and mutant proteins in the apo-state, as well as bound to 
DOG in the presence of mixed micelles (Figure 8 and Figure 16).  This is consistent with 
the available C1 domain structures revealing similar structures for constructs with Trp or 
Tyr at position 22 (example in Figure 3).  In addition, Figure 8B shows similar residual 
dipolar coupling values of PKC and Y123W.  Residual dipolar coupling values reflect 
changes in the backbone angle relative to the alignment of the protein in the magnetic 
field, thus report directly on the protein structure.  Together, these data provide strong 
evidence for the residue at position 22 modulating DAG affinity without having a 
significant effect on the structure. 
In the absence of structural changes, the dynamic properties of apo C1B and 
W252Y are explored.  Intrinsic dynamics on timescales ranging from the sub-ns 
vibrational motion to the millisecond timescale conformational exchange have been 
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found to correlate with ligand binding affinity and specificity in other protein systems.
96
  
Model-free analysis was used to determine S
2
 order parameters for C1B and Y123W, 
while reduced spectral density mapping was applied to C1B and W252Y.  Both 
methods revealed the fast vibrational motions on the sub-ns timescale are not affected by 
the identity of residue 22 (Figure 9A and Figure 17A).  In contrast, differences in R2 
rates revealed a dramatic quenching in conformational exchange dynamics of the ligand 
binding loops when Trp was at position 22 instead of Tyr (Figure 9B and Figure 17B).  
Quantification of the process using R1 revealed that all of the constructs are undergoing 
a fast conformational exchange process involving the ligand binding loop residues; but, 
the exchange is faster in the Tyr containing constructs, with fewer loop residues affected 
by the process. 
Table 3 lists the results of R1 and binding measurements of all four constructs, 
showing the similar trend observed in both novel and conventional PKC isoforms.  The 
decrease in kex for Trp containing constructs (1.6-fold for PKC and 2.3-fold for PKC) 
means the presence of Trp at position 22 lowers the k1, k-1, or both.  Because the apo 
chemical shifts which represent the weighted average of the two conformations are not 
considerably affected by the identity of residue 22, the excited state is very minor in 
comparison to the ground state, thus k1 is much larger than k-1.  Therefore, it is most 
likely that the kex differences are due to Trp at 22 lowering k-1 by increasing the stability 
of the excited state, which would contribute least to the observed apo chemical shifts. 
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Table 3. DOG binding affinity and conformational exchange summary for novel 
and conventional C1B and their position 22 mutants. 
 
 
 
 
The location of the exchanging residues in the structure, in combination with 
previous C1 structural and dynamic studies, provides insight into the possible 
exchanging conformations.  The conserved QG motif in all DAG binding C1 domains 
(Figure 3) is involved in five of the six hydrogen bonds that stabilize the ligand binding 
loops according to the C1B crystal structure.22  All of the residues in this hydrogen 
bonding network both in the loops and at the loop hinges are in exchange in the Trp 
containing constructs, while only the residues in the loops and in the 4 hinge region 
show significant dispersion when Tyr is at position 22 (Figure 11C and Figure 18B and 
C).  Further importance of this hydrogen bonding network to DAG affinity comes from 
mutating this conserved Gln residue to Glu such that two of the 6 loop stabilizing 
hydrogen bonds is eliminated in both C1B97 and C1B.98  While the mutant C1B 
domains still bound phorbol ester, binding to DAG or a cyclic-DAG-mimic was 
eliminated or severely attenuated, respectively.  In addition, the amides in this side-chain 
hydrogen bonding network undergo 
1
H exchange with water more rapidly than other 
residues in hydrogen bonding geometry in the structure (Figure 20).  This is further 
supported by molecular dynamics simulations using a structure from the C1B NMR 
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structure ensemble, which revealed ligand binding loop opening correlates with the 
partial loss of Gln128 hydrogen bonding network.
97
  Taken together, these studies 
suggest the conformational exchange is due to the transient forming and breaking of 
ligand binding loop hydrogen bonds.   
Specifically, I propose that a closed loop conformation is the high energy state 
sampled in solution and is more stabilized in the Trp containing constructs.  This 
conformation which contains the hydrogen bonding network between the loops holding 
them in close proximity to one another, is the conformation competent for DAG binding.  
This hypothesis is supported by the conformational exchange rates of the Tyr and Trp 
containing C1B constructs presented here and previously, the Gln128 mutant which 
destabilizes the closed loop conformation and eliminates DAG binding, the molecular 
dynamics simulation which reveals hydrogen bond loss and loop opening takes longer in 
the Trp containing construct, and the differences in H2O exchange rates of C1B and 
W252Y (Figure 19).  Furthermore, a measurement of C1 binding loop tip-to-tip distance 
in the solution ensembles of five different PKC C1 domains (C1A, C1A, C1B, 
C1B, and C1B) reveals the ligand opening sizes all vary, with the least variability 
being 2 Å (C1B) and the largest over 5 Å (C1B).  Another indication of binding loop 
dynamics is seen in the high B-factors for the ligand binding loops in a recent C1B 
crystal structure solved to 1.3 Å.
99
  This hypothesis also lends insight into the dramatic 
differences in affinity for smaller ligands such as diacylglycerol and the large cyclic 
ligands such as bryostatins and phorbol esters.  The lower energy open loop 
conformation can bind to the large ligand, while the higher energy closed loop 
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conformation is required to bind the smaller ligands.  This insight coupled with a better 
understanding of the dynamic loop sampling taking place in the different C1 domains 
could be used to develop better drugs targeting a specific protein or PKC isoform. 
It is difficult to speculate on the role that the Trp side-chain plays in stabilization 
of the closed loops.  The Trp side-chain is solvent exposed and not involved in any 
detectable interactions according to the side-chain H1 rapid water exchange and lack of 
inter-residue NOEs (Figure 21).  Position 22 side-chain is solvent exposed and mobile in 
all of the C1 solution structures, except for that of the weak DAG binding munc13 C1 
where the side-chain is positioned between the ligand binding loops.  However, the 
C1B crystal structure reveals a  ring stacking between Trp252 side-chain and a 
conserved zinc coordinating His269.  Since, the Tyr side-chain in not large enough to 
reach the distance to His269 and form this interaction, the  ring stacking between 
Trp252 and His269 could be stabilizing the higher energy closed loop conformation if it 
occurs in solution.  Even when interacting with His269, the Trp side-chain is solvent 
exposed; therefore, it is not surprising that the N1 does not show dispersion in R1 when 
going from one solvent exposed state to another as the chemical shifts may not change. 
In summary, NMR based ligand binding studies and relaxation measurements 
demonstrate the different properties of the conventional C1B and a novel C1B 
mimicking mutant, Y123W, as well as the novel C1B and a conventional C1B 
mimicking mutant, W252Y.  The Trp residue at position 22 increases the DAG affinity 
over an order of magnitude by one or both of the following mechanisms:  1) Trp side-
chain stabilizes a high energy apo conformation that is competent for DAG binding 
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and/or 2) Trp side-chain more readily partitions into the hydrophilic/ hydrophobic 
interface than Tyr, increasing ligand-free membrane binding affinity, and in turn driving 
the first step of DAG binding.  The second possible mechanism will be discussed in 
Chapter III.  All of the data together provides a strong case for applying these driving 
mechanisms to understanding differences in ligand binding affinities amongst C1 
domains from different PKC isoforms.  By designing small molecules which bind a 
specific C1 domain to stabilize the open or closed conformation, or modulate the 
dynamics between the exchanging conformations, it may be possible to develop drugs 
for cancers and cognitive impairment with a single mode of action. 
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CHAPTER III  
EFFECTS OF LIGAND BINDING AND POSITION 22 IDENTITY ON C1B 
MICELLE INTERACTIONS

 
 
Background 
The experiments presented offer insight into the interactions of C1B with a 
membrane-like hydrophobic environment and with membrane components that have 
been reported to activate PKC.  In addition to revealing differences between isoforms 
that lead to their functional divergence, these interactions can also be used as restraints 
in order to determine the solution structure of C1B in the bound state.  The binding 
studies presented in Chapter II revealed the residues affected by ligand binding in the 
presence of mixed micelles.  However, it is difficult to separate the residues which are 
affected by ligand binding, by micelle binding, or by both events.  These types of 
interactions will be required to determine the structure of a C1 domain bound to ligand 
in a hydrophobic environment.  A better understanding of the C1 structure in the active 
form of PKC could reveal key interactions for targeting PKC for treatment of human 
diseases. 
The first step in C1 ligand binding is thought to be an initial interaction with 
membranes in order to begin a two-dimensional search for membrane-bound DAG.
86
  
                                                 

 Parts of this chapter are reprinted with permission from Stewart MD, Morgan B, Massi 
F and Igumenova TI (2011) Probing the determinants of diacylglycerol binding affinity 
in the C1B domain of protein kinase C. Journal of Molecular Biology 408: 949-70. 
Copyright 2011 Elsevier. 
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However, as detailed in Chapter I, little is known about the affinity or identity of 
residues which interact with membranes in the absence of ligand.  To investigate these 
properties, NMR studies were conducted on the C1B, Y123W, C1B, and W252Y 
constructs used in Chapter II (Figure 4) in the presence of micelles, to mimic a ligand-
free membrane-like environment.  Surprisingly, these studies reveal a more extensive 
interface with micelles in the absence of ligand than when ligand is bound.  In addition, 
Trp at position 22 increases the protein-micelle interface in C1B constructs and 
increases the ligand-free micelle affinity and depth of insertion in C1B constructs.  
These differences in the initial membrane binding event likely play a role in the DAG 
affinities and specificities seen in the various PKC isoforms in vivo. 
Currently, the only experimentally determined structure of a C1-ligand complex 
is the crystal structure of C1B bound to a water soluble phorbol ester known as phorbol 
13-acetate (P13A).
22
  Three residues (Thr242, Leu251, and Gly253) form hydrogen 
bonds with the alcohol and carbonyl groups that are marked on the ligand structure in 
Figure 22.  In addition, van der Waals interactions occur between the three-, five-, and 
seven-carbon rings of the ligand and the hydrophobic pocket formed by the 12 and 34 
loops.  P13A does not contain hydrophobic tails like most other phorbol esters.  
However, it is hypothesized that the tails do not contribute to binding, because the 
phorbol ester ring atoms where they attach make the least protein contact in the complex.  
This is supported by molecular dynamics studies using a more typical phorbol ester, 
phorbol 12,13 dibutyrate (PDBu), which show similar hydrogen bonding and van der 
Waals interactions as reported in the crystal structure.
100
  Figure 22 shows the location of 
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the hydrophobic C3H7 tails on PDBu and highlights the ligand groups which form 
hydrogen bonds with C1 in the simulation.   
 
 
 
Figure 22. Structures of P13A, PDBu, and DOG.  Groups predicted to form hydrogen 
bonds to C1 are marked with red asterisks. 
 
 
 
None of these protein ligand contacts have been verified in solution or in a 
hydrophobic environment to more accurately represent the ligand-C1 complex in the 
cell.  In order to test which residues are important for phorbol ester binding in a more 
native-like environment, binding experiments were conducted on 37 single residue 
mutants in the presence of lipids.
101
  These studies revealed that all three mutants of the 
proposed Thr252 interacting residue retained tight binding, while mutation of the non-
coordinating Leu254 resulted in complete loss of binding.  The explanation of this is not 
clear from the crystal structure of the complex, highlighting the need for further 
investigation of the interactions in the C1-phorbol ester-lipid complex.  Furthermore, 
ligand contacts with the diacylglycerol head group, the native C1 second messenger, 
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have only been predicted from docking studies (predicted hydrogen bonding functional 
groups are marked in Figure 22). 
In this chapter, NMR is used to investigate C1B in the presence of P13A, 
PDBu, and PDBu in micelles.  Comparison of the different ligand-bound states reveals 
an additive effect on most loop residues due to binding of the rings of the phorbol ester, 
the presence of the hydrophobic phorbol ester tails, and the presence of the membrane 
mimic.  This is in contrast to the prediction from the P13A-bound crystal structure and 
simulations described above.  A comparison of C1B bound to micelles with the 
DOG/micelle binding studies in Chapter II reveals which residues are specifically 
affected by binding to micelles and those more affected by the presence of DOG.  
Furthermore, these studies reveal DOG binding causes a change in orientation of the C1 
domain insertion in the membrane mimic.  These changes in orientation could be 
transferred to the other regulatory domains to lead to the PKC activation by second 
messengers. 
Phosphatidylserine (PS) is another important biological ligand of the C1B 
domain, because it both increases PKC activation and regulates cellular localization.  
Cellular localization is controlled primarily through isoform specific interactions with 
receptors for activated C-kinase (RACKs) as well as varying affinities for membrane 
components, such as PS, that are not equally distributed throughout the intra-cellular 
membranes.
102
  Because the cellular localization regulates which substrates PKC has 
access to, the signaling events brought about by activation of different PKC isoforms 
strongly depend on the membrane specific localization.   
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While PS has been shown to be an activator of all PKC isoforms, the affinity and 
specificity varies between isoforms.  In identical studies, PKC was found to have a 
high affinity for PS compared to PKCin both the presence and absence of DAG.103  
While both C1 and C2 domains have been reported to bind to PS, the C1 domain is 
thought to confer the specificity for PS over other anionic phospholipids.
104
  However, 
this is not true for all isoforms.  The C1 domain of PKC, PKC, and PKC are specific 
for PS, while those of PKC and PKC bind non-specifically to PS.105  In this chapter, 
the effect of PS on DOG-bound C1B is measured to propose the first ever PS binding 
site on a C1 domain.  Similar studies using C1 domains from other PKC isoforms will be 
useful for determining the origin of PS specificity. 
Methods 
Micelle binding and affinity studies by NMR 
C1B, Y123W, C1B, and W252Y were prepared and assigned in the same 
NMR buffer as described in Chapter II.  Uniformly 
15
N enriched C1B and Y123W 
were added to 10 mM DPC/DPS micelles in a ratio of 7:3 and observed by HSQC.  The 
protein residues which shifted or were severely attenuated were noted.   
To obtain the relative affinities of C1B or W252Y to DPC/DPS micelles, a fast-
HSQC (fHSQC) 
106
 was collected using a Bruker 800 Avance system with a cryoprobe 
on separate samples containing varying detergent concentrations (5-200 mM) with 0.1 
mM protein in the above NMR buffer with less salt 20 mM KCl).  Titration curves were 
constructed for all cross-peaks that shift more than 0.05 ppm due to detergent addition 
by plotting the overall change in chemical shift () normalized to 1H using Equation 
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1versus the absolute detergent concentration (L0).  The curves were then fit with 
Equation 2.  Total chemical shift perturbation analysis was calculated as the difference 
between the apo spectrum and the spectrum at 75 mM detergent using Equation 1. 
The depth of C1B and W252Y insertion into the micelle in the presence and 
absence of DOG was probed using 1-palmitoyl-2-stearoyl-14-doxyl-sn-glycero-3-
phosphocholine (14-doxyl PC), a lipid with a paramagnetic doxyl tag on the 
hydrophobic tail from Avanti.  A fHSQC spectrum
106
 was obtained using a Bruker 800 
Avance system with a cryoprobe on a reference sample containing 100 mM mixed 
micelles (8:2 DPC:DPS), 0.15 mM protein, and NMR buffer with less salt (20 mM KCl).  
The paramagnetic sample contained the same concentration of DPC, DPS, and protein 
with 1.3 mM 14-doxyl PC incorporated into the micelles.  The peak intensity ratio of the 
reference and paramagnetic spectra were determined using NMRpipe and then corrected 
such that the H231 ratio was unity.  This ratio could then be compared between C1B 
and W252Y in both the absence of DOG and in the presence of saturating concentration 
of DOG (1 mM).  Experimental error was estimated from the root-mean-square noise 
level of the base plane in each spectrum. 
Micelle-free ligand binding studies of C1B 
In order to separate changes in chemical shift due to ligand binding from those 
due to micelle binding in the C1B species, micelle-free NMR studies were carried out 
on C1B 72 amino acid construct (C1B72) bound to P13A and PDBu.  A 72 amino 
acid construct corresponding to residues 92-163 of C1B from PKC Mus musculus gene 
was cloned into the PET SUMO vector from Invitrogen.  Over-expression in E. coli and 
 76 
 
isotopic labeling was carried out as described in Chapter II.  The cells were lysed using 
BPER lysis reagent in the presence of lysozyme, DNAase, and HALT protease inhibitor 
(Thermo Scientific).  The soluble fraction was purified using nickel affinity 
chromatography, and the fusion protein pooled and desalted into 20 mM tris-
(hydroxymethyl)aminomethane buffer pH 7.0 with 150 mM NaCl.  The buffer 
exchanged fusion protein was immediately cleaved using SUMO protease.  Cleavage 
was > 90% complete in less than two hours.  C1B72 was separated from SUMO and 
SUMO protease by nickel affinity chromatography followed by gel filtration.  The pure 
protein was exchanged into buffer containing 20 mM MES pH 6.0, 8% D2O, and 0.02% 
sodium azide.  All studies using C1B72 were performed in this buffer unless stated 
otherwise.  Backbone assignments were carried out on the apo protein using triple 
resonance HNCACB and CBCA(CO)NH experiments.
61
 
The water soluble phorbol ester, P13A, was obtained from Alexis Biochemicals 
and titrated into 80 M C1B72 at concentrations between 0 and 2.4 mM in separate 
samples from a concentrated P13A stock in DMSO.  DMSO was added to the P13A 
titration samples to maintain a constant 9% v/v.  The change in chemical shift of either 
1
H or 
15
N for significantly shifting residues was fit to Equation 2 with Kd as a global 
parameter.  The overall chemical shift perturbation was calculated using Equation 1 and 
the chemical shifts of C1B72 in apo and 2.4 mM P13A spectra. 
A sample for solid-state studies was prepared by adding 3.3 mM PDBu in DMSO 
to 9 mg of 0.88 mM uniformly 
15
N and 
13
C enriched C1B72 in NMR buffer.  The 
protein precipitation was ~80% efficient as analyzed by SDS PAGE.  Solid-state spectra 
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were collected by Tatyana Polenova’s group at University of Delaware.  Two-
dimensional NCO
107
 and dipolar assisted rotational resonance (DARR)
108
 spectra were 
used in combination with the three-dimensional spectrum of NCACX
109
, to obtain 
nitrogen and non-aromatic carbon chemical shifts. 
To ensure the precipitated protein represented the folded, PDBu-bound form, a 
sample similar to the above was prepared, then the unprecipitated protein in the 
supernatant was removed, and the pellet was resuspended in DPC/DPS micelles made in 
the C1B72mer NMR buffer described above.  The sample was then observed with 
solution NMR 
15
N HSQC.  The cross-peaks from the 50 amino-acid “core” of the 
domain are very similar to the PDBu micelle-bound C1B53 described in Chapter II, 
indicating the PDBu-bound protein in the pellet is not disordered.   
Measuring C1B detergent contacts 
In order to determine the contacts between C1B and ligand/micelles, a sample 
of 0.5 mM C1B53, 0.65 mM PDBu, and 50 mM DPC/DPS micelles in a 7:3 ratio was 
prepared as described in Chapter II in the imidazole NMR buffer and 20 mM potassium 
chloride.  Samples used for NOESY experiments contain 20% fully protonated DPC 
obtained from Avanti Polar Lipids in order to determine protein to DPC contacts.  
Samples used for 
15
N edited NOESY contained 
15
N uniform protein labeling.  The 
sample used for 
13
C edited NOESY was prepared with 
15
N and 
13
C uniformly enriched 
protein, lyophilized, and then resuspended in 99.99% D2O.  NOESY experiments were 
performed as described in the Varian BioPack User Guide using the supplied pulse 
sequence with a 100 ms mixing time on a Varian VNMRS 900 MHz instrument.  
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Detergent chemical shifts were assigned using literature values for similar molecules in 
similar conditions and a
 13
C HSQC spectra of just the mixed micelles collected in a non-
constant time manner on a Varian VNMRS 600 MHZ instrument.
110-112
 
Results 
Trp at position 22 in C1B mutant, Y123W, increases the interaction surface with 
ligand-free micelles 
According to the current model,
86
 the association of C1B with DAG- and 
phorbol ester containing membranes occurs via a two-step mechanism: 1) a non-specific 
association of the protein with membranes, and then 2) a two-dimensional search for the 
membrane-embedded ligand.  To investigate the effect of the mutation on the initial 
membrane-binding event, 
15
N-enriched C1B and Y123W were incubated with ligand-
free DPC/DPS micelles.  The 
15
N
 
-
1
H HSQC spectra of the two proteins in the presence 
of micelles were collected and compared with those of the corresponding apo-states 
(blue compared to black spectra in Figure 6).  In both C1B and Y123W, the intensities 
of several cross-peaks are substantially attenuated in the presence of micelles, sometimes 
leading to complete peak disappearance.  This indicates that the kinetics of the binding 
process is intermediate on the chemical-shift timescale.  In addition, several cross-peaks 
are shifted in the micelle-containing sample of Y123W compared to the apo-state. 
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Figure 23. Mapping of the interaction surface of C1B(A) and Y123W (B) with 
ligand free micelles.  The cross-peaks of residues that interact with DPC/DPS micelles 
are either significantly attenuated (yellow) or shifted (orange) compared to their 
positions in the micelle-free spectra. (A) In C1B, the entire 34 loop, comprising 
residues Tyr123-Gly129, and Tyr109 of loop 12 are involved in the interactions with 
micelles.  (B) In Y123W, both 12 and 34 loops and several adjacent residues are 
involved in the interactions with micelles.  In (B), the Tyr at position 123 was replaced 
with Trp in the ensemble-averaged NMR structure of C1B using WHATIF.87  Overall, 
the total surface area involved in the interaction with micelles is larger in the mutant than 
in C1B. 
 
 
 
The perturbed residues are mapped onto the structure of C1B in Figure 23 for 
C1B (A) and Y123W (B).  In C1B, the intensities of cross-peaks corresponding to 
Tyr109 of loop 12 and the entire 34 loop comprising the Tyr123-Gly129 stretch are 
severely attenuated as a result of interactions with micelles.  Compared to C1B, many 
more residues in Y123W respond to the presence of detergent micelles.  They include 
the entire loop and hinge regions of 12 (Lys105-Cys115) and 34 (Ser120-Gly129).  In 
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addition, residues Cys118, Asp136, Asn138, Lys141, Gln142, Cys143, and Val147 are 
also affected by interactions with micelles, as manifested in the change of their chemical 
shifts.  It is evident that when mapped onto the C1B structure, the perturbed regions in 
the Y123W mutant form a surface that encompasses almost the entire top half of the 
domain.  These results suggest that Trp at position 123 facilitates the interactions of 
C1B with DPC/DPS micelles.  25 residues out of the total 53 are affected by these 
interactions in the mutant, as opposed to just 8 in C1B.  This difference in interaction 
modes disappears when the specific binding to DOG takes place, as shown in Figure 8C 
and D.  Thus, the Y123W mutation most likely affects the kinetics of the association of 
C1B with lipid membranes in the two-step binding mechanism.86   
Micelle-free phorbol ester studies exhibit varying degrees of C1B interaction with 
ligand rings, hydrophobic chains, and micelles 
Due to the exchange broadening observed in C1B when bound to micelles, it is 
impossible to access the degree of chemical shift change due to micelle binding versus 
ligand binding.  For this purpose, NMR studies were carried out on C1B bound to 
phorbol ester in the absence of micelles.  The purpose of incorporating micelles in the 
ligand binding studies in Chapter II was not only to mimic the membrane where C1 
binds to ligands in the cell, but also to provide solubility of the hydrophobic complex 
formed after ligand-binding.  To avoid this problem for micelle-free ligand titrations, the 
water soluble phorbol ester, P13A, was used.   
P13A was added to a 72 amino acid construct of C1B (C1B72) in a step-wise 
fashion up to 2.4 mM and observed by 
15
N-
1
H HSQC.  The change in chemical shift of 
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all significantly affected residues could be plotted versus the ligand concentration and fit 
to Equation 2 to obtain a global Kd of 0.61 ± 0.01 mM.  Representative residues can be 
seen in Figure 24.  Because C1B binding of PDBu in the presence of micelles was 
slow-exchange on the NMR time scale (Figure 7), the affinity to phorbol ester with and 
without micelles cannot be directly compared.  However, this binding is 25 fold weaker 
than even the weakly binding diacylglycerol in the presence of micelles.  Conventional 
PKC C1B domains have been reported to bind to phorbol ester in the presence of 
liposomes in the low M range.  Using these data, the presence of a membrane mimic is 
estimated to enhance phorbol ester binding 50-75 fold.
28,104
   
 
 
 
Figure 24. P13A affinity of C1B72 as measured by change in chemical shift during 
NMR observed titration.  Curves represent a global fit of all significantly shifting 
residues to Equation 2 with a Kd of 0.61 ± 0.01 mM. 
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Figure 25. Chemical shift perturbation due to binding P13A (green) or PDBu in the 
presence of micelles (orange). Missing data are denoted with asterisks.  The ligand 
binding loops are highlighted in gray.   
 
 
 
The difference in chemical shifts between apo and P13A-bound C1B72 are 
plotted in green in Figure 25 for the residues in the core of the protein.  Residues in both 
the 12 and 34 loops respond to P13A binding.  Two proline residues (112 and 148), as 
well as two exchange-broadened residues (Gly109 in 12 and Leu124 in 34) are 
missing from the analysis (asterisks in Figure 25).  This is in contrast to the spectrum of 
C1B72 bound to PDBu in the presence of micelles in which no residues are exchange-
broadened beyond detection, including Gly109 which is missing in the apo spectrum.  
When considered with the exchange broadening observed upon binding micelles alone 
(Figure 23) this indicates that both ligand and micelles are needed to quench the 
conformational exchange observed in the loops in Chapter II. 
When the change in chemical shift due to binding P13A is compared to the 
chemical shift differences due to binding PDBu in micelles (Figure 25), several residues 
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are almost equally perturbed, such as Phe114, Leu122 and Gln128. This indicates the 
change in environment experienced in these regions is due to phorbol ester binding, 
rather than burial in a hydrophobic environment.  This is surprising since none of the 
amides from these residues are directly hydrogen bonded to the P13A ligand in the 
C1B crystal structure.  Instead, the amide groups which are reported to form protein-
P13A hydrogen bonds (Gly124 and Thr113) only shift to half of the final perturbation 
seen when binding PDBu and micelles.  This suggests that either the presence of 
micelles alters the structure of the protein-ligand complex or the protein-ligand interface 
is still accessible to detergent.  With the exception of Thr113 and Phe114, the other 
residues in the 12 loop experience a vast majority of their chemical shift change from 
binding to micelles rather than ligand.   
To determine if the differences seen here are due to the nature of the ligand itself 
(P13A versus PDBu) or due to the presence of micelles, a sample was prepared of 
C1B72 bound to PDBu in the absence of micelles.  Because of the insolubility of the 
complex, uniformly enriched 
15
N and 
13
C protein was precipitated into a pellet by 
addition of the hydrophobic PDBu ligand.  Then, solid-state NMR techniques were used 
to collect two-dimensional NCO and DARR spectra as well as a three-dimensional 
NCACX spectrum in order to determine the chemical shifts of non-aromatic 
15
N and 
13
C 
atoms in the protein.  As demonstrated by the DARR spectrum seen in Figure 26, the 
spectra are nicely resolved and indicative of folded protein in the ligand-precipitated 
pellet. 
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All of the residues in the 50 amino-acid core of the protein are present in the 
spectra, except for the 34 loop residues Leu125, Ile126, and His127.  Mobile residues 
are often missing from solid-state NMR spectra, indicating that this loop is likely 
undergoing motion even when bound to PDBu.  This supports the claim in the previous 
section that both ligand and micelles are needed to quench the loop motion. 
 
 
Figure 26. An excerpt of the solid-state DARR spectrum of C1B72 bound to 
PDBu.   The spectrum reveals transfer from side-chain carbons (y-axis) to all side-chain 
and backbone carbons (x-axis) within the same residue.  The approximate regions of 
carbon chemical shifts are labeled. 
 
 
 
The changes in 
15
N chemical shifts for non-proline residues in and around the 
ligand binding loops are plotted in Figure 27 for each of the three phorbol ester bound 
states.  The three residues located in the loop hinge regions (Phe114, Leu122 and 
Gln128) that showed equal perturbation due to phorbol ester binding regardless of 
micelle presence also have equal shifts when using PDBu as the ligand.  However, most 
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of the loop residues which showed significantly larger perturbation in the presence of 
micelles, have a PDBu-bound 
15
N chemical shift between that of PDBu-bound in the 
presence of micelles and P13A-bound in solution.  This indicates that the addition of the 
hydrophobic tails in PDBu compared to P13A as seen in Figure 22 do have an effect on 
ligand binding residues contrary to what was predicted from the P13A-bound C1B 
crystal structure.
22
  However, micelle binding in the presence of ligand still has the 
largest overall effect on the ligand binding loops.  The degree of difference made by the 
presence of micelles will be better assessed by assignment of the 
13
C chemical shifts for 
all non-aromatic side-chain carbons in the PDBu-bound solid-state spectra.  These can 
then be compared with the chemical shifts of the same atoms in the PDBu micelle-bound 
C1B53 construct, which will be assigned in order to interpret the NOEs discussed in 
the next section. 
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Figure 27. Comparison of 
15
N chemical shift changes in phorbol ester bound states.  
The difference in 
15
N chemical shifts of non-proline residues in and around the ligand 
binding loops between the apo-state and PDBu-bound-state in micelles (orange), PDBu-
bound without micelles observed with solid-state NMR (blue), and P13A-bound without 
micelles(green).  Lines connect sequential residues with available 
15
N chemical shift 
data.   
 
 
 
C1Bdetergent interactions revealed from NOESY experiments 
Chemical shifts report on differences in the environment of a particular nuclei, 
which can occur either by direct binding to a ligand or changes in protein structure due 
to the ligand binding.  To directly assess the proximity of affected residues to the 
detergent micelles, three-dimensional 
15
N-edited and 
13
C-edited NOESY spectra were 
collected.  In these experiments, two dimensions are used to resolve a given 
1
H-
15
N or 
1
H-
13
C pair and NOE cross-peaks arise in the third dimension at the chemical shift of 
any 
1
H within ~5 Å.  The volume of the NOE cross-peak is proportional to the distance 
between the two 
1
H atoms.  The chemical shifts of 
1
H in the detergent molecules were 
assigned as described in the methods section. 
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Figure 28. Strips of the 
15
N edited NOESY spectrum illustrating NOE cross-peaks 
from loop residues to DPC and DPS.  The NOE peak is labeled with the numbering 
corresponding to the DPC molecule shown on the left or the DPS molecule shown on the 
right and the chemical shifts are marked with a black (red) dotted line for DPC (DPS). 
 
 
 
Figure 28 shows the NOEs detected from the backbone amides of residues in the 
ligand binding loop and hinge regions to 
1H’s in DPC and DPS.  An all-atom assignment 
of the protein is underway to assign the NOE cross-peaks with certainty.  However, from 
the initial assessment of the hinge residues, Thr113 and Leu121, strong NOEs are 
observed to methylenes directly adjacent to the phosphate of DPS (C3 and C2 
respectively).  This indicates the hinge regions of the loops are in close proximity to the 
lipid head group, thus the surface of the micelle.  Conversely, the residues in the loops 
(Ser111, Gly124, and Leu125) have stronger NOEs than the hinge residues to 
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methylenes in the hydrophobic tails of DPC and DPS, indicative of deeper insertion in 
the micelle.  The 
13
C- edited NOESY shows a similar pattern in the NOEs from the 
backbone H of the loop and hinge residues.  Assignment of the side-chain atoms will 
provide more probes for assessing the degree of interaction with the detergent micelles.  
Not only do these experiments provide qualitative information about the placement of 
residues in the micelle, but quantification of the NOE cross-peak intensity will also 
supply valuable distance restraints for determining the first solution structure of a ligand-
bound C1 domain once all 
1
H in the protein and ligands are assigned. 
Trp at position 22 in C1B increases micelle affinity in the absence of ligand 
Due to the intermediate exchange regime of micelle binding in C1B, it was not 
possible to measure the affinity to the micelles alone.  To quantify micelle affinity and 
measure dependence on position 22 identity, C1B and W252Y were titrated with 5-200 
mM DPC/DPS mixed micelles and observed using NMR fHSQC spectra.  Cross-peaks 
in both constructs gradually shift due to micelle binding to reflect an average of the 
bound and unbound populations (Figure 29A and B). This so called fast-exchange 
behavior allows for the Kd to be determined by fitting the change in chemical shift at 
increasing detergent concentrations to Equation 2 as shown in Figure 29E and described 
in the methods.   
The residues in the 12 and 34 loops bind micelles with a higher affinity than 
residues in the -helix, so global fitting was done separately for residues in these two 
groups.  The groups are shown in Figure 29C and D.  The C1B residues in the 12 and 
34 loops exhibit tight binding behavior.  These curves can be fit with two straight lines 
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with an inflection point at 9.0 ± 0.3 mM as demonstrated for Leu250 in Figure 29E, 
which is set as the upper limit for the Kd of C1B.  This is significantly tighter than the 
loop residues in W252Y, which bind with a Kd of 10.9 ± 0.6 mM.  While the -helix 
from both constructs binds weaker than the 12 and 34 loops, the respective regions are 
each weaker in the W252Y mutant when compared to C1B.  Several residues located 
close to both the loops and helix in three-dimensional space also respond to micelle 
binding.  These residues were fit individually with Kd’s which range from 5.8 – 8.7 mM 
for C1B and 16.1 – 21.9 mM for W252Y.  These values are between the Kd’s found for 
the loops and helix in each respective construct.  While it is unclear what gives rise to 
the separate Kd values found in the loop residues versus helix residues, the following 
experiments in this chapter provide insight into the possible explanations.  Overall, the 
mutation leads to at least 2 to 3-fold decrease in mixed micelle affinity for all regions of 
the protein that respond to micelle binding.  
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Figure 29. C1B and W252Y binding to DPC/DPS mixed micelles. An overlay of 
HSQC spectra excerpts collected on uniformly 
15
N enriched C1B (A) or W252Y (B) at 
increasing concentrations of DOG micelles (blue to red rainbow-colored).  Residues 
which fit with a lower Kd (dark green), higher Kd (yellow), or between the two Kd values 
(green) are highlighted on the crystal structure of C1B(C) or W252Y homology model 
(D).  (E) The change in chemical shift due to binding is plotted for representative 
residues that fit with a higher or lower Kd in yellow and dark green respectively.  Curves 
represent the fit to Equation 2 with the “higher” or “lower” Kd as a global parameter. 
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Figure 30. Chemical shift perturbation of C1B and W252Y due to micelle binding 
at 0.75 mM detergent.  The change in chemical shift calculated with Equation 1 is 
plotted in (A) and mapped onto the C1B crystal structure in (B) and W252Y homology 
model in (C).  Residues broadened due to conformational exchange are marked with 
purple asterisks in (A) or colored purple in (B) and (C).  Trp252 side-chain is colored 
according to the shift of the NH1 amide.  The figure shows that while binding occurs in 
the same region of both proteins, the chemical shift is larger in C1B than W252Y for 
comparable residues. 
 
 
 
C1B and W252Y residues located on the -helix and both ligand binding loops 
show a large change in chemical shift due to mixed micelle binding.  The chemical shift 
perturbation is not quantifiable for many loop residues due to exchange broadening in 
apo, micelle-bound, or both spectra (colored purple or marked with a purple asterisk in 
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Figure 30).  While the identities of affected residues are the same, comparison of the six 
significantly shifting residues that are quantifiable in both constructs reveals a greater 
chemical shift perturbation due to micelle binding in the C1B construct.   
Interestingly, the change in chemical shift due to micelle binding of NH1 on the 
Trp252 side-chain is 90% of the overall chemical shift change seen due to DOG binding 
in micelles.  This supports the hypothesis drawn in Chapter II that the side-chain does 
not contact the ligand, and likely does not change structure based on ligand binding.  In 
addition, it alludes to the importance of the position 22 side-chain in the initial 
partitioning into the interface of hydrophilic / hydrophobic environment of the micelle, 
which mimics the membrane interface. 
The backbone of several residues display similar behavior, in that > 80% of the 
chemical shift change they experience upon binding DOG in micelles is also seen for 
binding micelles in the absence of DOG (Figure 14 and Figure 30).  In W252Y, three 
significantly shifting residues fall into this category: Asn237, Cys244, and Leu254.  The 
first two residues form the 12 hinges and Leu254 is located on the tip of the 34 loop.  
In C1B, two of the above residues are broadened beyond detection, but Cys244 
displays the same behavior as in W252Y.  In addition, Leu259 on 4, and the helix 
residues Lys271 and Glu274, also have this pattern.  These data are reminiscent of what 
was observed in the C1B72 micelle-free ligand binding studies: that the loop hinge 
regions and helix residues interact more with the micelle, as opposed to directly with the 
ligand.   
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Leu254 is the only residue in the middle of the ligand binding loop that responds 
mostly to micelle binding rather than DOG binding.  This residue also has the largest 
chemical shift difference between PDBu and DOG binding (both in the presence of 
micelles).  Leu254 PDBu-bound versus DOG-bound chemical shift difference is greater 
than 1.2 ppm, while the difference between the cross-peaks for other residues in these 
two spectra, even those proposed in hydrogen bonding interactions, are less than half of 
that.  Together, this indicates Leu254 is likely distanced more from DAG, than it is from 
phorbol ester in three-dimensional space.  This provides a restraint for the eventual 
structure determination of C1B bound to DAG and indicates a difference from the 
phorbol ester-bound structure. 
DPS interacts with C1B 34 loop and -helix 
In order to determine which residues bind to DPS in the mixed micelles used in 
these studies, the chemical shifts of DOG saturated C1B in mixed micelles (DPC/DPS 
7:3 ratio) is compared with those in micelles composed of only DPC.  The HSQC of 
these two samples are overlayed with the apo-state as shown in Figure 31.  The residues 
with a large change in chemical shift due to DPS incorporation in micelles are located at 
the N-terminal side of the -helix, and in the hinge regions of the 34 ligand bind loop 
(indicated with red arrows in Figure 31A and mapped onto the structure in Figure 31C).  
Interestingly, the residues on the 12 loop and at the tip of the 34 loop, which show a 
strong response to DOG binding in DPC micelles, are not significantly affected by DPS 
incorporation (Figure 31C). 
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Figure 31. The effect of DPS micelle incorporation on C1B chemical shifts.  A) 
Overlay of C1B15N-1H HSQC spectra in the apo-state (black), bound to 0.5 mM DOG 
in the presence of 10 mM DPC micelles (blue), or the same DOG and micelle 
concentration with 30% DPS incorporated (red).  Significantly affected residues are 
labeled on the spectra. Asterisks denote residues with missing apo peaks due to 
broadening and helix residue labels are underlined.  The change in chemical shift due to 
binding DOG in DPC micelles is shown with blue arrows in (A) and mapped onto the 
C1B crystal structure with a gray to blue gradient in (B).  The difference in chemical 
shift due to DPS incorporation is shown with red arrows in (A) and mapped onto the 
structure with a gray to red gradient in (C).  For both (B) and (C), the residues with 
missing data and zinc atoms are colored white. Residues in the 12 and 34 loops are 
drastically shifted due to DOG/DPC binding, while residues in the -helix are mostly 
shifted due to DPS incorporation. 
 
 
 
As shown by the red arrows compared to the blue arrows on the HSQC spectra, 
the vast majority of the perturbation experienced by the -helix residues (underlined in 
Figure 31) when binding DOG in mixed micelles is due to the presence of DPS.  The 
identities of the -helix residues most perturbed by DPS incorporation are His270, 
Lys271, and Glu274.  His, Lys, and Glu residues were also identified as the DPS binding 
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residues in the conserved membrane-targeting FYVE domain.
113
  This indicates the 
changes in chemical shifts observed for these residues in C1B are likely due to direct 
DPS binding rather than a change in protein or micelle structure from DPS 
incorporation.  These residues and those in close proximity also respond to DPC/DPS 
micelle binding with a separate and weaker Kd from the loop residues in the previous 
section (Figure 29).  Given the separation of residues by affinities looks very similar to 
the separation seen due to DPC versus DPS binding, the residues identified here likely 
represent the first known phosphoserine binding site in a C1 domain. 
Comparison of the overall chemical shift changes due to DOG/DPC/DPS binding 
to those of DOG/DPC binding also indicates the C1B domain changes orientation in the 
micelle in such a way that the helix is closer to the micelle.  This was also observed in 
the micelle binding study of the FYVE domain, which changes orientation 25º upon 
binding DPS.
113
  To test changes in orientation of C1B in micelles as well as test for 
direct micelle binding of the -helix residues, the micelle proximity of each residue is 
measured in the next section.  
DOG binding and position 22 identity change the depth and orientation of CIB in 
micelles 
Differences in micelle orientation are indicated by the effect of DPS as discussed 
in the previous section.  In addition, C1B and Y123W studies with ligand free micelles 
discussed above point to a difference in the protein interface with ligand-free micelles 
that could not be measured in these constructs due to the intermediate NMR timescale.  
To gain insight into the effect of ligand binding and the position 22 identity on the 
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interaction with micelles, the depth of insertion of C1B and W252Y into micelles is 
probed in both the presence and absence of DOG.  This was done through incorporation 
of small quantities of a lipid with a paramagnetic tag on the 14
th
 carbon (14-doxyl PC) 
into the mixed DPC/DPS micelles.  The paramagnetic relaxation effect (PRE) due to the 
proximity of a residue to the paramagnetic tag was determined by comparing the peak 
volumes in an fHSQC spectrum from identical samples with and without 14-doxyl PC.  
In addition to revealing differences in insertion due to residue 22 identity, the PRE 
values can be used as restraints in future structure refinement. 
 
 
 
Figure 32. Depth of micelle insertion measured with paramagnetic relaxation 
enhancement (PRE).  Doxyl-14 labeled PC is incorporated in mixed micelles (A) or 
mixed micelles with DOG (B).  PRE is plotted for C1B (black) and W252Y (cyan) 
normalized to His231.  The differences in PRE between C1B and W252Y are mapped 
onto the C1B apo crystal structure to the right of the graphs. 
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In both the presence and absence of DOG, the largest PRE was seen for residues 
in the 12 and 34 loops, with significant PRE for residues on the N-terminal side of the 
-helix (Figure 32).  This is consistent with the two most N-terminal -helix residues 
(His270 and Lys271) interacting with the DPS head groups as proposed in the previous 
section.  An interaction with the DPS head groups would bring the helix residues close 
enough to the paramagnetic tag located in the hydrophobic core of the micelle to affect 
their relaxation properties.  However, they would not be expected to be relaxed beyond 
detection as observed for the loop residues that are inserted into the hydrophobic core of 
the micelle. 
Both constructs have a significantly larger PRE in the absence of DOG for 
residues in the 12 and 34 loops and two residues which are on the N-terminal side of 
the 34 loop (Ser249 and Leu251) when compared to the PRE in the presence of DOG 
(Figure 32).  In addition, C1B residues on the N-terminal side of the 12 loop (Tyr236 
and Asn237), residues between the loops (245-258), and residues on the N-terminal side 
of the -helix (267-270) are also more inserted in the absence of DOG than when it is 
present.  In the context of the mutant these residues do not significantly change the depth 
of insertion based on DOG presence.  This indicates that while both constructs have a 
more extensive interface with ligand-free micelles than in DOG-bound micelles, the Trp 
containing construct varies more due to ligand binding. 
Residues with a significantly different PRE between C1B and W252Y are 
highlighted in Figure 32 on the apo C1B crystal structure (1PTQ).  In the absence of 
DOG, C1B residues at the back of the binding loops in the shown orientation are more 
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inserted than they are in W252Y (colored black in Figure 32A).  However, once the 
constructs bind to DOG, both sides of the ligand binding loops are more inserted in the 
W252Y construct (cyan residues in Figure 32B).  This means that both DOG binding 
and position 22 identity lead to different orientations in the membrane-like environment. 
Discussion 
The goals of the ligand and micelle studies presented in this chapter were 
twofold: 1) Determine the effect of residue 22 identity on affinity and interaction with 
micelles. 2) Establish which residues interact with the ligand, the micelles, or both for 
use as structural restraints in future NMR structure determination.  For C1B constructs, 
ligand binding was assessed with solution NMR titrations of hydrophobic ligands (DOG 
and PDBu) in the presence of micelles, solution NMR titration of a hydrophilic ligand 
(P13A) without micelles, and solid-state NMR studies bound to a hydrophobic ligand 
(PDBu) in the absence of micelles.  Micelle binding could not be accessed directly due 
to the intermediate exchange regime.  However, in C1B constructs, the effects of 
residue 22 identity on micelle binding can be determined, as well as differences in 
residues involved in micelle binding versus ligand binding. 
Both Trp and Tyr have been found to localize to the same part of lipid bilayers: 
the interface of the hydrophobic tails and hydrophilic head groups.
114,115
  However, Trp 
partitions more readily into the interface.
116
  To determine the role of Trp at position 22 
in C1 domain membrane partitioning, the affinity of C1B and W252Y for DPC/DPS 
mixed micelles was determined in the absence of any additional ligand using NMR 
(Figure 29).  Both constructs associate with micelles in a saturable fashion, indicating 
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they have at least one specific interaction site.  This has important implications in the 
context of PKC maturation.  Immature PKC protein has been reported to bind to 
membranes in the absence of second messengers, before becoming the phosphorylated 
mature form.
117
  It is possible that one or both C1 domains supply a membrane 
interaction site. 
The change in NMR chemical shifts that occur upon micelle titration were used 
to determine the micelle affinity.  While C1B was reported to bind to 
phosphatidylglycerol (PG) containing lipids with ~100 mM Kd,
10
 the affinity of a C1 
domain to the native anionic head group, PS, has not been measured.  Here, the Kd 
measured using the loop residues in C1B construct is significantly tighter for DPC/DPS 
micelles (< 10 mM).  Because the number of detergent molecules per micelle is not 
known for this system, this Kd is determined from a fit using detergent concentration as 
the ligand.  Once the number of molecules per micelles is available, this Kd will be much 
lower (likely 1-2 orders of magnitude).
113
  However, in both cases, 1) PG containing 
lipids and 2) PS containing detergent micelles, the affinity is much weaker than in the 
presence of ligand (DAG or phorbol ester).  From the C1B72 titration with P13A, it is 
clear that the affinity for ligand in the absence of micelles is also weak (0.6 mM).  
Together, these data point to the synergy of ligand and micelle binding to produce a 
stable complex capable of activating PKC. 
Both the loop and helix residue Kd’s were tighter in C1B than W252Y by at 
least 2- to 3-fold.  While this difference in micelle affinity is smaller than the difference 
in DAG affinity between C1B and W252Y (> 30-fold as described in Chapter II), the 
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higher affinity for a ligand-free lipid environment where C1B is then restricted to a two-
dimensional search for the ligand as proposed from analysis of the C1 binding kinetics,
86
 
could contribute to the higher DAG sensitivity seen in constructs containing Trp at 
position 22.  This idea is supported by the finding that the C1B W252G mutant, which 
still binds phorbol ester, is unable to bind to lipid bilayers containing phorbol ester.
101
 
For both constructs, the loop residues fit with a Kd significantly tighter than 
residues in the helix.  Because the residues all fit well to a single-site binding equation, 
one explanation is a single C1 molecule can bind to more than one micelle.  This 
scenario is unlikely due to steric hindrance from the close proximity of the loop and 
helix residues.  In addition, the line widths of the residues that do not shift upon binding 
micelles broaden significantly in response to the first binding event and then do not 
show a second broadening event.  Because line widths report on the rate of the complex 
tumbling in solution, this indicates the tighter Kd site for the loop residues is the only 
micelle binding event.  This also makes it unlikely that the micelle changes size or shape 
significantly due to the increase in detergent concentration, or this too would be reported 
in broadening of the line widths.   
The best explanation for the second binding event involving the -helix residues 
is that C1 bound to micelles recruits DPS from the unbound micelles at increasing 
concentrations of detergent.  Specifically, this process must occur through DPS 
equilibrium between micelle-bound and free in solution, and the free DPS with the C1-
micelle complex, in order for the line widths to remain the same during the second 
binding event.  Little is known about the nature of DPC/DPS micelles and their critical 
 101 
 
micelle concentration, so it is difficult to comment on how likely these equilibria are in 
solution.  However, given the line widths report only one micelle binding event, the 
binding data fit to two separate single-site binding events (Figure 29), DPS appears to 
bind the residues which fit with the second Kd (Figure 31), and the helix residues bind 
but are not deeply inserted in the micelle (Figure 32), DPS redistribution to C1-bound 
micelles from micelles in excess of C1 fits all the available data.  
Even though all PKC isoforms are activated by PS and PS specificity is thought 
to be conferred by the C1 domain in several isoforms, this is the first report of a specific 
PS binding site in C1.
104
  The C1B residues that respond the most to DPS 
incorporation, His270 and Lys271, have a similar identity to those seen in other PS 
binding sites.
113
  These residues correspond to Lys141 and Gln142 in C1B, which also 
shift due to binding DPC/DPS micelles in the Y123W mutant (Figure 23).  In all C1 
domains found in conventional and novel PKC isoforms, there are positively charged 
residues in at least one of these two positions, and many have a positive residue at both 
positions (Figure 3).  Consecutive positive residues has been identified as a common PS 
binding motif in proteins not related to PKC.
118
  However, when comparing the C1 
domains that bind specifically to PS to the ones that bind equally as well to any 
negatively charged phospholipid, there is not a clear trend in variability of the residues at 
this position.  Future studies similar to the ones reported here using C1 domains from 
other isoforms along with mutagenesis will be useful for determining which residues 
confer PS specificity. 
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An NMR investigation of conventional C1B and its position 22 mutant, 
Y123W, points to the Trp containing construct having a more extensive interface with 
ligand-free mixed micelles (Figure 23).  However, the binding was intermediate on the 
chemical shift timescale, so the affinity and depth of insertion could not be determined.  
Since C1B is in the fast exchange regime for most residues, the effect of position 22 
identity on the depth of micelle insertion can be measured.  This was assessed by 
comparing the PRE due to proximity to a PC lipid tagged with doxyl on the 14
th
 tail 
position that is incorporated into the mixed micelles.  The pattern of insertion is similar 
overall for the observable residues, but four residues on the opposite side of the protein 
from position 22 are significantly more inserted in the Trp construct (Figure 32A).  This 
likely represents a difference in orientation in the ligand-free micelles due to position 22 
identity.  In vivo, Trp at position 22 could orient the membrane-bound C1 domain in a 
position that is more favorable for DAG binding once it is encountered in the 
membranes. 
 However, once the domains bind to DOG the opposite trend is seen in insertion 
for four loop residues, including the residue at position 22 (Figure 32B).  This is 
consistent with what is seen for C1B constructs when comparing micelle only binding 
in Figure 23 with DOG saturation in the presence of micelles in Figure 8.  In C1B 
fewer residues are affected by micelles in the absence of DOG than in the presence, 
while Y123W has more residues which are affected by micelle binding in the absence of 
DOG than in the presence.  This change in domain orientation that occurs due to DOG 
binding could signal release of the neighboring regulatory domains in order to activate 
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PKC.  This type of signaling event was reported for a multi-domain membrane-binding 
protein which changes orientation upon binding the lipid second messenger 
phosphatidylinositol 4,5-bisphosphate.
119
 
These studies also provide information to separate residues which are responsible 
for ligand binding from those responsible for micelle binding.  This can be seen in 
Figure 32, where the -helix residues and ligand hinge regions are deeper inserted in 
micelles before ligand binding.  Chemical shift perturbation analysis of C1B residues 
bound to micelles compared to DOG binding in the presence of micelles revealed that 
almost all of the perturbation of the residues in these regions occurs due to interactions 
with the micelles (Figure 14 and Figure 30).  Both experiments indicate the loop hinges 
experience an environmental change due to micelle binding, rather than binding to DOG. 
While it was not possible to directly assess differences between micelle-bound 
and ligand-bound states in C1B, a similar result was seen in the comparison of the 
chemical shift perturbation of C1B bound to phorbol esters in the presence and absence 
of micelles (Figure 25).  In this case, the residues in the hinge regions shifted less than 
20% when binding P13A as compared to PDBu in micelles.  While some of this 
difference may be due to the hydrophobic tails found in PDBu (Figure 27), micelle 
binding still had a significantly larger effect on the hinge region than ligand binding 
alone.   
Why do the hinge regions respond more to micelle binding than to binding DOG 
or phorbol ester?  The ligand hinge region forms a series of hydrogen bonds seen in the 
C1B crystal structure.  As described in Chapter II, I propose these hydrogen bonds 
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stabilize the closed loop conformation competent for ligand binding.  One possible 
explanation for the behavior observed here is that micelle binding also stabilizes the 
hydrogen bonds, selecting for the conformation more competent for DOG binding.  This 
theory would be consistent with changes in amide chemical shifts for residues that are 
involved in hydrogen bond formation.  However, because the conformational exchange 
is still seen in the presence of micelles for both constructs (Figure 23 and Figure 30), it is 
clear ligand binding is necessary to lock the protein in one conformation.   
A second possibility is that the hinge regions interact with the polar ligand head 
groups.  This theory is supported by the 
15
N NOESY experiments, which revealed strong 
cross-peaks between loop hinge residues in C1B and atoms in detergent head groups 
(Figure 28) as well as in the changes in chemical shift seen in the 34 loop hinges of 
C1B in response to DPS incorporation (Figure 31).  If this is the case, determining the 
structure of C1B bound to ligand in a hydrophobic environment will be important for 
elucidating these specific interactions.  In addition to the conclusions drawn here, the 
chemical shifts, PRE, and NOESY results presented provide valuable information that 
can be used directly as secondary structure and distance restraints for determining the 
ligand-bound structure of C1B.  These will be discussed in more detail in Chapter V. 
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CHAPTER IV  
ROLE OF CYS151 IN C1B REACTIVITY

 
 
Background 
In addition to the C1 domain’s regulation of PKC via second messengers and 
membrane targeting, it also has been implicated in activation of PKC by reactive oxygen 
species.  PKC activation by H2O2, in the absence of second messengers, was found to 
occur from modification of the regulatory domain.
120
  Other studies narrowed down the 
modification to the C1 domain when they found that treatment of PKC with either 
superoxide
121
 or H2O2
122
 resulted in zinc release.  These properties give PKC the ability 
to both sense and transmit signals based on the redox environment in the cell.
123
  
However, the manner in which PKC is activated by reactive oxygen species is still 
unknown. 
Several zinc finger proteins have been implicated as redox-switches.  Inactive 
Hsp33 exists with zinc coordinated to 4 cysteine residues under normal cellular 
conditions.
124
  Upon oxidation, zinc is released and the cysteines form two disulfide 
bonds, leading to the zinc-binding domain unfolding and activation of Hsp33 which 
functions to defend the bacterial cell from oxidative damage.
125
  Under normal cellular 
conditions the anti-sigma factors, RsrA and ChrR, bind to and inactivate sigma 
                                                 

 Parts of this chapter are reprinted with permission from Stewart MD & Igumenova TI 
(2012) Reactive cysteine in the structural Zn2+ site of the C1B domain from PKCα.  
Biochemistry 51: 7263–7277.  Copyright 2012 American Chemical Society. 
 106 
 
transcription factors.  Upon oxidation, the anti-sigma factors form at least one disulfide 
bond, releasing zinc and sigma, allowing sigma to increase transcription of oxidative 
damage proteins.
126,127
  Similarly, Keap1, a mammalian zinc binding protein holds Nrf2 
in the cytosol until activated by stress inducers.  Once activated, Keap1 releases zinc and 
Nrf2 allowing Nrf2 to translocate to the nucleus and activate the antioxidant response 
element.
128
    
Through the work in this study, a similar type of mechanism for PKC activation 
by reactive oxygen species is proposed.  H2O2 or iodoacetamide (IAC) treatment of C1B 
or the construct that contains C1B and the following C2 regulatory domain (C1B-C2) led 
to zinc loss and selective unfolding of the C1B domain.  However, when the Zn(2) 
coordinating Cys151 was mutated to glycine (C151G), the construct reacted slower to 
H2O2 or IAC treatment.  Only C1B and C1B-C2, which contain Cys151, reacted in an 
assay for solvent exposed cysteines.  Together, the data point to modification of C1B 
cysteines, with the most reactive cysteine being Cys151, causing zinc release and 
domain unfolding.  The loss of structure in the C1 domain could then lead to the loss of 
the auto inhibitory properties of the regulatory domain, thus PKC activation. 
Consistent with the reactivity and solvent exposure assays, NMR revealed C1B 
exchanges between a conformation in which Cys151 is solvent exposed and easily 
accessible to reactive oxygen species, and the conformation in which it is coordinated to 
zinc.  First, HSQC spectra of C1B revealed several residues surrounding Zn(2) site 
existed in two conformations, with the largest chemical shift difference for Cys151.  ZZ-
exchange NMR was used to calculate the rate of exchange between the two conformers 
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of about 3 per second with an activation energy of 70 kJ at pH 5.7 and 25˚C.  Lowering 
the pH or mutating Cys151 to glycine eliminated the zinc coordinated population, while 
an increase in pH favored the zinc coordinated population.  Finally, residual dipolar 
couplings were used to refine the structures of both protein conformations revealing the 
first structure of a C1 domain in which Cys151 is not zinc coordinated, leaving it more 
accessible to reactive oxygen species.   
Methods 
Protein over-expression and purification 
The E. coli codon-optimized DNA sequence of C1B domain from Mus 
musculus coding for a 50-residue construct of C1B, comprising residues H102 through 
Cys151 of PKC, was cloned into a pET-SUMO expression vector (Invitrogen) as a C-
terminal fusion with histidine-tagged SUMO.
129
  This construct will be referred to as 
C1B50.  Mutagenic DNA for the C151G mutant was constructed from the wild-type 
C1B gene in the pET-SUMO vector using a Stratagene QuickChange site-directed 
mutagenesis kit and suitable PCR primers.  The DNA sequence coding for a 194-residue 
construct encompassing the C1B-C2 domain (Ser99 - Gly292)  from Mus musculus were 
amplified by PCR using the PKC cDNA clone (Open Biosystems) as a template.  
These constructs were cloned into the pET-SUMO vector as above.  Purified plasmids of 
all the constructs were transformed into BL21(DE3) E.coli cells for protein over-
expression and purification. 
The isolated C2 domain was expressed and purified as described previously.
130
 
C1B-C2 was purified using the C2 purification protocol with minor modifications.  
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Preparation of C1B50 and the C151G mutant differed slightly from the C1B53 
purification described in chapter I.  The fusion protein was purified using a HisTrap 
HP Ni affinity column (GE Healthcare Life Sciences).  The fractions containing fusion 
protein were pooled and SUMO was cleaved from C1B or C151G at 25 C using 
SUMO protease.  The products of SUMO protease cleavage reaction were separated by 
gel-filtration using HiPrep 16/60 Sephacryl S-100 column (GE Healthcare Life 
Sciences) in 50 mM MES pH 6.5 and 150 mM KCl.  For NMR experiments, unless 
otherwise stated, the protein was concentrated to ~0.5 mM, and exchanged in the buffer 
containing 10 mM [
2
H-4]-imidazole at pH 6.5 (Cambridge Isotopes), 150 mM KCl, 8% 
2
H2O, 1 mM tris(2-carboxyethyl)phosphine (TCEP), and 0.02% NaN3.  The purity of all 
constructs was assessed using SDS-PAGE.  
Resonance assignments 
C1B50 
1
H, 
13
Cα, 
13
Cβ, and 
15
N resonances were assigned from gradient-
enhanced CBCA(CO)NH, HNCACB, and C(CO)NH 3D NMR spectra
61
 obtained on a 
600 MHz Varian Inova spectrometer at 25°C.  Assignment experiments were carried out 
on a uniformly 
15
N and 
13
C enriched 0.5 mM sample in the above mentioned buffer at 
pH 6.5 or pH 5.7.  The H
δ2
 protons of histidine side-chains were assigned using the 2D 
(HB)CB(CGCD)HD experiment.
131
  C151G mutant assignments were transferred from 
wild-type.  The residue-specific differences in chemical shifts between the C1B50 
conformers were calculated according to the following equation:
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where H, N, Cα, and Cβ are the chemical shift differences between the 
1
HN, 
15
N, 
13
Cα, and 
13
Cβ nuclei, respectively.  All NMR data was processed using NMRDraw 
3.0
59
 and assigned using Sparky 3.133.
132
  For all NMR experiments the temperature was 
calibrated using methanol below 30C and ethylene glycol above 30C.   
Exchange kinetics 
The kinetics of the two populations in slow exchange for the uniformly 
15
N 
enriched C1B50 was measured using a NMR ZZ-exchange experiment.133  Peak 
volume analysis was carried out using a peak integration function for NMRDraw.
59
  The 
time dependence (Ξ(t)) of the ratio of auto (aAA and aBB) and exchange (aAB and aBA) 
peak volumes:
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was globally fit with IGOR as a quadratic coefficient (ζ) using 6 well resolved residues 
(103,104 133,147,149,and 151).  Residue 149 was not used at 30˚C due to unresolved 
cross-peaks and autopeaks.  Residue 103 experienced severe peak broadening at low 
temperatures and therefore it was not used in calculations between 10 and 20˚C.  The 
experiments were carried out at 5 temperatures: 9.4, 15.0, 19.8, 25.0 and 30.2 °C.  
Residue-specific  values were plotted as a function of mixing time and fitted to the 
following equation: 
Equation 13 
2'
11)( tkkt   
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where k1 and k-1 are the forward and pseudo-first order reverse rate constants for the 
exchange reaction between a and b.  The data for all residues were fitted globally to 
obtain the product of two rate constants, k1k-1.  
The apparent equilibrium constant for the exchange reaction was defined as Kapp 
= [b]/[a].  Kapp was determined using an average of the ratio of the peak volumes from 
the two populations for 9 well-resolved residues (103, 131, 133, 134, 140, 145, 147, 149, 
and 151) in fully relaxed 
15
N-
1
H HSQC spectra collected with the 5 s relaxation delay.  
The kinetic rate constants were then calculated using the k1k-1 and k1/k-1 values obtained 
from the ZZ-exchange data and Kapp, respectively.  The activation enthalpies and 
entropies for the forward and reverse reactions were determined from fitting the data 
with the Eyring equation: 
Equation 14 
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where k is the rate constant for the reaction; kB is the Boltzmann constant;  is the 
transmission coefficient assumed to be 1 in most types of analyses; h is the Planck 
constant; and S≠ and H≠ are the entropy and enthalpy of activation, respectively.  
Activation energies, Ea, were obtained from fitting the data with the Arrhenius equation: 
Equation 15 
RTEaAek
/  
where A is the pre-exponential factor. 
Probing for C1B reactivity 
[U-
15
N]-enriched C1B50, C151G, C1B-C2, and isolated C2 domains were 
treated with H2O2 solution to probe their response to reactive oxygen species.  HSQC 
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experiments collected every 1-1.5 hours starting approximately 0.5 hours after addition 
of H2O2 to a final concentration of 1.25 mM.  To ensure comparable signal-to-noise 
ratios in the NMR spectra, the protein concentration varied with the length of the protein 
construct: 0.1 mM C1B50 or C151G, 0.15 mM C2, and 0.25 mM C1B-C2.  To 
quantify the rate of signal decay, the cross-peak intensities were plotted against the time 
elapsed from addition of H2O2 to the mid-point of each HSQC collected until ~20% of 
cross-peak intensity remained.  The data were fit to an exponential decay using the 
Curvefit software available from Dr. Arthur G. Palmer’s laboratory at Columbia 
University (http://www.palmer.hs.columbia.edu/software/curvefit.html).  After the cross-
peak intensities decayed to less than 10% of their original cross-peak intensity, the 
amount of Zn
2+
 released into solution was quantified spectroscopically using 4-(2-
pyridylazo)-resorcinol (PAR) (Fisher Scientific).
135
   
To determine the Zn
2+
 content of the intact C1B50, C151G, and C1B-C2 
constructs, the protein solution was diluted to 2-5 M in 4 mM H2O2 (VWR 
International) and 50 mM Tris buffer (pH 7.5) that was previously ran over the Chelex-
100 resin (Sigma) to remove trace metal ions.  This solution was incubated at 42 ºC for 
50 minutes then cooled to room temperature.  PAR was added to a final concentration of 
0.1 mM.  The increase in absorbance at 500 nm was measured and compared to that of 
the control sample treated identically but lacking the protein solute.  The zinc content 
was quantified using a standard calibration curve (1-12 M Zn
2+
 concentration range) 
under buffer conditions identical to those used for protein samples.  Each measurement 
was repeated at least three times.  The results showed that C1B50, C151G, and C1B-
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C2 released 1.8 ± 0.1, 2.0 ± 0.1, and 2.2 ± 0.1 molar equivalents of zinc, respectively.  
This is in agreement with the results obtained on the MBP-C1Bα fusion protein, which 
released two molar equivalents of zinc when treated with H2O2.
136
  The results also 
demonstrate that coordination to Zn(2) is maintained in C151G throughout purification 
despite the loss of Cys151Sγ-Zn(2) bond. 
To establish if Zn
2+
 is released by C1B upon H2O2 treatment at 25 ºC, PAR 
assays were carried out on the supernatants of NMR samples treated with H2O2.  After 
the intensity of the NMR signals had decayed to less than 10% of the original, the 
supernatant was removed and diluted into the above Tris buffer and 0.1 mM PAR.  No 
additional H2O2 was added.  The protein concentration was varied such that the zinc 
released was 3-12 M to be within the range of the standard calibration curve.  The 
calibration curve samples consisted of 1-12 M Zn2+ standard solution, the same volume 
of NMR buffer as the supernatant assays, Tris buffer, and 0.1 mM PAR.  After dilution, 
all the samples were equilibrated for five minutes at room temperature before measuring 
the absorbance at 500 nm. 
Mass-tagging of C1B50 (50 μM), C151G (35 μM), and C1B-C2 (10 μM) was 
accomplished by incubation with 0.25 mM polyethylene glycol maleimide 5,000 (PEG-
mal, NANOCS) at room temperature for 5 hours in a buffer containing 10 mM imidazole 
at pH 6.5, 150 mM KCl, and 1 mM TCEP.  In addition, either 0.1 mM Ca
2+
 or 0.1 mM 
ethylenediaminetetraacetic (EDTA) was added to two of the C1B-C2 samples.  After 5 
hours, the reactions were quenched by the addition of 50 mM dithiothreitol (DTT) and 
incubation at room temperature for 15 minutes.
137
  The samples were subsequently 
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boiled for 5 minutes in an equivalent volume of 2X SDS-PAGE loading buffer (BioRad) 
and loaded onto a 15% SDS-PAGE.  All chemicals were obtained from Fisher Scientific 
unless otherwise stated. 
To alkylate the reactive cysteines, [U-
15
N]-enriched C1B50, C151G, and C1B-
C2 were treated with IAC at 10 times the cysteine concentration for one hour in the dark 
at room temperature before quenching the reaction with dithiothreitol.  The final 
concentration of IAC in the NMR samples was 6, 6, and 12 mM for the C1B50, 
C151G, and C1B-C2 constructs, respectively.  HSQC experiments were recorded to 
evaluate the state of the protein samples. 
Determining pKa values 
15
N uniformly enriched C1B50 in the above mentioned NMR buffer was 
titrated between pH 5 and 8.5 using concentrated HCl and NaOH.  Similarly, 
15
N 
uniformly enriched C151G mutant and C1B53 were titrated between pH 5 and 8.25 
except without the presence of buffer.  The pKa values were the same within error 
regardless of the construct or presence of buffer.  The pH was measured with an accumet 
AB15 pH meter from Fisher Scientific with a Hamilton biotrode electrode before and 
after each NMR experiment and the pH values were averaged if they differed.  The 
values are not corrected for the 8% D20.  The chemical shift of 
15
N - 
1
H backbone and 
aromatic side-chain resonances at varying pH were monitored by HSQC and fHSQC
106
 
respectively on a 600 MHz Varian Inova at 25°C. 
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The dependence on pH of residue-specific 
15
N or 
1
HN chemical shifts, whichever 
was larger, was fit to a modified Henderson-Hasselbach equation:
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Equation 16 
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where  is the observed chemical shift at a given pH, offset is the chemical shift offset, 
and delta is the chemical shift change in the titration process with the acid dissociation 
constant Ka1.  The chemical shifts of residues that responded to two titration events 
were fit to the following equation: 
Equation 17 
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where 1 and 2 designate the parameters associated with the first and second ionization 
events. 
The pH dependence of the populations was determined by integrating the area 
under the peaks using Sparky.  Then the fraction of a given population at each pH was 
calculated for each residue by dividing the intensity of each peak (a or b) by the sum of 
the intensities of both populations (a+b).  The fraction in either population a or b (Fa or 
Fb) were globally fit using IGOR to the following equations:  
Equation 18 
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Equation 19 ab
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where the pKaapp is the apparent pKa of Cys151. 
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Dynamics measurements 
The R1, R2, and NOE relaxation rate constants were collected and analyzed as 
described in Chapter II. 
Structure determination with residual dipolar couplings 
Partially aligned samples of C1B50 were made in stretched or compressed 7% 
polyacrylamide gels.  The stretched gels, composed of 7% acrylamide with 37.5:1 bis-
acrylamide (BIORAD), 0.1% w/v ammonium persulfate (Fisher Scientific) and 0.08% 
v/v N,N,N',N'-Tetramethylethylenediamine (Fisher Scientific), were cast at a diameter of 
6 mm.  The gel was removed from the cast and washed in water for at least 3 hours.  The 
gels were then dried overnight on a parafilm support. The dried gel was placed back into 
the 6 mm chamber and soaked overnight with 0.5 mM protein.  The soaked gel was 
stretched into a 4.2 mm NMR tube using a tube and apparatus
78
 obtained from New-Era 
to reach a 0.7 stretch ratio.  The compressed gels were made and treated in the same way 
except the cross-linker ratio was 20:1 acrylamide:bis-acrylamide and the gel cast was 3.2 
mm internal diameter.  The 25 mm length dried gel was placed into a 4.2 mm diameter 
shighemi tube with 0.5 mM protein and the plunger was placed so that the gel expanded 
to a length of 17.5 mm for a compression ratio of 0.7. 
All RDC experiments were performed on a 600 MHz Varian Inova at 25°C for 
an isotropic sample and the partially aligned samples.  In phase anti-phase (IPAP)
79
 
HSQC spectra were collected for 15.2 hours with 512 complex points in the indirect 
dimension.  
1
H was apodized with a cosine-bell window function and zero filled to 2K 
points.  64 points were added to the indirect dimension by forward backward linear 
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prediction, followed by apodization with a cosine-bell window function and zero filling 
to 1K points.  HNCOCA spectra were collected in an IPAP manner for 98 hours with 64 
complex points in the 
15
N dimension and 140 complex points in the 
13
C dimension.  
Spectra were processed as reported previously.
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134 RDC values obtained from population b and residues not undergoing 
conformational exchange in stretched and compressed gel samples were utilized to refine 
the Cys151 coordinated C1B structure with the simulated annealing protocol described 
previously
140
 in XPLOR.
141
  The starting structure for refinement was the recently 
deposited NMR structure of PKCα C1B (PDB ID 2ELI).142  This structure was 
determined from NOEs present at pH 7.0 where greater than 90% of the protein is in the 
Cys151 coordinated conformation, thus it should be very close to the RDC refined 
structure.  The first structure of the 2ELI conformational ensemble was taken as a 
starting model.  All RDC values were scaled to 
1
DNH to take into account the differences 
in bond lengths and gyromagnetic ratios of the nuclei involved.  In addition, the force 
constants used for different RDC types were scaled to the 
1
DNH force constant according 
to the inverse of the relative experimental error ratios squared.  These calculations 
resulted in the following scaling factors for the force constants: 
1
DNH=1 (by default), 
1
DCαHα=2.104, 
1
DNCO= 0.238, and 
2
DHNCO= 0.151.  The (ϕ, ψ) dihedral angles and 80 
long range NOEs from the 2ELI NMR restraint deposit file in the PDB were used as 
additional restraints.  Long-range NOEs were defined as those separated in primary 
structure by two or more residues, and were only used if both residues did not have 
significantly different RDC values or chemical shifts in the two conformations.  
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Additionally, 6 backbone hydrogen-bonds were identified using WHATIF
87
 and used in 
refinement.  The zinc coordination restraints differed for conformers a and b.  For 
C1Bα50b, the distances from the zinc atoms to the coordinating atoms were restrained to 
2.3 Å and 2.5 Å for nitrogen and sulfur, respectively, in tetrahedral coordination 
geometry.  For C1Bα50a, the distance and angles involving the Sγ of Cys151 in the zinc 
coordination sphere were not restrained due to the thiolate protonation at low pH.  All 
other zinc-coordinating residues were restrained with the same distances and geometry 
as for conformation b.  Because TALOS dihedral angle predictions for residues with 
different RDC values in conformers a and b did not make a significant difference in the 
final structure of a, the NMR structure-derived angles were used for the first step of the 
refinement. 
The overall refinement protocol was as reported by Chou and Bax with minor 
modifications.
140
  The parameters are summarized in Table 4.  The axial (Da) and 
rhombic (Rh) components of the alignment tensor were allowed to vary during the 
minimization steps.  Two high-temperature and one low-temperature simulated 
annealing steps were carried out.  The final values for the tensor components were: 
Da=7.78(8.06) and Rh=0.54(0.49) for conformer b(a) in a compressed gel, and Da=-
22.6(-22.0) and Rh=0.53(0.55) for conformer b(a) in a stretched gel.  The reported 
structures of a and b are the regularized average structures determined using the top 5% 
of the 50 lowest-energy structures obtained in the final refinement step.   
The average of the best 10% of structures determined above of the Cys151 
coordinated conformation was used as a starting structure for refinement of the Cys151 
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solvent exposed structure with the 130 RDC values for population a and residues not 
undergoing conformational exchange.  The same procedure as above was used for 
refinement.  Starting dihedral angle restraints were chosen to match the starting structure 
except where TALOS
143
 predictions using the chemical shifts of 
1
HN, 
15
N, 
13
C, and 
13
Cfor population a differed by more than 30 degrees, then the TALOS predictions 
were used as described previously for refinement of liganded versus apo calmodulin.
140
  
All images of structures were created using Chimera.
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Table 4. Parameters of the simulated annealing protocol. 
Restraint Type or 
Parameter 
High Temperature 
Refinement 
Low Temperature 
Refinement 
Temperature 200 → 20 K, T = 10 K 20 K → 1 K, T = 1 K 
Dihedral angles ( and ψ) 200 kcal mol
-1
 rad
-2
 200 → 50 kcal mol-1 rad-2 
RDCs (Normalized to 
1
DNH) 
0.0005 → 1.0 kcal mol-1 
Hz
-2
 
1.0 kcal mol
-1
 Hz
-2 
 
Radius of gyration 50 kcal mol
-1
 Å
-2
 50 kcal mol
-1
 Å
-2
 
Hydrogen bonds  2 → 20 kcal mol-1 Å-2 20 kcal mol-1 Å-2 
Ramachandran potential 0.02 → 0.2 unitless 0.2 unitless 
Van der Waals radius 0.002 → 4.0 kcal mol-1 Å-4 4.0 kcal mol-1 Å-4 
Improper angles 0.1 → 1.0 kcal mol-1 deg-2 1.0 kcal mol-1 deg-2 
Bond angles 0.4 → 1.0 kcal mol-1 deg-2 1.0 kcal mol-1 deg-2  
Long-range NOEs 2.0 → 20 kcal mol-1 Å-2 20 kcal mol-1 Å-2  
Pre-annealing dynamics 10 ps at 200 K, 0.2 K 
tolerance 
10 ps at 20 K, 0.02 K 
tolerance 
Time per temperature step 5.0 ps 5.0 ps 
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Results 
Cys151 is reactive irrespective of the protein context 
C1B50 corresponds to the minimum folded core of the C1B domain, in which 
the side-chains of the first (His102) and last (Cys151) residues are involved in Zn(2) 
coordination.  C151G variant has Cys151 mutated to the Gly residue.  The primary 
structure and zinc coordinating residues for these two constructs are shown in Figure 33.  
The rationale behind constructing this variant was two-fold: (i) to gain insight into the 
relative reactivity of cysteine residues in C1B, and (ii) to eliminate the coordination 
bond between Zn(2) and Cys151.  This mutation preserves the overall fold of C1B, 
according to the NMR data discussed below.  The C1B-C2 construct (see Figure 2) is 
194 amino acids long and comprises both the C1B and C2 domains of PKC.  The C2 
domain is a Ca
2+
-responsive peripheral membrane domain lacking native cysteines.  
Having the C2 domain in this construct mimics the protein context of C1B in the full-
length PKC. 
 
 
 
 
Figure 33. Primary structures of the two 50 residue C1B constructs.   The mutation 
site is highlighted in yellow; zinc-coordinating residues are highlighted in cyan; the loop 
residues are underlined. 
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Figure 34. H2O2 treatment of C1B-containing proteins results in the loss of native 
structure.  (A) Representative data for three C1B residues in C1B50 (black), C151G 
(red), and C1B-C2 (blue).  (B) Representative data for three C2 residues in isolated C2 
(purple) and C1B-C2 (blue).  Curves represent the exponential fits to the C151G and 
C1B-C2 data; C1B50 and C2 points are connected with lines for illustration purposes.  
(C) The number of Zn
2+
 ions released per protein molecule in solution when treated with 
1.25 mM H2O2 at 25 ºC until 10% NMR cross-peak intensity remained (open bars) and 
with 4 mM H2O2 at 42 ºC for one hour (shaded bars). 
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To oxidize the reactive cysteine(s), all three constructs were treated with 1.25 mM 
hydrogen peroxide.  As a negative control, the isolated Ca
2+
-complexed C2 domain that 
lacks native cysteine residues was also treated.  The progress of the protein reactions with 
H2O2 was monitored by NMR.  For all C1B-containing constructs, the H2O2 treatment 
resulted in the gradual disappearance of NMR cross-peaks from the 
15
N-
1
H HSQC 
spectra.  Because the solution remains clear for the duration of ~12-24 hour NMR 
experiments, this phenomenon is attributed to the formation of soluble high-molecular 
weight aggregates that are unobservable due to slow rotational diffusion and/or 
aggregation processes that are intermediate on the NMR chemical shift timescale.  Figure 
34 shows the data for three representative residues that belong either to the C1B (A) or 
the C2 (B) domains. 
It is evident from Figure 34A that the stability of C1B with respect to oxidation 
by H2O2 depends on whether Cys is present at position 151.  The signal corresponding to 
the native population of C1B50 decays within 2 hours of initiating the H2O2 treatment.  
However, the C151G variant lacking one coordination bond to Zn(2) (see Figure 33) is 
more stable, with a quantifiable average signal decay rate of 0.06 hr
-1
.  The residue-
specific decay rates are rather uniform throughout C151G, with a standard deviation of 
0.01 hr
-1
 (Figure 35).  Peroxide treatment of the two-domain construct C1B-C2, where 
Cys151 immediately precedes the linker region connecting the two domains, results in 
the average signal decay rate of 0.45 hr
-1
, about ~8-fold higher than that of the C151G 
variant.  The residue-specific decay rates of C1B-C2 are plotted in Figure 35. 
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Figure 35. Rates of cross-peak disappearance as a result of H2O2 treatment. Constructs treated were (A) C151G and (B) 
C1B-C2.  The red line marks Cys151 in C1B. 
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Figure 34B shows the results of the negative control experiment carried out on the 
isolated Ca
2+
-complexed C2 domain that lacks native cysteine residues.  The signal 
intensity does not change significantly in the course of the NMR experiment indicating 
that the isolated C2 domain is not susceptible to oxidation by H2O2.  In contrast, the N-HN 
cross-peaks corresponding to the C2 domain in the C1B-C2 construct decay with an 
average rate of 0.36 hr
-1
.  These data demonstrate that H2O2 acts specifically on the 
cysteine-containing C1B domain, but the resulting aggregation process affects C2 when 
linked to C1B. 
Fully folded C1B-containing constructs including the C151G variant contain two 
Zn
2+
 ions per protein molecule (Figure 34C, shaded bars).  These data were obtained 
using PAR assay under conditions favoring complete Zn
2+
 release: 1-hour incubation with 
4 mM H2O2 at 42 C.  PAR assay was also carried out on the supernatants of all H2O2-
treated NMR samples at 25 C, with no additional H2O2 added to the protein solutions.  In 
all three constructs, a partial release of Zn
2+
 ions from C1B is observed (Figure 34C, open 
bars). 
Given the release of structural Zn
2+
 ions and extensive protein precipitation 
observed for H2O2-treated NMR samples after ~24-48 hours, it can be concluded that the 
treatment with H2O2 results in at least partial loss of the native C1B structure. 
To test for cysteine solvent exposure, mass-tagging assays were conducted on 
C1B50, C151G, and C1B-C2.  Mass-tagging was accomplished by reacting the 
proteins with PEG-maleimide (PEG-mal 5,000), as shown in Figure 36A.  Covalent 
modification of each cysteine residue adds 5 kDa of molecular weight.  The mass-tagged 
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protein species are subsequently resolved on the SDS-PAGE gel (Figure 36B), in which 
the 5 kDa increase in molecular weight manifests itself as an ~8-10 kDa shift on the gel. 
C1B50 is modified primarily at one cysteine residue (lane 6).  C151G is not 
modified by PEG-mal (lane 8), which means that Cys151 is the most reactive residue in 
C1B50.  C1B-C2 shows a “ladder” pattern of one, two, and >3 modified Cys residues, 
with the primary species being the single Cys-modified protein (lane 2).  Addition of 
Ca
2+
 to C1B-C2 does not influence the “ladder” pattern (lane 3); indicating that Ca2+ 
binding by the C2 domain has little effect on the reactivity of cysteines in the C1B 
domain.  Treating C1B-C2 with EDTA unfolds the protein by removing the structural 
Zn
2+
 ions.  As a result, all cysteine residues become solvent-exposed and modified by 
PEG-mal with the formation of high molecular weight species (lane 4). 
A similar pattern of cysteine reactivity was obtained upon treating the protein 
constructs with cysteine-specific alkylating agent, IAC.  Modification of C1B50 by 
IAC completely unfolded the C1B domain as was evident from the 
15
N-
1
H HSQC 
spectra (Figure 37A).  In contrast, the population of the fully folded protein was still 
present in the C151G variant after the completion of IAC reaction.  Treatment of C1B-
C2 with IAC selectively unfolded the C1B domain but left the C2 domain unaffected in 
the C1B-C2 construct (Figure 37B).  Similar to H2O2 treatment at 25ºC, IAC treatment 
resulted in partial zinc loss for all of the constructs (1.1-1.9 zinc atoms/ C1B were 
released into solution).  This suggests that while all three protein constructs have one or 
more reactive cysteines whose alkylation results in the loss of native structure of C1B, 
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the presence of Cys151 in the protein (C1B50 and C1B-C2) makes it more susceptible 
to such a reaction. 
 
 
Figure 36. Mass-tagging assays carried out on C1B50, C151G, and C1B-C2.  (A) 
Reaction between the sulfhydryl groups of exposed cysteine residues and PEG-mal.  (B) 
SDS-PAGE results of the PEG-mal treatment of three C1B constructs.  Arrows point to 
the single-Cys modified species in C1B50 and C1B-C2. 
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Figure 37. Modification of C1B containing constructs with IAC.  (A) Overlay of the 
15
N-
1
H HSQC spectra of the IAC-
treated C1B50 (black) and C151G (red).  (B) Overlay of the 15N-1H HSQC spectra of the native (blue) and IAC-treated C1B-
C2 (orange).  Cross-peaks labeled with asterisks correspond to the C1B domain in the native C1B-C2 construct.  Upon IAC 
treatment, these cross-peaks shift to the central region of the spectrum. 
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In summary, the oxidation and alkylation data are consistent with Cys151 being 
the most reactive among the six cysteines in C1B.  Its covalent modification results in 
the loss of C1B native structure and subsequent covalent modification of all other 
cysteines accompanied by partial Zn
2+
 release.  C1B50 shows unique dynamics of the 
Zn(2) coordination sphere that includes Cys151.  This dynamics was characterized using 
solution NMR techniques. 
C1B50 exists in two conformations 
The structural and functional cores of C1 domains are formed by 50 amino acid 
residues.
145
  C1B50 behaved as a homogeneous protein preparation in all purification 
steps.  However, the 
15
N-
1
H HSQC spectrum of the [U-
15
N]-enriched C1B50 showed a 
larger number of 
15
N-
1
HN cross-peaks than was expected based on the size of the protein 
construct.  Using triple-resonance NMR experiments, sequence-specific assignment of 
[U-
13
C,
15
N]-enriched C1B50 was carried out.  Out of 48 non-proline residues, 17 gave 
rise to a pair of N-HN cross-peaks with distinct chemical shifts.  The cross-peak pairs are 
labeled with the double-headed arrows in the HSQC spectrum of C1B50 (Figure 38A).  
This behavior indicates the presence of two conformations of C1B50 that co-exist in 
solution.  The exchange between the conformers is slow on the NMR chemical-shift 
timescale. 
To gain insight into the identity of the exchanging conformers, the chemical shift 
differences calculated according to Equation 11 are mapped onto the ensemble-averaged 
NMR structure of C1B.67 The results are shown in Figure 38B.  The residues whose 
electronic environment differs most between the two conformations are located in the 
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vicinity of the Zn(2) coordination site.  Cys151, the most C-terminal residue of the 
domain, experiences the largest combined chemical shift perturbation with the  value of 
1.3 ppm.  The S atom of the Cys151 side-chain is involved in the coordination bond 
with Zn(2), according to all known C1 domain structures.  However, most of these 
structures were determined using NMR, which cannot be used to determine zinc 
coordination directly.  The coordination geometry of Zn(2) is shown in Figure 38C.  
The C151G variant of C1B50 presents only three protein ligands to Zn(2) 
instead of four.  The C151G mutation was shown to preserve the functionality of a 
homologous C1B domain from PKC, as determined by the ability of the domain to bind 
phorbol esters.
146
  In Figure 38A, the HSQC spectrum of the [U-
15
N]-enriched C151G 
variant is shown in red and overlaid onto the spectrum of the wild-type protein.  It is 
evident that C151G exists in one conformation only, and this conformation is one of the 
two sampled by the wild-type C1B50.  The molar ratio of Zn2+ ions to protein is 2 in 
the C151G variant (Figure 34C), indicating that the protein maintains coordination to 
Zn(2) despite the loss of the Cys151S–Zn(2) bond. 
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Figure 38. C1B50 exists in two slowly exchanging conformations. (A) Overlay of 
the 
15
N-
1
H HSQC spectra of C1B50 and C151G variant.  The insets show the 
expansions for Lys131, Phe104, and Val147.  (B) Chemical shift perturbation ( 
mapped onto the structure of C1B.67  The coordinates are the courtesy of Dr. U. 
Hommel.  (C) Coordination geometry of Zn(2) showing four protein ligands. 
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Based on this set of experiments, it can be concluded that the conformational 
exchange process in the wild-type C1B50 corresponds to Cys151 alternating between 
Zn(2)-coordinated and uncoordinated states. 
The conformational exchange process is modulated by the pKa of the Cys151 side-chain 
There were significant changes in the fractional populations of the conformers in 
the C1B50 NMR spectra recorded at two different pH values.  To explore the pH 
dependence systematically 
15
N-
1
H HSQC spectra of C1B50 were recorded at pH 
values ranging from 5.0 to 8.5. 
For the 17 residues that have distinct cross-peaks in the two conformers of 
C1B50, there was a complete redistribution of conformer populations over the sampled 
pH range.  The low-pH conformer designated a for “acidic” conditions is the dominant 
form at pH < 6; the high-pH conformer designated b for “basic” conditions is the 
dominant form at pH > 6.  Conformer a corresponds to the uncoordinated Cys151, based 
on the near-identity between its spectrum and that of the C151G variant (Figure 38A).  
For several residues, including some from the aforementioned group of 17, there was a 
pH-dependent shift in their N-HN cross-peak positions.  The shift reflects the titration 
behavior of the proximal ionizable side-chain(s) and is “fast” on the NMR chemical shift 
timescale. 
Three specific examples illustrating the pH titration behavior of C1B50 are 
shown in Figure 39A.  All three residues, Phe104, Asp133, and Cys132, have two 
populations that give rise to distinct cross-peaks.  In Asp133, the pH change results 
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simply in the redistribution of populations a and b.  In Phe104 and Cys132, this process 
is accompanied by the pH-dependent shift of the conformer b cross-peaks. 
 
 
Figure 39. pH dependence of the C1B50 HSQC spectra.  (A) Expansion of the 15N-
1
H HSQC spectra showing examples of residues with fast and/or slow exchange 
behavior.  (B) pH dependence of populations a and b.  The fractional populations were 
calculated using the cross-peak volumes of all residues that have well-resolved peaks in 
the two conformations.  The solid line represents a global fit of the data to Equation 18 
and Equation 19. 
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For all protein residues that are not subject to extensive line-broadening at high 
and low pH values, the fractional populations of conformers a and b were calculated.  
The fractional populations are plotted against pH in Figure 39B.  The solid line 
represents a global fit of the data to Equation 18 and Equation 19.  Equal populations of 
a and b are present at pH 5.8.  The data indicate that the loss of coordination bond 
between the S of Cys151 and Zn(2) is a pH-dependent process with an apparent pKa of 
5.8.  This pKaapp value either represents the side-chain pKa of the Cys151 itself, or the 
pKa of some other ionizable group in the protein.  The most likely candidates would be 
titratable histidine residues – their average pKa value in proteins is 6.6, with a standard 
deviation of 1.
147
 
To test if any of the five histidines are responsible for the pH dependence of the 
conformational exchange, the titration curves for all pH-responsive residues were 
constructed by plotting the change in 
15
N and 
1
H chemical shifts as a function of pH.  
The NMR-detected titration curves for His107, His117, and His127 are shown in Figure 
40.  The three histidines titrated with pKa values of 6.7 ± 0.1 (His107), 5.6 ± 0.1 
(His117), and 6.1 ± 0.1 (His127).  None of these residues are in slow exchange on the 
NMR chemical-shift timescale. 
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Figure 40. 
1
H and 
15
N-detected pH titration curves of His107, His117, and His127. 
Vertical lines mark the corresponding pKa values.  Curves are a result of fitting to 
Equation 16. 
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The two remaining histidines – His102 and His140 – coordinate Zn(2) and Zn(1), 
respectively.  The amine group of the N-terminal His102 is not detectable in the NMR 
spectra.  The backbone cross-peak of His140 is in slow exchange between the 
populations a and b (see Figure 38A).  To estimate the pKa values of His102 and 
His140, fHSQC
106
 experiments tuned for the detection of side-chain resonances were 
collected.
148,149
  The NMR spectra at two pH values, 4.7 and 7.0, and the table of 
chemical shifts are given in Figure 41.  The N
δ1
 and N
ε2
 shifts at both pH values are 
consistent with those observed for the Zn
2+
-coordinated histidines in proteins.
150-152
  
There is no indication that the protonation state of either His102 or His140 side-chain 
changes in the pH range from 4.7 to 7.0.  This means that the pKa values of His102 and 
His140 are less than 4.7. 
Based on these results, the histidine residue(s) can be ruled out as the primary 
ionizable group with pKaapp of 5.8.  The pH dependence of the conformational exchange 
process likely stems from the de-protonation of the Cys151 side-chain that occurs 
concomitantly with the loss of its coordination bond with Zn(2).  Hence, the pKaapp of 
Cys151 in the C1B50 is 5.8. 
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Nucleus His102 His140 
pH = 4.7 pH = 7.0 pH = 4.7 pH = 7.0 
15
N
1
 215.1 216.2 220.6 220.9 
15
N
2
 168.9 167.2 168.8 168.4 
1
H
2
 7.37 7.34 7.69 7.66 
1
H
1
 8.09 8.02 7.49 7.48 
Figure 41. Histidine side-chain pH titration.  Overlay of the C1B50 
15
N-
1
H fHSQC 
spectra at pH 7.0 (blue) and 4.7 (red).  The cross-peaks corresponding to the side-chains 
of the Zn
2+
- coordinating histidines His102 and His140 are connected with dashed and 
solid lines, respectively.  The chemical shifts are summarized in the table.   
 136 
 
There is an ionizable group with pKa 7.1-7.2 
In addition to three histidine side-chains, another ionizable group was detected 
with an apparent pKa of 7.2 ± 0.1 in C1B50 and 7.1 ± 0.1 in C151G.  The NMR-
detected titration curves for the residues that responded to this pKa are given in Figure 
42A.  The parameters of the individual fit to Equation 16 or Equation 17 are summarized 
in Table 5.  It is evident that the C151G variant mirrors the behavior of conformer a of 
C1B50 and thereby enables probing of the “high-pH” response of conformer a, whose 
population in the wild-type protein becomes less than 10% at pH 7.0. 
The residues responding to the ionizable group with pKa 7.1-7.2 are mapped 
onto the ensemble-averaged NMR structure in Figure 42B.  The responsive residues are 
located in the vicinity of the Zn(2) coordination sphere, which comprises Cys132, 
Cys135, His102, and Cys151. 
The assignment of the functional group with pKa 7.1-7.2 is ambiguous.  There 
are four possible candidates for this ionizable group: the C-terminal carboxyl, N-
terminal amine, Cys135, and Zn
2+
-coordinated water molecule.  The carboxyl and amine 
groups are the least likely candidates because they are solvent exposed and hence 
unlikely to have perturbed pKa values.  In addition, the most C-terminal residues, 
Cys151 in C1B50 and Gly151 in C151G, do not respond to the pKa of 7.1-7.2. 
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Figure 42. pH titration of an ionizable group close to Zn(2). (A) NMR-detected pH 
titration curves for the nuclei/residues that respond to the protonation event with an 
apparent pKa of 7.1-7.2 in C1B50 and C151G.  Low-pH points for L150a and T134a 
could not be obtained because of the peak broadening/overlap.  (B) N-HN groups of 
residues in (A) mapped onto the C1B structure.   
 
 
 
Table 5. pKa values determined from fitting of residues in Figure 42. 
Residue pKa, C1B50 b pKa, C151G 
K103 7.2 ± 0.1 7.2 ± 0.1 
F104 7.2 ± 0.1 7.1 ± 0.1 
T134 7.4 ± 0.1 
5.4 ± 0.1 
7.0 ± 0.1 
C135 7.0 ± 0.1 7.0 ± 0.1 
V147 7.4 ± 0.1 
5.6 ± 0.1 
7.2 ± 0.1 
5.4 ± 0.1 
L150 7.2 ± 0.1 7.2 ± 0.1 
 
 
The prerequisite for Cys135 being the primary ionizable group is that its thiol – 
not thiolate – is involved in coordination with Zn(2).  The thiol versus thiolate 
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coordination in structural Zn
2+
 sites has been a subject of much discussion in the 
literature.
153-156
  According to the ab initio calculations, the structural signature of thiol 
coordination is the increase of the S–Zn distance by 0.3-0.4 Å.156  In the same study, the 
Zn
2+
 sites in a homologous C1B domain from PKC (PDB ID 1PTQ22) were identified 
as having a geometry compatible with thiol coordination.  The longest S–Zn distance, 
2.51 Å, was observed in Cys264; the equivalent of this residue in C1B is Cys135. 
Another viable candidate is a Zn
2+
-coordinated water molecule.  A conversion of 
Cys151 side-chain to the thiol form in the C1B50a conformer or its replacement with 
Gly in the C151G variant creates a coordination vacancy in the Zn(2) site.  Given the 
solvent accessibility of Zn(2), a water molecule will most likely fill this vacancy.  
Coordination of water by Zn
2+
 depresses its pKa to ~7.
157,158
  The presence of water in 
the coordination sphere of Zn(2) in C1B50b would require a distortion of the 
tetrahedral geometry to accommodate an extra ligand.  This distortion was observed in 
C1B molecular dynamics simulations.97 
Kinetics and thermodynamics of the Cys151S–Zn(2) bond formation 
The formation of the Cys151Sγ–Zn(2) bond can be represented as an inter-
conversion between conformer a, in which Sγ is a thiol, and conformer b, in which Sγ is 
a thiolate coordinated to Zn(2).  The pH dependence of the process is incorporated into 
the pseudo-first order rate constant to reflect the constant pH values in the sample 
maintained by the buffering agent. 
To characterize the exchange process between a and b, the populations of the 
conformers was adjusted to roughly equal parts by setting the pH to 5.75.  At this pH, 
 139 
 
the equilibrium constant Kapp obtained by direct integration of a and b peaks in the NMR 
spectra, is 1.15 at 25 ˚C.  Within the experimental error, Kapp = exp[-G
0
/RT] does not 
depend on temperature in the investigated temperature range, from 10 to 30 ˚C.  This 
means that the enthalpic contribution to the G0 of the exchange reaction is rather small.  
Given a rather modest value of G0 associated with Kapp ≈ 1.2, it can be concluded that 
both H0 and S0 make small individual contributions to G0 rather than acting via an 
enthalpy-entropy compensatory mechanism. 
Two-dimensional ZZ-exchange NMR experiments were used to characterize the 
kinetics of C1B50 inter-conversion between conformations a and b.  These 
experiments probe the slow exchange processes with kex values in the range from 0.1 to 
10 s
-1
.  kex is the sum of the forward and reverse rate constants, k1 and k-1. 
The expansions of the ZZ-exchange spectra showing the behavior of Cys151 
peaks at two mixing times, 70 ms and 360 ms, are presented in Figure 43A.  The gradual 
build-up of the cross-peaks due to exchange between populations a and b is evident.  To 
enable the determination of activation parameters, the ZZ-exchange experiments were 
carried out at 5 temperature values.  For each temperature and mixing time, the 
parameter  was calculated according to Equation 12.   is plotted against the mixing 
time in Figure 43B, with solid lines showing the fits to Equation 13. 
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Figure 43. Kinetics of Cys151 inter-conversion between thiolate and thiol forms.  
(A) Expansions of the ZZ-exchange spectra showing the buildup of the Cys151 
exchange cross-peaks at two mixing times, 70 and 360 ms.  (B)  at pH = 5.75 as a 
function of mixing time and temperature.  Solid lines are the fits to Equation 13.  (C) 
Eyring plots for the forward (k1) and reverse (k-1) kinetic rate constants that are 
summarized in the table.  H≠, S≠, and Ea are the activation enthalpy, entropy, and 
energy, respectively. 
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The rate constants k1 and k-1 calculated from  and Kapp are summarized in the 
table of Figure 43C.  The temperature dependence of k1 and k-1 was used to construct 
the Eyring plots shown in the same figure.  The fit of these plots generated the enthalpy 
and entropy of activation, ΔH≠ and ΔS≠.  These values are given in Figure 43C for the 
forward and reverse reactions.  In both cases, the ΔS≠ values are close to zero, which 
indicates that the total number of degrees of freedom available to the system does not 
change significantly between the transition state and the corresponding ground state. 
The Arrhenius analysis was carried out to obtain the activation energies of 
Cys151Sγ–Zn(2) bond formation/breakage: 70 and 77 kJ/mol for the forward and 
reverse reactions, respectively.  These energies are rather large, giving rise to small 
values of the kinetic rate constants; extrapolation of the data to 37 ˚C produces the rate 
constants of ~9.6 s
-1
. 
Elimination of one thiolate ligand alters the C1B dynamics 
To determine the consequences of Zn(2) losing one of its protein ligands on the 
C1B dynamics, backbone relaxation parameters (R1, R2, and 
1
H-
15
N NOE) were 
obtained for the C151G and C1B50 variants at pH 6.5. 
Residue-specific transverse relaxation rate constants, R2, report on the sub-
nanosecond (sub-ns) dynamics of N-HN groups through their dependence on the spectral 
density function J sampled at three frequencies: 0, H, and N, where H (N) are the 
Larmor frequencies of 
1
H (
15
N).  In addition, conformational exchange processes that 
occur on the microsecond-to-millisecond (s-ms) timescale contribute to R2 via the Rex 
term.  For proteins with moderate rotational diffusion anisotropy like C1B, elevated R2 
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values indicate that a particular N-HN group is subject to chemical exchange, i.e. its Rex 
> 0. 
In Figure 44A, the differences in site-specific R2 values are plotted for C151G 
and C1B50b.  Many residues in C151G have elevated R2 values compared to those in 
C1B50b.  This behavior indicates an increase in the s-ms conformational dynamics of 
the protein backbone.  The perturbed residues belong to the N-terminal region (Lys103 
and Phe104), the QG motif (Gly129), Zn(2) “knuckle” and its vicinity (Asp133, Cys135, 
Asp136, Met137), and the C-terminal helix (Cys143, Ile145, Val147).  Mapping R2 
values onto the C1B structure illustrates that most of the dynamically perturbed 
residues are clustered at the bottom half of C1B near the Zn(1) and Zn(2) structural 
sites (Figure 44B). 
To compare the high-frequency motions in C1B constructs, the residue-specific 
spectral density values J(0.87H) were calculated using the reduced spectral density 
mapping approach.  H was 2  600 MHz for all relaxation experiments.  J(0.87H) 
values report on the sub-nanosecond dynamics of the N-HN groups of the protein 
backbone.  Figure 44C compares the J(0.87H) values for the two C1B constructs at 
pH 6.5.  The spectral density profile is mostly flat throughout the primary structure and 
does not differ significantly between the variants.  However, the C-terminal region 
spanning the Val147-Cys151 segment shows a high degree of flexibility.  C151G, with 
its uncoordinated C-terminus, has the largest value of J(0.87H).  The dynamics of 
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Cys151 in C1B50b is attenuated due to its coordination to Zn(2), but Leu150 retains 
substantial mobility. 
In summary, eliminating one protein ligand from the Zn(2) coordination sphere 
results in the increase of the backbone dynamics of C1B on at least two timescales: 
sub-ns and s-ms.  The C-terminal region acquires substantial flexibility on the sub-ns 
timescale when not constrained by the thiolate–Zn(2) bond.  Residues in the vicinity of 
the Zn(1) and Zn(2) structural sites, including the C-terminal helix, become more 
dynamic on the s-ms timescale.  The effect is most evident for Asp133 and Asp136 of 
the Zn(2) “knuckle” motif (Figure 44A).  Adding Zn2+ to the C151G NMR sample had 
little effect on the R2 values.  This means that the conformational exchange in C151G is 
not due to the inter-conversion between Zn
2+
(2)-bound and Zn
2+
(2)-free forms.  The 
identity of the conformer sampled by C151G remains to be determined. 
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Figure 44. Elimination of Cys151 ligand perturbs the C1B dynamics.  (A) R2, calculated as the difference between the 
residue-specific R2 values of C151G and those of C1B50b are plotted against the primary structure.  Residues that 
experienced > 1 s
-1
 increase in R2 values in the C151G variant are highlighted in cyan.  (B) R2 for the C151G and C1B50b 
pair mapped onto the three-dimensional structure of C1B.  Residues, for which R2 values are not available, are in shown in 
white.  (C) Spectral density values J(0.87H) for C151G and C1B50b.  The C-terminal region, highlighted in grey, is 
flexible on the sub-ns timescale.  The vertical lines mark two residues for which the differences in flexibility between the 
constructs are most pronounced, Leu150 and Cys151. 
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Zinc coordination dynamics occur on a faster timescale in longer constructs 
The studies of PKC C1B domain in Chapter II were conducted on a 53 residue 
construct which contains an additional two N-terminal residues (Ser and Lys) and one 
additional C-terminal residue (Gly) as shown in Figure 45A.  This construct does not 
have two slow exchanging populations.  The difference plots between the N-HN 
chemical shifts of C1B53 and those of a and b conformers of C1B50 are given in 
Figure 45B.  It is evident from the plots that the chemical shift differences between the 
constructs are quite substantial in the N- and C-terminal regions.  Moreover, extending 
C1B50 by three amino acids does not lock the protein in conformation b.  In fact, for 
some residue/nuclei combinations, the pattern of chemical shift perturbations has 
opposite signs for a and b.  These residues are highlighted with gray in Figure 45B; the 
most dramatic examples are shown in HSQC overlays of C1B50 and C1B53 in the 
insert.  This pattern suggests the presence of a dynamic averaging process in C1B53 
that is fast on the NMR chemical-shift timescale and involves protein conformations 
similar (but not identical) to those of a and b of the C1B50.  The elevated R2 values 
observed for the C-terminal residues in C1B53 lend support to the existence of this 
dynamic process. 
R2
 
measurements of C1B53 in chapter II show elevated R2
 
values for residues 
in the C-terminus.  Elevated R2 is indicative of conformational exchange on a 
microsecond to millisecond timescale.  This chemical exchange process was too fast to 
be characterized by 
15
N relaxation dispersion experiments.  It is tempting to speculate 
that the elevated R2 values reflect the conformational exchange between two C-terminal 
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conformations that are similar to those in conformers a and b of C1B50.  Consistent 
with this theory, the C151G mutant and C1B50b which represent the two 
conformations in exchange have decreased R2
 
for residues in the C-terminus, as shown 
in Figure 46.  This is expected because the process is on the seconds timescale in 
C1B50 instead of the microsecond to millisecond timescale.  The increased disorder in 
the C-terminal region compared to the core residues of C1B53 as reported by the order 
parameter in chapter II, also indicates the C-terminus is not restricted by zinc 
coordination like the other zinc coordinating residues, even in this longer construct. 
However, unlike the C1B50 exchange, the process in C1B53 is not pH 
dependent.  A pH titration of C1B53 observed by HSQC revealed the cross-peak 
position, which represents the average of two exchanging conformations, does not shift 
between positions representative of conformation a and b in C1B50.  This could be due 
to the Zn(2) being more shielded from solvent from the addition of three amino acids 
adjacent to the zinc coordinating residues.  In addition, the positively charged Lys101 
which is not present in C1B50 (Figure 45A), could stabilize the negatively charged 
Cys3His coordination sphere of Zn(2).  Also, evident from the pH titration was the 
presence of the ionizable group with pKa of 7.4 in the vicinity of Zn(2).  The change in 
chemical shift for residues which show a strong response to this pKa are plotted in 
Figure 47.  This indicates some solvent accessibility still exists in the Zn(2) site in order 
for ionization to occur of either a zinc coordinated water molecule or zinc coordinated 
Cys135 if this is the same ionizable group present in C1B50. 
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Figure 45. C1B50 versus C1B53.  (A) Comparison of C1B50 and C1B53 primary structures.  Zn2+-coordinating 
residues are highlighted in cyan; amino acids that are different between the constructs are highlighted in yellow.  (B) 
Chemical shift differences between C1B53 and those of the C1B50 a and b conformers.  Residues 112 and 148 are 
prolines with no N-HN groups. Amino acids, for which chemical shift perturbations with opposite signs were observed for at 
least one nucleus, are highlighted in grey.  For clarity of presentation, identical chemical shifts are used for the C1B50 
residues whose shifts are coincident in populations a and b. 
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Figure 46. Transverse relaxation rate constants R2 measured for three C1B variants: C1B50b, C151G, and C1B53.  
The conserved QG motif, whose dynamics is important for ligand binding, has elevated R2 values in all three constructs.  
Residues with significantly perturbed conformational dynamics in either C151G or C1B53 are shaded. 
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Figure 47. Zn(2) site is solvent accessible in C1B53.  The difference between the 
observed chemical shift and the chemical shift of the deprotonated form corrected for the 
gyromagnetic ratio of 
1
H for residues significantly affected by ionization with pKa of 7.4 
in C1B53.  Curves represent a fit to Equation 17. 
 
 
 
 
 
Figure 48. C1B53 is reactive. (A)  C1B53 untreated (U) and treated (T) with PEG-
MAL and (B) H2O2 as observed by SDS PAGE gel and NMR HSQC spectra overlay 
respectively.  (*) denotes zinc coordinating residues. 
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To determine if Cys151 is still reactive in C1B53, the reactivity of C1B53 
was tested in the same manner as C1B50.  The same PEG-MAL exposure was 
conducted on C1B53mer and two higher molecular weight products appear just as in 
C1B50 (Figure 36 and Figure 48A).  Sensitivity to reactive oxygen species was 
monitored with HSQC spectra taken after H2O2 exposure.  C1B53 peaks also disappear 
with time, however the rate is more similar to C1B-C2 than C1B50 (Figure 34 and 
Figure 48B).  This is consistent with the theory that the three additional residues provide 
some solvent protection of Cys151, but it remains reactive regardless of the construct 
length. 
Thiolate-to-thiol conversion of Cys151 “opens up” the C1B domain 
To evaluate the effect of the loss of Cys151-Zn(2) coordination on secondary 
structure, the temperature dependence of the chemical shifts was measured for both 
conformations.  HSQC spectra of C1Bα50 collected at 9.4, 15.0, 19.8, 25.0, 30.2, and 
35.4 ºC are overlaid in Figure 49.  The temperature coefficients of 
1
HN calculated from 
those spectra ranged from -15.5 (Ile145a) to 0.2 (His117) ppb/K.  According to the 
previous reports, the coefficients more positive than -4.5
159
 or -5 ppb/K
160
 are typical for 
amide protons engaged in hydrogen-bonding interactions. Ser149 is the only residue in 
C1Bα50a and C1Bα50b that crosses the -5 ppb/K “cutoff”: its temperature coefficient 
changes from -4.3 ppb/K in conformation b to -8.8 ppb/K in conformation a.  The amide 
group of Ser149 does not have any hydrogen-bonding partners in the known C1Bα 
structure.  It is likely the loss of Cys151Sγ–Zn(2) coordination bond does not 
significantly alter the hydrogen-bonding network of C1Bα50. 
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To determine if the conversion of Cys151 into the thiol form affects the protein 
structure in non-secondary structure elements, refinement was carried out using the 
existing NMR structure of C1B and the residual dipolar couplings (RDCs) measured 
for conformers a and b.  It was evident from the HSQC spectra and temperature 
titrations that the overall protein fold was preserved upon Cys151 protonation and that 
the conformational changes were not drastic.  For such cases, the RDC-based approach 
is more efficient than the de novo structure determination. 
The RDC measurements were carried out simultaneously for both conformers on 
the same protein sample with pH of 5.75.  A total of 228 and 210 RDCs were measured 
for C1B50b and C1B50a, respectively.  The largest differences between the RDC 
values of conformers a and b were observed in the C-terminal region of the protein.  An 
example is given in Figure 50A for the two residues, Ser149 and Cys151.  The splitting 
between the cross-peaks is the sum of the one-bond J-coupling constant, 
1
JNH, and the 
residual dipolar coupling, 
1
DNH.  Because the 
1
JNH coupling constants are fairly uniform 
for all amide groups (~92 Hz), the differences in the observed splittings mostly reflect 
the differences in RDCs. 
The data in Figure 44C indicate that the C-terminal region is flexible.  To 
properly account for this flexibility in the refinement procedure, half-open square well 
RDC potential was used for all dynamic residues in the protein with NOE values less 
than 0.5.  Other important details of the refinement procedure were the use of long-range 
NOEs to constrain the loop regions and definition of Zn
2+
 coordination geometry.  The 
refinement was carried out as a two-step protocol that included high- and low-
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temperature simulated annealing steps.  The parameters of the simulated annealing are 
given in Table 4. 
 
 
 
 
Figure 49. Temperature titration of C1B50.   An overlay of C1Bα50 HSQC spectra 
at increasing temperatures from 9.4 (blue) to 35.4 ºC (magenta) in 5º increments. 
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Figure 50. RDC-based structure refinement of C1B50a and C1B50b.   (A) 
Expansions of the 
15
N-
1
H IPAP spectra of C1B50 in stretched gels.  The differences 
between the doublet splittings of Ser149 and Cys151 in conformers a and b are evident.  
(B) Calculated versus observed RDCs for stretched (s) and compressed (c) gels.  (C) 
Two views of superimposed regularized average structures of C1B50a and C1B50b.  
The distances between the N- and C-termini are defined as the distances between the C 
atoms of His102 and Cys151. 
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The agreement between calculated and observed RDCs is shown in Figure 50B.  
The agreement is excellent for most residues, with the RNH factor of 10% and 6% for the 
conformers a and b aligned in the compressed gel.  The top 5% of the structures from the 
low-temperature simulated annealing step were used to generate the regularized average 
structures given in Figure 50C. 
Relative to the starting model, the backbone RMSD values are 1.4 Å for both 
conformers.  These values reduce to 1.0 Å (b) and 1.1 Å (a) if the N- and C-termini are 
excluded and only residues 6-44 are used.  Superposition of conformers a and b gives 
RMSD values of 1.6 Å (residues 1-50) and 1.0 Å (residues 6-44).  The structures are 
essentially super-imposable in the top half that includes ligand-binding loops.  The 
largest differences are observed in the N- and C-terminal regions, as well as the 
“knuckle” region of the Zn(2) site.  The structural changes result in the bottom half of 
the domain opening up.  The distance between the N- and C-termini, measured between 
the C atoms of His102 and Cys151 increases from 4.8 Å to 7.9 Å upon the formation 
of Cys151 thiol. 
The implications of this conformational change for the C1B structure and 
function are two-fold.  First, any modification of the Cys151 thiolate is likely to increase 
the accessibility of the solvent (and other reactants) to the Zn(2) site.  Second, the 
conformational change could be transmitted to the linker region that connects C1B to 
C2 and thereby influence the relative orientation of the two domains. 
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Discussion 
By using NMR to monitor the C1B domain from PKC it was demonstrated that 
the C-terminal cysteine (Cys151) is in exchange between a deprotonated zinc 
coordinated conformation (b) and a free protonated conformation (a).  This was 
established by the observation that the chemical shifts of the C151G mutant are 
analogous to the conformation of C1B50 at low pH (Figure 38).  Dynamics in zinc 
coordination number and geometry have been reported for proteins with catalytic zinc 
sites.
161
  However, zinc coordination dynamics of a structural zinc site have never been 
well characterized.  NMR of the structural zinc finger from the mengovirus leader 
protein revealed two conformations of the zinc binding region in slow exchange 
(lifetimes >1ms),
162
 but a direct link to zinc binding dynamics was not established.  In a 
classical zinc finger of a human enhancer binding protein the kinetics of a slow 
exchange process between one major form and two minor forms was characterized.
163
  
The two zinc coordinating histidine residues exhibited the largest chemical shift 
differences between the different populations, but changes in zinc coordination state 
were never confirmed.  Zinc finger proteins play a role in regulation of almost all 
cellular processes.  Thus, further characterization of these dynamics could reveal a wide 
spread mechanism of regulation. 
Similar to the dynamics reported for these structural zinc fingers,
162,163
 the 50 
amino acid construct of C1B produced NMR spectra with two populations for several 
residues.  The existence of two slowly exchanging conformations was demonstrated with 
ZZ-exchange NMR (Figure 43).  ZZ-exchange calculations reveal the exchange to be 
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about 3 s
-1 
at pH 5.75 and 25ºC, on the same time scale as the exchange reported by 
Clore et Al for zinc binding histidines.
163
  This indicates a large activation energy for the 
exchange.   
By changing the pH the populations could be reversibly shifted with an apparent 
pKa of 5.8 (Figure 39), a clear indication that the equilibrium process involves ionization 
of one the exchanging residues.  The only ionizable residues in slow exchange are 
Lys103 and Cys151.  The side-chain of Lys103 is solvent exposed in all of the structures 
in the NMR ensemble
67
 and therefore should have a pKa well above 10. However, 
Cys151 is predicted to coordinate one of the two structural zinc atoms in C1B (Figure 
38C) and not be available for protonation.  This result could be explained by Cys151 
being solvent exposed in one of the two slow exchanging conformations and thus able to 
be protonated.  To test this hypothesis, a mutant was made in which Cys151 was mutated 
to glycine, providing a side-chain which is incapable of coordinating zinc.  The chemical 
shifts mimic that of the acidic conformation, consistent with the low pH conformer being 
protonated and no longer zinc coordinated. 
The available structures of C1 domains represent only the Cys151 coordinated 
conformation.  To experimentally determine the structure of the Cys151 exposed 
conformer, RDCs were collected and used for structure refinement.  As hypothesized, 
the structure determined using population b RDCs was the conformer with Cys151 
coordinated to zinc and similar to the structures of the other C1 domains that have been 
determined.  The structure that dominates at low pH determined from population a 
RDCs shows significant changes in the structure in the C-terminal region.  The 
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proximity of this region to the following C2 domain provides a potential mechanism for 
the type of large domain rearrangements that occur upon PKC activation by second 
messengers.  While this structure was determined of the isolated C1B domain, cysteine 
exposure and reactivity assays (Figure 34, Figure 36, Figure 37, and Figure 48), the 
presence of an ionizable group with pKa 7.4 (Figure 47), dynamics measurements 
(Figure 46), as well as molecular dynamics simulation of longer constructs supports 
similar conformational exchange process in the context of the full length protein. 
 
 
Figure 51. Zn(2) site model in (A) C1B50 and (B) C1B53.   Species represented are 
those predicted to be the dominate species in solution. 
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Figure 52. Snapshot taken at the end of the 10ns MD simulation. Zn(2) has 
octahedral geometry with three coordinated water molecules (shown in red and white) 
and three coordinated protein residues (His102, Cys132, and Cys135).  Cys151 S is 
7.1Å from zinc at this time in the simulation.   
 
 
 
When Cys151 is not coordinated to zinc, chemistry dictates there be another zinc 
coordinating ligand.  Zinc bound to protein is most commonly coordinated by four 
ligands, with a fifth ligand not being unusual if one of the ligands is water.
51
  Water is 
the most likely candidate for the additional ligand.  This is supported by the C1B 
residues in close proximity to zinc titrating with a 7.3 pKa (Figure 42), consistent with 
water that is coordinated to zinc
157
.  The same titration behavior is seen in C151G and 
C1B53 (Figure 47) indicating that the water is present in longer constructs and 
regardless of the zinc coordination state.  Figure 51 illustrates this hypothesis for 
C1B50, showing water coordination at low pH and a possible water molecule present 
even at high pH.  C1B53 is depicted with the Lys101 stabilizing the zinc coordination 
sphere, however there is also a possibility of zinc coordinated water in the longer 
construct as well. 
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In addition to the experimental evidence, the model presented in Figure 51 is also 
supported by molecular dynamics simulations of the C1B53.97  The simulations start 
with a member of the NMR ensemble
67
 in which both zinc atoms are tetrahedrally 
coordinated by one histidine and three cysteine residues.  In one trajectory, after 2.6 ns 
the terminal-zinc adopts trigonal bipyramidal coordination with the histidine, three 
cysteines, and a water molecule which enters the coordination sphere.  A second water 
molecule enters the coordination sphere at 3.1 ns at which point zinc takes on an 
octahedral coordination with the histidine, three cysteines, and two water molecule 
ligands.  At 5.8 ns a third water molecule enters the zinc coordination sphere as Cys151 
moves away maintaining the octahedral geometry.  The same three water molecules 
remain coordinated to zinc for the remainder of the 10ns simulation. Figure 52 shows a 
snapshot taken at the end of the 10ns simulation highlighting the three zinc coordinated 
water molecules and the increased distance between Cys151 and zinc.  Once cysteine 
leaves the zinc coordination sphere the distance from S to zinc varies up to 9.5Å.  In an 
independent 10 ns trajectory, Cys151 lost and then regained zinc coordination twice.   
Consistent with the PEG-mal solvent exposure assay which revealed that only 
Cys151 loses zinc coordination, Zn(1) maintains all four protein ligands in 3 
independent MD simulation trajectories.  Zn(1) spent most of the time in tetrahedral 
geometry, but adopted trigonal bipyramidal geometry several times when a very short 
lived water (0.01-2 ns) entered the Zn(1) coordination sphere.  The tetrahedral geometry 
can be seen clearly at the end of the MD simulation as shown in Figure 52.  In this way 
Zn(1) serves as an internal control to show that loss of Cys151 coordination by the 
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terminal-zinc is not likely due to the type of zinc interaction model applied during the 
simulation.  The presence of zinc bound water and non-tetrahedral geometry was 
observed in the simulation regardless of the type of zinc model used. 
97
  While these 
simulations were performed on a shorter time scale than the process that leads to the 
observed conformational exchange in the C1B spectra, the Cys151 zinc coordination 
dynamics and the presence of zinc bound water mimics the zinc coordination dynamics 
observed in NMR experiments and cysteine exposure assays. 
Exposure of C1B50, C1B53, C1B-C2 and C151G to a cysteine modification 
agent, revealed Cys151 is the most solvent exposed cysteine (Figure 36 and Figure 48A).  
It is also the most reactive cysteine as revealed by treatment with H2O2 and IAC (Figure 
34, Figure 37, and Figure 48B).  Constructs which contained Cys151 reacted faster than 
C151G.  Also evident from these studies is that the C1B domain releases zinc and 
unfolds upon modification, revealing a possible activation mechanism for PKC proteins.  
Oxidative conditions in vivo and in vitro have been shown to activate PKC in the 
absence of second messengers and lead to the release of zinc,
121,122
 however it was 
unclear how the oxidation agents gained access to the cysteines that were thought to all 
be tightly coordinated to zinc.  The dynamic sampling of a conformation in which 
Cys151 is solvent exposed provides a possible site for reactive oxygen species attack.  
The unfolding of the regulatory domain due to modification would likely free PKC from 
its auto-inhibited state and bring about activation by reactive oxygen species.   
In conclusion, this is the first identification and characterization of zinc 
coordination dynamics in a zinc finger protein.  C1B50 samples a previously unknown 
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structure which differs in zinc coordination number and geometry from any known C1 
domain structures.  This alternate conformation, in which a zinc coordinating cysteine 
loses coordination and becomes solvent exposed, provides a possible mechanism for 
PKC activation by oxidative stress.  These findings shed new light on the more active 
functional role that zinc coordination can play in zinc finger proteins. 
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CHAPTER V 
SUMMARY OF FINDINGS AND FUTURE DIRECTIONS 
 
The findings presented here are a significant advancement toward understanding 
the C1 domain ligand specificities and reactivity and their effect on PKC activity.  PKC 
signaling is involved in the processes of cell division, adhesion, and death.  C1 ligand 
binding is a required step in the canonical PKC activation mechanism.  The various 
regulatory domain ligand affinities and specificities dictate the conditions in which PKC 
is activated, its localization in the cell, and therefore the signaling cascades that take 
place that lead to differing cellular events.  Controlled cell death and regeneration are 
key processes in the treatment of many human diseases and disorders; thus 
understanding PKC regulation is an important step toward developing treatments. 
As discussed in Chapter I, several naturally occurring small molecules that bind 
to the C1 domain have proved useful for treatment of cancer, stroke, and Alzheimer’s 
disease.  However, in order to design drugs with a specific mode of action we must first 
understand how the PKC isoforms are regulated differently.  One established difference 
is the identity of a hydrophobic residue at position 22 in the C1B domain of conventional 
and novel PKC that dictates the ligand affinity and specificity.  To determine how this 
residue differentially regulates PKC, the structure, dynamics, and ligand binding 
properties of C1B domains from the conventional PKC isoform and the novel PKC 
isoform along with position 22 mutants of these constructs are reported in Chapter II. 
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For both C1B and C1B, the identity of residue 22 had little effect on the 
structure of the domain in the apo-state or bound to ligand as judged by the similarity in 
chemical shifts and residual dipolar couplings.  Measurement of sub-nanosecond 
dynamics also revealed that fast vibrational motions were not affected by position 22 
identity.  However, ligand binding studies demonstrated that when Trp is at position 22 
in either C1B or C1B, the domain increases DOG affinity by more than an order of 
magnitude compared to Tyr. 
Relaxation dispersion experiments revealed conformational exchange in the 
ligand binding loops in both conventional and novel isoforms in the absence of ligand.  
However, the rate of exchange is decreased and the number of residues affected by the 
exchange is increased when Trp is at position 22.  Because of the location of the 
dynamic residues in the ligand binding loop hinges and the role of conserved residues in 
forming loop stabilizing hydrogen bonds observed in the C1B crystal structure, I 
hypothesize that the exchange the loops experience is between open and closed 
conformations.  These findings, in combination with available structural information 
from C1 domains of different PKC isoforms and molecular dynamics simulations, lead 
to the conclusion that Trp at position 22 stabilizes the higher energy closed loop 
conformation that is required for binding small ligands, such as diacylglycerol, better 
than Tyr.  This is an important difference established between novel and conventional 
PKC C1B domains that can be exploited in future drug design studies in order to develop 
treatments with a single mode of action. 
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For future studies, it would be useful to determine the structure of both the open 
and closed loop conformations.  This is difficult to accomplish in the apo-state since the 
high energy closed loop conformation is only weakly populated.  However, some insight 
could be gained by determining the structure of C1 bound to both a small ligand, such as 
DOG, and a larger ligand, such as PDBu, if the two ligands bind to and stabilize 
different loop conformations.  From these structures it could be possible to determine the 
interactions of the Trp side-chain that stabilize the closed loop conformation in the apo-
state, which are absent when Tyr is at position 22. 
Progress toward this objective has already been accomplished and reported in 
Chapter III.  Two conditions of PDBu-bound C1B suitable for structure determination 
were described.  The first is a method for efficiently precipitating C1B with PDBu for 
solid-state NMR data collection.  The backbone atom assignment of this state is 
complete and shows that it is a feasible method for determining C1 domain ligand-bound 
structures.  These assignments and chemical shift perturbations reported here can be 
used as structural restraints for the secondary structure and ligand binding interface.  
Solution NMR data has been collected in the second condition for an all-atom 
assignment and NOE restraint calculations of C1B bound to PDBu in micelles.  The 
lipid PRE assay described for measuring the depth of C1B insertion in micelles can be 
applied to this system as an additional structure restraint.  Furthermore, these conditions 
may also be suitable for determining the structure of C1 domains bound to potential 
drugs, such as the bryostatin compounds.  These structural studies could shed a much-
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needed light on what dictates the drastic differences reported for C1 domain ligand 
affinities and specificities. 
The identity of the residue at position 22 was also observed to play a role in the 
interaction with micelles in the absence of a ligand.  For the C1B constructs, micelle 
binding of the Trp containing mutant led to intermediate exchange or peak shifting for 
approximately half the residues in the domain compared to just one ligand binding loop 
in the case of Tyr.  From this drastic change in the number of affected micelle-binding 
residues it can be concluded that the identity of residue 22 impacts the micelle-binding 
affinity, structure, or interaction interface.  However, because of the intermediate 
exchange regime, this could not be determined.  For C1B constructs, Trp at position 22 
increased the affinity for micelles at least 2-3 fold and increased the depth of insertion 
when compared to Tyr.  Because C1 domains likely first insert into the membrane and 
then undergo a two-dimensional search for membrane bound ligand, these differences in 
affinity and depth of insertion could play a large role in dictating diacylglycerol binding 
kinetics.  Future simulation and docking studies could take advantage of the 
experimentally determined depths of insertion for the loop and helix residues to visualize 
the positioning of the residue 22 side-chain in the membrane-bound structure and assess 
the binding surface accessibility to a membrane-bound ligand. 
In addition to the activation of PKC by regulatory domain membrane binding, 
PKC signaling is also triggered in response to reactive oxygen species.  Chapter IV 
reports the investigation into the reactivity of C1B in relation to the activation of PKC by 
reactive oxygen species.  Reaction of C1B with hydrogen peroxide, iodoactemide, and 
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polyethylene glycol maleimide and observation of the products using NMR or gel 
electrophoresis, showed that modification leads to loss of zinc and protein unfolding.  
This behavior also persists in the context of the subsequent regulatory domain as 
demonstrated by the reaction and modification of the C1B-C2 construct.  When these 
experiments were carried out on a Cys151 to Gly mutant (C151G), it is clear Cys151 is 
the most reactive cysteine in C1B from PKC.   Future investigation of the C151G 
mutation in the context of the full length PKC under conditions reactive oxygen species 
signaling could be used to determine the role of Cys151 reactivity in vivo.  Similar 
studies could also be used to test the reactivity of the equivalent residue in the C1A 
domain, Cys86. 
The structure, dynamics, and kinetics of an exchange between two conformations 
in C1B50 due to changes in ionization of the Cys151 side-chain were characterized 
using pH titrations, residual dipolar coupling measurements, relaxation experiments, and 
zz-exchange NMR experiments.  In one conformation, Cys151 side-chain is coordinated 
to zinc as observed in all available C1 structures.  In the second conformation, zinc 
coordination of Cys151 is lost, and the C-terminal tail adopts a structure in which 
Cys151 is exposed to solvent.  The solvent exposed Cys151 is more accessible to 
reactive oxygen species; a possible explanation for the observed increase in reactivity.  
The tail also becomes dynamic on the microsecond-millisecond timescale.  Future 
dynamics studies of the C151G mutant could be done to characterize the conformational 
exchange in this alternate conformation.  Elevated dynamics were also seen in C1B C-
terminal residues, but more studies need to be done to determine if the exchange seen in 
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this isoform is also due to changes in zinc coordination.  Taken together, these results 
suggest that zinc coordination dynamics have an effect on C1B structure and could be a 
key finding in understanding how PKC is activated under conditions of oxidative stress. 
In conclusion, the findings presented here provide insight into the role of the 
C1B domain in the activation and differential regulation of PKC isoforms.  Future 
investigations using similar methods will be fundamental in elucidating the mechanisms 
used for complex regulation of other multi-domain signaling proteins. 
 
 
 
 168 
 
REFERENCES 
 
 
(1)Anilkumar, N.; Parsons, M.; Monk, R.; Ng, T.; Adams, J. C. EMBO J 2003, 22, 5390. 
(2)Dempsey, E. C.; Newton, A. C.; Mochly-Rosen, D.; Fields, A. P.; Reyland, M. E.; 
Insel, P. A.; Messing, R. O. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279, L429. 
(3)Poole, A. W.; Pula, G.; Hers, I.; Crosby, D.; Jones, M. L. Trends Pharmacol. Sci. 
2004, 25, 528. 
(4)Newton, A. C. Biochem. J. 2003, 370, 361. 
(5)Mochly-Rosen, D.; Gordon, A. S. The FASEB Journal 1998, 12, 35. 
(6)Braz, J. C.; Gregory, K.; Pathak, A.; Zhao, W.; Sahin, B.; Klevitsky, R.; Kimball, T. 
F.; Lorenz, J. N.; Nairn, A. C.; Liggett, S. B.; Bodi, I.; Wang, S.; Schwartz, A.; Lakatta, 
E. G.; DePaoli-Roach, A. A.; Robbins, J.; Hewett, T. E.; Bibb, J. A.; Westfall, M. V.; 
Kranias, E. G.; Molkentin, J. D. Nat. Med. 2004, 10, 248. 
(7)Masur, K.; Lang, K.; Niggemann, B.; Zanker, K. S.; Entschladen, F. Mol. Biol. Cell 
2001, 12, 1973. 
(8)Alkon, D. L.; Sun, M.-K.; Nelson, T. J. Trends Pharmacol. Sci. 2007, 28, 51. 
(9)Hains, A. B.; Vu, M. A. T.; Maciejewski, P. K.; van Dyck, C. H.; Gottron, M.; 
Arnsten, A. F. T. Proceedings of the National Academy of Sciences 2009, 106, 17957. 
(10)Newton, A. C. Chemical Reviews 2001, 101, 2353. 
(11)Saito, N. In Protein Kinase C Protocols; Newton, A., Ed.; Humana Press: 2003; 
Vol. 233, p 93. 
(12)Orr, J. W.; Newton, A. C. Biochemistry 1992, 31, 4661. 
(13)Cho, W.; Stahelin, R. V. Biochimica et Biophysica Acta (BBA) - Molecular and Cell 
Biology of Lipids 2006, 1761, 838. 
(14)Brodie, C.; Blumberg, P. M. Apoptosis 2003, 8, 19. 
(15)Carrasco, S.; Merida, I. Mol. Biol. Cell 2004, 15, 2932. 
(16)Kazi, J. U.; Soh, J.-W. Biochem. Biophys. Res. Commun. 2007, 364, 231. 
 169 
 
(17)Graybill, C.; Wee, B.; Atwood, S. X.; Prehoda, K. E. J. Biol. Chem. 2012. 
(18)Wang, Y.; Seibenhener, M. L.; Vandenplas, M. L.; Wooten, M. W. J. Neurosci. Res. 
1999, 55, 293. 
(19)Leonard, T. A.; Ró; ycki, B.; Saidi, L. F.; Hummer, G.; Hurley, J. H. Cell 2011, 144, 
55. 
(20)Slater, S. J.; Seiz, J. L.; Cook, A. C.; Buzas, C. J.; Malinowski, S. A.; Kershner, J. 
L.; Stagliano, B. A.; Stubbs, C. D. J. Biol. Chem. 2002, 277, 15277. 
(21)Stahelin, R. V.; Wang, J.; Blatner, N. R.; Rafter, J. D.; Murray, D.; Cho, W. J. Biol. 
Chem. 2005, 280, 36452. 
(22)Zhang, G.; Kazanietz, M. G.; Blumberg, P. M.; Hurley, J. H. Cell 1995, 81, 917. 
(23)Sánchez-Bautista, S.; Corbalán-García, S.; Pérez-Lara, A.; Gómez-Fernández, J. C. 
Biophys. J. 2009, 96, 3638. 
(24)Ananthanarayanan, B.; Stahelin, R. V.; Digman, M. A.; Cho, W. H. J. Biol. Chem. 
2003, 278, 46886. 
(25)Zhou, M.; Horita, D. A.; Waugh, D. S.; Byrd, R. A.; Morrison, D. K. J. Mol. Biol. 
2002, 315, 435. 
(26)Geczy, T.; Peach, M. L.; El Kazzouli, S.; Sigano, D. M.; Kang, J.-H.; Valle, C. J.; 
Selezneva, J.; Woo, W.; Kedei, N.; Lewin, N. E.; Garfield, S. H.; Lim, L.; Mannan, P.; 
Marquez, V. E.; Blumberg, P. M. J. Biol. Chem. 2012, 287, 13137. 
(27)Pu, Y.; Peach, M. L.; Garfield, S. H.; Wincovitch, S.; Marquez, V. E.; Blumberg, P. 
M. J. Biol. Chem. 2006, 281, 33773. 
(28)Dries, D. R.; Gallegos, L. L.; Newton, A. C. J. Biol. Chem. 2007, 282, 826. 
(29)Ogbourne, S. M.; Suhrbier, A.; Jones, B.; Cozzi, S.-J.; Boyle, G. M.; Morris, M.; 
McAlpine, D.; Johns, J.; Scott, T. M.; Sutherland, K. P.; Gardner, J. M.; Le, T. T. T.; 
Lenarczyk, A.; Aylward, J. H.; Parsons, P. G. Cancer Res. 2004, 64, 2833. 
(30)Hampson, P.; Kavanagh, D.; Smith, E.; Wang, K.; Lord, J.; Ed Rainger, G. Cancer 
Immunology, Immunotherapy 2008, 57, 1241. 
(31)Yi, P.; Schrott, L.; Castor, T.; Alexander, J. J. Mol. Neurosci. 2012, 48, 234. 
 170 
 
(32)Hongpaisan, J.; Sun, M.-K.; Alkon, D. L. The Journal of Neuroscience 2011, 31, 
630. 
(33)Sun, M.-K.; Hongpaisan, J.; Nelson, T. J.; Alkon, D. L. Proceedings of the National 
Academy of Sciences 2008, 105, 13620. 
(34)Sun, M.-K.; Hongpaisan, J.; Alkon, D. L. Proceedings of the National Academy of 
Sciences 2009, 106, 14676. 
(35)Korin, Y. D.; Brooks, D. G.; Brown, S.; Korotzer, A.; Zack, J. A. J. Virol. 2002, 76, 
8118. 
(36)Williams, S. A.; Chen, L.-F.; Kwon, H.; Fenard, D.; Bisgrove, D.; Verdin, E.; 
Greene, W. C. J. Biol. Chem. 2004, 279, 42008. 
(37)Marquez, V. E.; Blumberg, P. M. Accounts of Chemical Research 2003, 36, 434. 
(38)Truman, J.-P.; Rotenberg, S. A.; Kang, J.-H.; Lerman, G.; Fuks, Z.; Kolesnick, R.; 
Marquez, V. E.; Haimovitz-Friedman, A. Cancer Biology & Therapy 2009, 8, 54. 
(39)Nakagawa, Y. Bioscience, Biotechnology, and Biochemistry 2012, 76, 1262. 
(40)Wang, Q. J.; Fang, T.-W.; Fenick, D.; Garfield, S.; Bienfait, B.; Marquez, V. E.; 
Blumberg, P. M. J. Biol. Chem. 2000, 275, 12136. 
(41)Wang, Q. J.; Bhattacharyya, D.; Garfield, S.; Nacro, K.; Marquez, V. E.; Blumberg, 
P. M. J. Biol. Chem. 1999, 274, 37233. 
(42)Nakagawa, Y.; Irie, K.; Yanagita, R. C.; Ohigashi, H.; Tsuda, K.-i.; Kashiwagi, K.; 
Saito, N. J. Med. Chem. 2006, 49, 2681. 
(43)Wender, P. A.; Baryza, J. L.; Brenner, S. E.; DeChristopher, B. A.; Loy, B. A.; 
Schrier, A. J.; Verma, V. A. Proceedings of the National Academy of Sciences 2011, 
108, 6721. 
(44)LaValle, C. R.; George, K. M.; Sharlow, E. R.; Lazo, J. S.; Wipf, P.; Wang, Q. J. 
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2010, 1806, 183. 
(45)Yang, C.; Liu, Y.; Coluccio Leskow, F.; Weaver, V. M.; Kazanietz, M. G. J. Biol. 
Chem. 2005, M411629200. 
(46)Yang, D.; Kedei, N.; Li, L.; Tao, J.; Velasquez, J. F.; Michalowski, A. M.; Tóth, B. 
I.; Marincsák, R.; Varga, A.; Bíró, T.; Yuspa, S. H.; Blumberg, P. M. Cancer Res. 2010, 
70, 7905. 
 171 
 
(47)Takeishi, K.; Taketomi, A.; Shirabe, K.; Toshima, T.; Motomura, T.; Ikegami, T.; 
Yoshizumi, T.; Sakane, F.; Maehara, Y. J. Hepatol. 2012, 57, 77. 
(48)Wilkinson, S.; Paterson, H. F.; Marshall, C. J. Nat. Cell Biol. 2005, 7, 255. 
(49)Heikkila, T.; Wheatley, E.; Crighton, D.; Schroder, E.; Boakes, A.; Kaye, S. J.; 
Mezna, M.; Pang, L.; Rushbrooke, M.; Turnbull, A.; Olson, M. F. PLoS ONE 2011, 6, 
e24825. 
(50)Andreini, C.; Banci, L.; Bertini, I.; Rosato, A. J. Proteome Res. 2005, 5, 196. 
(51)Auld, D. S. Biometals 2001, 14, 271. 
(52)Frederickson, C. J.; Koh, J.-Y.; Bush, A. I. Nat. Rev. Neurosci. 2005, 6, 449. 
(53)Li, W.; Zhang, J.; Wang, J.; Wang, W. J. Am. Chem. Soc. 2007, 130, 892. 
(54)Grishin, N. V. Nucleic Acids Res. 2001, 29, 1703. 
(55)Ilbert, M.; Graf, P. C.; Jakob, U. Antioxid. Redox Signal. 2006, 8, 835. 
(56)Kroncke, K. D.; Klotz, L. O. Antioxid. Redox Signal. 2009, 11, 1015. 
(57)Cosentino-Gomes, D.; Rocco-Machado, N.; Meyer-Fernandes, J. R. Int J Mol Sci 
2012, 13, 10697. 
(58)Marley, J.; Lu, M.; Bracken, C. J. Biomol. NMR 2001, 20, 71. 
(59)Delaglio, F.; Grzesiek, S.; Vuister, G. W.; Zhu, G.; Pfeifer, J.; Bax, A. J. Biomol. 
NMR 1995, 6, 277. 
(60)Goddard, T. D.; Kneller, D. G.  Computer  Software. University of California, San 
Francisco, 2003. 
(61)Muhandiram, D. R.; Kay, L. E. Journal of Magnetic Resonance, Series B 1994, 103, 
203. 
(62)Schumann, F.; Riepl, H.; Maurer, T.; Gronwald, W.; Neidig, K.-P.; Kalbitzer, H. J. 
Biomol. NMR 2007, 39, 275. 
(63)Wilcox, C. S. Frontiers in Supramolecular Organic Chemistry and Photochemistry 
1991, 123. 
 172 
 
(64)Farrow, N. A.; Muhandiram, R.; Singer, A. U.; Pascal, S. M.; Kay, C. M.; Gish, G.; 
Shoelson, S. E.; Pawson, T.; Forman-Kay, J. D.; Kay, L. E. Biochemistry 1994, 33, 
5984. 
(65)García de la Torre, J.; Huertas, M. L.; Carrasco, B. Journal of Magnetic Resonance 
2000, 147, 138. 
(66)Tjandra, N.; Kuboniwa, H.; Ren, H.; Bax, A. Eur. J. Biochem. 1995, 230, 1014. 
(67)Hommel, U.; Zurini, M.; Luyten, M. Nature Structural and Molecular Biology 1994, 
1, 383. 
(68)Hall, J. B.; Fushman, D. J. Biomol. NMR 2003, 27, 261. 
(69)Lipari, G.; Szabo, A. J. Am. Chem. Soc. 1982, 104, 4546. 
(70)Mandel, A. M.; Akke, M.; Palmer, I. I. I. A. G. J. Mol. Biol. 1995, 246, 144. 
(71)Cole, R.; Loria, J. P. J. Biomol. NMR 2003, 26, 203. 
(72)Farrow, N. A.; Zhang, O.; Forman-Kay, J. D.; Kay, L. E. Biochemistry 1995, 34, 
868. 
(73)Farrow, N. A.; Zhang, O. W.; Szabo, A.; Torchia, D. A.; Kay, L. E. J. Biomol. NMR 
1995, 6, 153. 
(74)Peng, J. W.; Wagner, G. Biochemistry 1992, 31, 8571. 
(75)Peng, J. W.; Wagner, G. Journal of Magnetic Resonance 1992, 98, 308. 
(76)Sass, H.-J.; Musco, G.; Stahl, S. J.; Wingfield, P. T.; Grzesiek, S. J. Biomol. NMR 
2000, 18, 303. 
(77)Tycko, R.; Blanco, F. J.; Ishii, Y. J. Am. Chem. Soc. 2000, 122, 9340. 
(78)Chou, J. J.; Gaemers, S.; Howder, B.; Louis, J. M.; Bax, A. J. Biomol. NMR 2001, 
21, 377. 
(79)Ottiger, M.; Delaglio, F.; Bax, A. Journal of Magnetic Resonance 1998, 131, 373. 
(80)Hwang, T. L.; van Zijl, P. C.; Mori, S. J. Biomol. NMR 1998, 11, 221. 
(81)Hwang, T. L.; Shaka, A. J. Journal of Magnetic Resonance, Series A 1995, 112, 275. 
 173 
 
(82)Piotto, M.; Saudek, V.; Sklenář, V. J. Biomol. NMR 1992, 2, 661. 
(83)Sklenar, V.; Piotto, M.; Leppik, R.; Saudek, V. Journal of Magnetic Resonance, 
Series A 1993, 102, 241. 
(84)Zhang, O.; Kay, L. E.; Olivier, J. P.; Forman-Kay, J. D. J. Biomol. NMR 1994, 4, 
845. 
(85)Lemmon, M. A. Nat. Rev. Mol. Cell Biol. 2008, 9, 99. 
(86)Dries, D. R.; Newton, A. C. J. Biol. Chem. 2008, 283, 7885. 
(87)Vriend, G. Journal of Molecular Graphics 1990, 8, 52. 
(88)Millet, O.; Mittermaier, A.; Baker, D.; Kay, L. E. J. Mol. Biol. 2003, 329, 551. 
(89)Oxenoid, K.; Rice, A. J.; Chou, J. J. Protein Sci. 2007, 16, 1977. 
(90)Xu, R. X.; Pawelczyk, T.; Xia, T.-H.; Brown, S. C. Biochemistry 1997, 36, 10709. 
(91)Hritz, J.; Ulicny, J.; Laaksonen, A.; Jancura, D.; Miskovsky, P. J. Med. Chem. 2004, 
47, 6547. 
(92)Steffel, L. R.; Cashman, T. J.; Reutershan, M. H.; Linton, B. R. J. Am. Chem. Soc. 
2007, 129, 12956. 
(93)Skalicky, J. J.; Selsted, M. E.; Pardi, A. Proteins: Structure, Function, and 
Bioinformatics 1994, 20, 52. 
(94)Mori, S.; Abeygunawardana, C.; Berg, J. M.; van Zijl, P. C. M. J. Am. Chem. Soc. 
1997, 119, 6844. 
(95)Clore, G. M.; Bax, A.; Wingfield, P. T.; Gronenborn, A. M. Biochemistry 1990, 29, 
5671. 
(96)Kleckner, I. R.; Foster, M. P. Biochimica et Biophysica Acta (BBA) - Proteins and 
Proteomics 2011, 1814, 942. 
(97)Stewart, M. D.; Morgan, B.; Massi, F.; Igumenova, T. I. J. Mol. Biol. 2011, 408, 
949. 
(98)Choi, Y.; Pu, Y.; Peach, M. L.; Kang, J.-H.; Lewin, N. E.; Sigano, D. M.; Garfield, 
S. H.; Blumberg, P. M.; Marquez, V. E. J. Med. Chem. 2007, 50, 3465. 
 174 
 
(99)Shanmugasundararaj, S.; Das, J.; Sandberg, Warren S.; Zhou, X.; Wang, D.; 
Messing, Robert O.; Bruzik, Karol S.; Stehle, T.; Miller, Keith W. Biophys. J. 2012, 103, 
2331. 
(100)Pak, Y.; Enyedy, I. J.; Varady, J.; Kung, J. W.; Lorenzo, P. S.; Blumberg, P. M.; 
Wang, S. J. Med. Chem. 2001, 44, 1690. 
(101)Kazanietz, M. G.; Wang, S.; Milne, G. W. A.; Lewin, N. E.; Liu, H. L.; Blumberg, 
P. M. J. Biol. Chem. 1995, 270, 21852. 
(102)van Meer, G.; de Kroon, A. I. P. M. J. Cell Sci. 2011, 124, 5. 
(103)Medkova, M.; Cho, W. Biochemistry 1998, 37, 4892. 
(104)Johnson, J. E.; Giorgione, J.; Newton, A. C. Biochemistry 2000, 39, 11360. 
(105)Steinberg, S. F. Physiol. Rev. 2008, 88, 1341. 
(106)Mori, S.; Abeygunawardana, C.; Johnson, M. O.; van Zijl, P. C. Journal of 
Magnetic Resonance. Series B 1995, 108, 94. 
(107)Baldus, M.; Petkova, A. T.; Herzfeld, J.; Griffin, R. G. Molecular Physics 1998, 
95, 1197. 
(108)Takegoshi, K.; Nakamura, S.; Terao, T. Chemical Physics Letters 2001, 344, 631. 
(109)Pauli, J.; Baldus, M.; van Rossum, B.; de Groot, H.; Oschkinat, H. ChemBioChem 
2001, 2, 272. 
(110)Fernández, C.; Hilty, C.; Wider, G.; Wüthrich, K. Proceedings of the National 
Academy of Sciences 2002, 99, 13533. 
(111)Sanson, A.; Monck, M. A.; Neumann, J.-M. Biochemistry 1995, 34, 5938. 
(112)MacRaild, C. A.; Howlett, G. J.; Gooley, P. R. Biochemistry 2004, 43, 8084. 
(113)Kutateladze, T. G.; Capelluto, D. G. S.; Ferguson, C. G.; Cheever, M. L.; 
Kutateladze, A. G.; Prestwich, G. D.; Overduin, M. J. Biol. Chem. 2004, 279, 3050. 
(114)Killian, J. A.; von Heijne, G. Trends Biochem. Sci. 2000, 25, 429. 
(115)MacCallum, J. L.; Bennett, W. F. D.; Tieleman, D. P. Biophys. J. 2008, 94, 3393. 
 175 
 
(116)Wimley, W. C.; White, S. H. Nature Structural and Molecular Biology 1996, 3, 
842. 
(117)Newton, A. C. Am. J. Physiol. Endocrinol. Metab. 2010, 298, E395. 
(118)Caberoy, N. B.; Zhou, Y.; Alvarado, G.; Fan, X.; Li, W. Biochem. Biophys. Res. 
Commun. 2009, 386, 197. 
(119)Kuo, W.; Herrick, D. Z.; Cafiso, D. S. Biochemistry 2011, 50, 2633. 
(120)Gopalakrishna, R.; Anderson, W. B. Proceedings of the National Academy of 
Sciences U. S. A. 1989, 86, 6758. 
(121)Knapp, L. T.; Klann, E. J. Biol. Chem. 2000, 275, 24136. 
(122)Korichneva, I.; Hoyos, B.; Chua, R.; Levi, E.; Hammerling, U. J. Biol. Chem. 
2002, 277, 44327. 
(123)Maret, W. Antioxid. Redox Signal. 2006, 8, 1419. 
(124)Janda, I.; Devedjiev, Y.; Derewenda, U.; Dauter, Z.; Bielnicki, J.; Cooper, D. R.; 
Graf, P. C. F.; Joachimiak, A.; Jakob, U.; Derewenda, Z. S. Structure 2004, 12, 1901. 
(125)Graf, P. C. F.; Martinez-Yamout, M.; VanHaerents, S.; Lilie, H.; Dyson, H. J.; 
Jakob, U. J. Biol. Chem. 2004, 279, 20529. 
(126)Li, W.; Bottrill, A. R.; Bibb, M. J.; Buttner, M. J.; Paget, M. S. B.; Kleanthous, C. 
J. Mol. Biol. 2003, 333, 461. 
(127)Newman, J. D.; Anthony, J. R.; Donohue, T. J. J. Mol. Biol. 2001, 313, 485. 
(128)Dinkova-Kostova, A. T.; Holtzclaw, W. D.; Wakabayashi, N. Biochemistry 2005, 
44, 6889. 
(129)Butt, T. R.; Edavettal, S. C.; Hall, J. P.; Mattern, M. R. Protein Expr. Purif. 2005, 
43, 1. 
(130)Morales, K. A.; Lasagna, M.; Gribenko, A. V.; Yoon, Y.; Reinhart, G. D.; Lee, J. 
C.; Cho, W.; Li, P.; Igumenova, T. I. J. Am. Chem. Soc. 2011, 133, 10599. 
(131)Yamazaki, T.; Forman-Kay, J. D.; Kay, L. E. J. Am. Chem. Soc. 1993, 115, 11054. 
(132)Lee, W.; Westler, W. M.; Bahrami, A.; Eghbalnia, H. R.; Markley, J. L. 
Bioinformatics 2009, 25, 2085. 
 176 
 
(133)Farrow, N. A.; Zhang, O. W.; Forman-Kay, J. D.; Kay, L. E. J. Biomol. NMR 1994, 
4, 727. 
(134)Miloushev, V. Z.; Bahna, F.; Ciatto, C.; Ahlsen, G.; Honig, B.; Shapiro, L.; Palmer, 
A. G., 3rd Structure 2008, 16, 1195. 
(135)Hunt, J. B.; Neece, S. H.; Ginsburg, A. Anal. Biochem. 1985, 146, 150. 
(136)Zhao, F.; Ilbert, M.; Varadan, R.; Cremers, C. M.; Hoyos, B.; Acin-Perez, R.; 
Vinogradov, V.; Cowburn, D.; Jakob, U.; Hammerling, U. Antioxid. Redox Signal. 2011, 
14, 757. 
(137)Kosolapov, A.; Deutsch, C. Nat. Struct. Mol. Biol. 2009, 16, 405. 
(138)Webb, H.; Tynan-Connolly, B. M.; Lee, G. M.; Farrell, D.; O'Meara, F.; 
Sondergaard, C. R.; Teilum, K.; Hewage, C.; McIntosh, L. P.; Nielsen, J. E. Proteins 
2011, 79, 685. 
(139)Yang, D.; Tolman, J. R.; Goto, N. K.; Kay, L. E. J. Biomol. NMR 1998, 12, 325. 
(140)Chou, J. J.; Li, S.; Bax, A. J. Biomol. NMR 2000, 18, 217. 
(141)Schwieters, C. D.; Kuszewski, J. J.; Clore, G. M. Progress in Nuclear Magnetic 
Resonance Spectroscopy 2006, 48, 47. 
(142)N.Tochio, S. K., K.Saito, T.Tomizawa, S.Watanabe, T. Harada,  T. Kigawa, S. 
Yokoyama; Structural Genomics Proteomics Initiative, Ed. 2007. 
(143)Cornilescu, G.; Delaglio, F.; Bax, A. J. Biomol. NMR 1999, 13, 289. 
(144)Pettersen, E. F.; Goddard, T. D.; Huang, C. C.; Couch, G. S.; Greenblatt, D. M.; 
Meng, E. C.; Ferrin, T. E. Journal of Computational Chemistry 2004, 25, 1605. 
(145)Hurley, J. H.; Newton, A. C.; Parker, P. J.; Blumberg, P. M.; Nishizuka, Y. Protein 
Sci. 1997, 6, 477. 
(146)Kazanietz, M. G.; Wang, S.; Milne, G. W.; Lewin, N. E.; Liu, H. L.; Blumberg, P. 
M. J. Biol. Chem. 1995, 270, 21852. 
(147)Pace, C. N.; Grimsley, G. R.; Scholtz, J. M. J. Biol. Chem. 2009, 284, 13285. 
(148)Schubert, M.; Poon, D. K.; Wicki, J.; Tarling, C. A.; Kwan, E. M.; Nielsen, J. E.; 
Withers, S. G.; McIntosh, L. P. Biochemistry 2007, 46, 7383. 
 177 
 
(149)Pelton, J. G.; Torchia, D. A.; Meadow, N. D.; Roseman, S. Protein Sci. 1993, 2, 
543. 
(150)Schmiedeskamp, M.; Rajagopal, P.; Klevit, R. E. Protein Sci. 1997, 6, 1835. 
(151)Gooley, P. R.; Johnson, B. A.; Marcy, A. I.; Cuca, G. C.; Salowe, S. P.; Hagmann, 
W. K.; Esser, C. K.; Springer, J. P. Biochemistry 1993, 32, 13098. 
(152)Urbani, A.; Bazzo, R.; Nardi, M. C.; Cicero, D. O.; De Francesco, R.; Steinkuhler, 
C.; Barbato, G. J. Biol. Chem. 1998, 273, 18760. 
(153)Fabris, D.; Zaia, J.; Hathout, Y.; Fenselau, C. J. Am. Chem. Soc. 1996, 118, 12242. 
(154)Larabee, J. L.; Hocker, J. R.; Hanas, J. S. Arch. Biochem. Biophys. 2005, 434, 139. 
(155)Dudev, T.; Lim, C. J. Am. Chem. Soc. 2002, 124, 6759. 
(156)Simonson, T.; Calimet, N. Proteins 2002, 49, 37. 
(157)Kiefer, L. L.; Fierke, C. A. Biochemistry 1994, 33, 15233. 
(158)Parkin, G. Chemical Reviews 2004, 104, 699. 
(159)Baxter, N. J.; Williamson, M. P. J. Biomol. NMR 1997, 9, 359. 
(160)Skalicky, J. J.; Selsted, M. E.; Pardi, A. Proteins-Structure Function and Genetics 
1994, 20, 52. 
(161)Maret, W.; Li, Y. ChemInform 2010, 41. 
(162)Cornilescu, C. C.; Porter, F. W.; Zhao, K. Q.; Palmenberg, A. C.; Markley, J. L. 
FEBS Lett. 2008, 582, 896. 
(163)Clore, G. M.; Omichinski, J. G.; Gronenborn, A. M. J. Am. Chem. Soc. 1991, 113, 
4350. 
 
 
